AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
142.5|148.7|145.6|8592|All ICCC Groups Combined|59151007|0-14|All Races|Male and Female|1999|||
43.5|46.9|45.2|2669|I Leukemias, myeloproliferative & myelodysplastic diseases|59151007|0-14|All Races|Male and Female|1999|||
33.9|37.0|35.4|2095|I(a) Lymphoid leukemias|59151007|0-14|All Races|Male and Female|1999|||
6.8|8.3|7.5|444|I(b) Acute myeloid leukemias|59151007|0-14|All Races|Male and Female|1999|||
0.4|0.9|0.6|37|I(c) Chronic myeloproliferative diseases|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59151007|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|82|I(e) Unspecified and other specified leukemias|59151007|0-14|All Races|Male and Female|1999|||
14.4|16.4|15.4|908|II Lymphomas and reticuloendothelial neoplasms|59151007|0-14|All Races|Male and Female|1999|||
4.9|6.1|5.5|324|II(a) Hodgkin lymphomas|59151007|0-14|All Races|Male and Female|1999|||
5.4|6.6|6.0|353|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59151007|0-14|All Races|Male and Female|1999|||
2.1|2.9|2.5|149|II(c) Burkitt lymphoma|59151007|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|54|II(d) Miscellaneous lymphoreticular neoplasms|59151007|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|II(e) Unspecified lymphomas|59151007|0-14|All Races|Male and Female|1999|||
30.4|33.3|31.8|1881|III CNS and misc intracranial and intraspinal neoplasms|59151007|0-14|All Races|Male and Female|1999|||
2.6|3.5|3.0|177|III(a) Ependymomas and choroid plexus tumor|59151007|0-14|All Races|Male and Female|1999|||
13.6|15.5|14.5|858|III(b) Astrocytomas|59151007|0-14|All Races|Male and Female|1999|||
7.2|8.6|7.9|465|III(c) Intracranial and intraspinal embryonal tumors|59151007|0-14|All Races|Male and Female|1999|||
4.7|5.8|5.2|310|III(d) Other gliomas|59151007|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|30|III(e) Other specified intracranial & intraspinal neoplasms|59151007|0-14|All Races|Male and Female|1999|||
0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|59151007|0-14|All Races|Male and Female|1999|||
9.8|11.5|10.7|626|IV Neuroblastoma and other peripheral nervous cell tumors|59151007|0-14|All Races|Male and Female|1999|||
9.7|11.4|10.5|616|IV(a) Neuroblastoma and ganglioneuroblastoma|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59151007|0-14|All Races|Male and Female|1999|||
8.7|10.3|9.5|559|IX Soft tissue and other extraosseous sarcomas|59151007|0-14|All Races|Male and Female|1999|||
4.4|5.5|4.9|291|IX(a) Rhabdomyosarcomas|59151007|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|55|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|IX(c) Kaposi sarcoma|59151007|0-14|All Races|Male and Female|1999|||
2.3|3.1|2.7|157|IX(d) Other specified soft tissue sarcomas|59151007|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|55|IX(e) Unspecified soft tissue sarcomas|59151007|0-14|All Races|Male and Female|1999|||
0.2|0.4|0.3|16|Not classified by ICCC|59151007|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|247|V Retinoblastoma|59151007|0-14|All Races|Male and Female|1999|||
7.3|8.8|8.0|474|VI Renal tumors|59151007|0-14|All Races|Male and Female|1999|||
6.9|8.3|7.6|448|VI(a) Nephroblastoma and other nonepithelial renal tumors|59151007|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59151007|0-14|All Races|Male and Female|1999|||
1.7|2.5|2.1|122|VII Hepatic tumors|59151007|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.7|101|VII(a) Hepatoblastoma|59151007|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.4|21|VII(b) Hepatic carcinomas|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59151007|0-14|All Races|Male and Female|1999|||
6.5|7.9|7.1|422|VIII Malignant bone tumors|59151007|0-14|All Races|Male and Female|1999|||
3.7|4.7|4.2|247|VIII(a) Osteosarcomas|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(b) Chondrosarcomas|59151007|0-14|All Races|Male and Female|1999|||
2.0|2.8|2.3|138|VIII(c) Ewing tumor and related sarcomas of bone|59151007|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|19|VIII(d) Other specified malignant bone tumors|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59151007|0-14|All Races|Male and Female|1999|||
4.4|5.6|5.0|292|X Germ cell, trophoblastic tumors & neoplasms of gonads|59151007|0-14|All Races|Male and Female|1999|||
1.0|1.6|1.3|76|X(a) Intracranial & intraspinal germ cell tumors|59151007|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|79|X(b) Malignant extracranial & extragonadal germ cell tumors|59151007|0-14|All Races|Male and Female|1999|||
1.8|2.5|2.1|125|X(c) Malignant gonadal germ cell tumors|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(d) Gonadal carcinomas|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59151007|0-14|All Races|Male and Female|1999|||
5.3|6.5|5.9|345|XI Other malignant epithelial neoplasms and malignant melanomas|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(a) Adrenocortical carcinomas|59151007|0-14|All Races|Male and Female|1999|||
1.5|2.2|1.9|110|XI(b) Thyroid carcinomas|59151007|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|23|XI(c) Nasopharyngeal carcinomas|59151007|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.8|104|XI(d) Malignant melanomas|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(e) Skin carcinomas|59151007|0-14|All Races|Male and Female|1999|||
1.2|1.9|1.5|90|XI(f) Other and unspecified carcinomas|59151007|0-14|All Races|Male and Female|1999|||
0.4|0.7|0.5|31|XII Other and unspecified malignant neoplasms|59151007|0-14|All Races|Male and Female|1999|||
~|~|~|~|XII(a) Other specified malignant tumors|59151007|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|20|XII(b) Other unspecified malignant tumors|59151007|0-14|All Races|Male and Female|1999|||
146.7|152.9|149.8|8888|All ICCC Groups Combined|59476204|0-14|All Races|Male and Female|2000|||
44.2|47.7|45.9|2721|I Leukemias, myeloproliferative & myelodysplastic diseases|59476204|0-14|All Races|Male and Female|2000|||
35.5|38.6|37.1|2194|I(a) Lymphoid leukemias|59476204|0-14|All Races|Male and Female|2000|||
6.0|7.3|6.6|392|I(b) Acute myeloid leukemias|59476204|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|44|I(c) Chronic myeloproliferative diseases|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59476204|0-14|All Races|Male and Female|2000|||
1.1|1.7|1.4|82|I(e) Unspecified and other specified leukemias|59476204|0-14|All Races|Male and Female|2000|||
15.5|17.6|16.5|986|II Lymphomas and reticuloendothelial neoplasms|59476204|0-14|All Races|Male and Female|2000|||
5.2|6.5|5.8|348|II(a) Hodgkin lymphomas|59476204|0-14|All Races|Male and Female|2000|||
5.4|6.6|6.0|357|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59476204|0-14|All Races|Male and Female|2000|||
2.4|3.3|2.8|168|II(c) Burkitt lymphoma|59476204|0-14|All Races|Male and Female|2000|||
1.0|1.6|1.3|76|II(d) Miscellaneous lymphoreticular neoplasms|59476204|0-14|All Races|Male and Female|2000|||
0.4|0.9|0.6|37|II(e) Unspecified lymphomas|59476204|0-14|All Races|Male and Female|2000|||
31.7|34.7|33.2|1970|III CNS and misc intracranial and intraspinal neoplasms|59476204|0-14|All Races|Male and Female|2000|||
2.3|3.1|2.7|157|III(a) Ependymomas and choroid plexus tumor|59476204|0-14|All Races|Male and Female|2000|||
16.1|18.2|17.1|1019|III(b) Astrocytomas|59476204|0-14|All Races|Male and Female|2000|||
6.8|8.2|7.5|446|III(c) Intracranial and intraspinal embryonal tumors|59476204|0-14|All Races|Male and Female|2000|||
4.1|5.2|4.7|277|III(d) Other gliomas|59476204|0-14|All Races|Male and Female|2000|||
0.3|0.7|0.5|29|III(e) Other specified intracranial & intraspinal neoplasms|59476204|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|42|III(f) Unspecified intracranial and intraspinal neoplasms|59476204|0-14|All Races|Male and Female|2000|||
9.3|10.9|10.1|595|IV Neuroblastoma and other peripheral nervous cell tumors|59476204|0-14|All Races|Male and Female|2000|||
9.2|10.8|10.0|587|IV(a) Neuroblastoma and ganglioneuroblastoma|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59476204|0-14|All Races|Male and Female|2000|||
9.6|11.3|10.4|618|IX Soft tissue and other extraosseous sarcomas|59476204|0-14|All Races|Male and Female|2000|||
4.7|5.8|5.2|310|IX(a) Rhabdomyosarcomas|59476204|0-14|All Races|Male and Female|2000|||
0.7|1.2|0.9|56|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|IX(c) Kaposi sarcoma|59476204|0-14|All Races|Male and Female|2000|||
2.7|3.7|3.2|190|IX(d) Other specified soft tissue sarcomas|59476204|0-14|All Races|Male and Female|2000|||
0.8|1.3|1.0|61|IX(e) Unspecified soft tissue sarcomas|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|Not classified by ICCC|59476204|0-14|All Races|Male and Female|2000|||
3.8|4.9|4.4|257|V Retinoblastoma|59476204|0-14|All Races|Male and Female|2000|||
8.1|9.6|8.8|520|VI Renal tumors|59476204|0-14|All Races|Male and Female|2000|||
7.7|9.2|8.4|497|VI(a) Nephroblastoma and other nonepithelial renal tumors|59476204|0-14|All Races|Male and Female|2000|||
0.2|0.6|0.4|22|VI(b) Renal carcinomas|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59476204|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|130|VII Hepatic tumors|59476204|0-14|All Races|Male and Female|2000|||
1.6|2.3|1.9|114|VII(a) Hepatoblastoma|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(b) Hepatic carcinomas|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59476204|0-14|All Races|Male and Female|2000|||
5.9|7.2|6.5|389|VIII Malignant bone tumors|59476204|0-14|All Races|Male and Female|2000|||
3.1|4.1|3.6|213|VIII(a) Osteosarcomas|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(b) Chondrosarcomas|59476204|0-14|All Races|Male and Female|2000|||
2.2|3.1|2.6|156|VIII(c) Ewing tumor and related sarcomas of bone|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59476204|0-14|All Races|Male and Female|2000|||
4.4|5.6|5.0|297|X Germ cell, trophoblastic tumors & neoplasms of gonads|59476204|0-14|All Races|Male and Female|2000|||
1.2|1.8|1.5|88|X(a) Intracranial & intraspinal germ cell tumors|59476204|0-14|All Races|Male and Female|2000|||
0.9|1.4|1.1|66|X(b) Malignant extracranial & extragonadal germ cell tumors|59476204|0-14|All Races|Male and Female|2000|||
1.9|2.6|2.2|133|X(c) Malignant gonadal germ cell tumors|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(d) Gonadal carcinomas|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59476204|0-14|All Races|Male and Female|2000|||
5.2|6.5|5.8|347|XI Other malignant epithelial neoplasms and malignant melanomas|59476204|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|18|XI(a) Adrenocortical carcinomas|59476204|0-14|All Races|Male and Female|2000|||
1.6|2.3|1.9|114|XI(b) Thyroid carcinomas|59476204|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|20|XI(c) Nasopharyngeal carcinomas|59476204|0-14|All Races|Male and Female|2000|||
1.4|2.1|1.8|105|XI(d) Malignant melanomas|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|XI(e) Skin carcinomas|59476204|0-14|All Races|Male and Female|2000|||
1.2|1.8|1.5|87|XI(f) Other and unspecified carcinomas|59476204|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|59476204|0-14|All Races|Male and Female|2000|||
~|~|~|~|XII(a) Other specified malignant tumors|59476204|0-14|All Races|Male and Female|2000|||
0.4|0.7|0.5|31|XII(b) Other unspecified malignant tumors|59476204|0-14|All Races|Male and Female|2000|||
152.9|159.3|156.1|9328|All ICCC Groups Combined|59815030|0-14|All Races|Male and Female|2001|||
48.7|52.3|50.5|3002|I Leukemias, myeloproliferative & myelodysplastic diseases|59815030|0-14|All Races|Male and Female|2001|||
37.1|40.3|38.7|2294|I(a) Lymphoid leukemias|59815030|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|437|I(b) Acute myeloid leukemias|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|100|I(c) Chronic myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.6|96|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|75|I(e) Unspecified and other specified leukemias|59815030|0-14|All Races|Male and Female|2001|||
15.0|17.1|16.0|965|II Lymphomas and reticuloendothelial neoplasms|59815030|0-14|All Races|Male and Female|2001|||
5.3|6.6|5.9|357|II(a) Hodgkin lymphomas|59815030|0-14|All Races|Male and Female|2001|||
5.8|7.1|6.4|387|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59815030|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|135|II(c) Burkitt lymphoma|59815030|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|62|II(d) Miscellaneous lymphoreticular neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.3|0.6|0.4|24|II(e) Unspecified lymphomas|59815030|0-14|All Races|Male and Female|2001|||
31.4|34.4|32.9|1961|III CNS and misc intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
2.4|3.3|2.8|167|III(a) Ependymomas and choroid plexus tumor|59815030|0-14|All Races|Male and Female|2001|||
15.3|17.4|16.3|975|III(b) Astrocytomas|59815030|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|435|III(c) Intracranial and intraspinal embryonal tumors|59815030|0-14|All Races|Male and Female|2001|||
4.8|6.0|5.4|321|III(d) Other gliomas|59815030|0-14|All Races|Male and Female|2001|||
0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|21|III(f) Unspecified intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
10.7|12.5|11.6|692|IV Neuroblastoma and other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001|||
10.6|12.3|11.4|684|IV(a) Neuroblastoma and ganglioneuroblastoma|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001|||
9.7|11.3|10.5|628|IX Soft tissue and other extraosseous sarcomas|59815030|0-14|All Races|Male and Female|2001|||
4.6|5.8|5.2|307|IX(a) Rhabdomyosarcomas|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|IX(c) Kaposi sarcoma|59815030|0-14|All Races|Male and Female|2001|||
2.6|3.5|3.1|185|IX(d) Other specified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|60|IX(e) Unspecified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|Not classified by ICCC|59815030|0-14|All Races|Male and Female|2001|||
3.9|5.0|4.4|265|V Retinoblastoma|59815030|0-14|All Races|Male and Female|2001|||
7.9|9.4|8.6|510|VI Renal tumors|59815030|0-14|All Races|Male and Female|2001|||
7.5|9.0|8.2|488|VI(a) Nephroblastoma and other nonepithelial renal tumors|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59815030|0-14|All Races|Male and Female|2001|||
1.8|2.5|2.1|126|VII Hepatic tumors|59815030|0-14|All Races|Male and Female|2001|||
1.4|2.0|1.7|100|VII(a) Hepatoblastoma|59815030|0-14|All Races|Male and Female|2001|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59815030|0-14|All Races|Male and Female|2001|||
6.3|7.7|7.0|421|VIII Malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
3.3|4.3|3.8|231|VIII(a) Osteosarcomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(b) Chondrosarcomas|59815030|0-14|All Races|Male and Female|2001|||
2.2|3.1|2.6|159|VIII(c) Ewing tumor and related sarcomas of bone|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
4.5|5.6|5.0|303|X Germ cell, trophoblastic tumors & neoplasms of gonads|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|79|X(a) Intracranial & intraspinal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
1.1|1.7|1.4|84|X(b) Malignant extracranial & extragonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|121|X(c) Malignant gonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(d) Gonadal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59815030|0-14|All Races|Male and Female|2001|||
6.0|7.3|6.6|400|XI Other malignant epithelial neoplasms and malignant melanomas|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|17|XI(a) Adrenocortical carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|140|XI(b) Thyroid carcinomas|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|121|XI(d) Malignant melanomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(e) Skin carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|100|XI(f) Other and unspecified carcinomas|59815030|0-14|All Races|Male and Female|2001|||
0.5|1.0|0.7|43|XII Other and unspecified malignant neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|XII(a) Other specified malignant tumors|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.4|21|XII(b) Other unspecified malignant tumors|59815030|0-14|All Races|Male and Female|2001|||
152.0|158.4|155.2|9298|All ICCC Groups Combined|59931314|0-14|All Races|Male and Female|2002|||
47.7|51.3|49.4|2951|I Leukemias, myeloproliferative & myelodysplastic diseases|59931314|0-14|All Races|Male and Female|2002|||
35.5|38.6|37.0|2205|I(a) Lymphoid leukemias|59931314|0-14|All Races|Male and Female|2002|||
7.2|8.6|7.9|475|I(b) Acute myeloid leukemias|59931314|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|96|I(c) Chronic myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002|||
1.1|1.7|1.3|80|I(e) Unspecified and other specified leukemias|59931314|0-14|All Races|Male and Female|2002|||
14.7|16.7|15.7|947|II Lymphomas and reticuloendothelial neoplasms|59931314|0-14|All Races|Male and Female|2002|||
4.9|6.1|5.5|336|II(a) Hodgkin lymphomas|59931314|0-14|All Races|Male and Female|2002|||
5.5|6.7|6.1|365|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59931314|0-14|All Races|Male and Female|2002|||
2.3|3.2|2.7|164|II(c) Burkitt lymphoma|59931314|0-14|All Races|Male and Female|2002|||
0.9|1.5|1.2|70|II(d) Miscellaneous lymphoreticular neoplasms|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|II(e) Unspecified lymphomas|59931314|0-14|All Races|Male and Female|2002|||
33.1|36.1|34.6|2063|III CNS and misc intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002|||
3.1|4.1|3.6|215|III(a) Ependymomas and choroid plexus tumor|59931314|0-14|All Races|Male and Female|2002|||
15.5|17.5|16.5|984|III(b) Astrocytomas|59931314|0-14|All Races|Male and Female|2002|||
6.7|8.1|7.4|442|III(c) Intracranial and intraspinal embryonal tumors|59931314|0-14|All Races|Male and Female|2002|||
5.3|6.6|5.9|354|III(d) Other gliomas|59931314|0-14|All Races|Male and Female|2002|||
0.5|1.0|0.7|43|III(e) Other specified intracranial & intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|25|III(f) Unspecified intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002|||
10.2|11.9|11.1|662|IV Neuroblastoma and other peripheral nervous cell tumors|59931314|0-14|All Races|Male and Female|2002|||
10.1|11.8|10.9|654|IV(a) Neuroblastoma and ganglioneuroblastoma|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59931314|0-14|All Races|Male and Female|2002|||
10.0|11.7|10.8|650|IX Soft tissue and other extraosseous sarcomas|59931314|0-14|All Races|Male and Female|2002|||
4.8|6.0|5.3|319|IX(a) Rhabdomyosarcomas|59931314|0-14|All Races|Male and Female|2002|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|IX(c) Kaposi sarcoma|59931314|0-14|All Races|Male and Female|2002|||
3.0|3.9|3.4|208|IX(d) Other specified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002|||
0.7|1.2|0.9|54|IX(e) Unspecified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.4|21|Not classified by ICCC|59931314|0-14|All Races|Male and Female|2002|||
3.3|4.3|3.8|225|V Retinoblastoma|59931314|0-14|All Races|Male and Female|2002|||
7.6|9.1|8.3|493|VI Renal tumors|59931314|0-14|All Races|Male and Female|2002|||
7.3|8.8|8.1|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(b) Renal carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59931314|0-14|All Races|Male and Female|2002|||
1.6|2.3|1.9|114|VII Hepatic tumors|59931314|0-14|All Races|Male and Female|2002|||
1.2|1.9|1.5|92|VII(a) Hepatoblastoma|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|21|VII(b) Hepatic carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59931314|0-14|All Races|Male and Female|2002|||
6.2|7.6|6.9|416|VIII Malignant bone tumors|59931314|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.6|222|VIII(a) Osteosarcomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(b) Chondrosarcomas|59931314|0-14|All Races|Male and Female|2002|||
2.2|3.0|2.6|157|VIII(c) Ewing tumor and related sarcomas of bone|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.6|0.4|22|VIII(d) Other specified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002|||
4.7|5.9|5.2|318|X Germ cell, trophoblastic tumors & neoplasms of gonads|59931314|0-14|All Races|Male and Female|2002|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|59931314|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|88|X(b) Malignant extracranial & extragonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002|||
1.9|2.6|2.2|134|X(c) Malignant gonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(d) Gonadal carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59931314|0-14|All Races|Male and Female|2002|||
6.0|7.3|6.6|401|XI Other malignant epithelial neoplasms and malignant melanomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(a) Adrenocortical carcinomas|59931314|0-14|All Races|Male and Female|2002|||
1.7|2.4|2.0|123|XI(b) Thyroid carcinomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|59931314|0-14|All Races|Male and Female|2002|||
2.0|2.7|2.3|141|XI(d) Malignant melanomas|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(e) Skin carcinomas|59931314|0-14|All Races|Male and Female|2002|||
1.4|2.0|1.7|103|XI(f) Other and unspecified carcinomas|59931314|0-14|All Races|Male and Female|2002|||
0.4|0.8|0.6|37|XII Other and unspecified malignant neoplasms|59931314|0-14|All Races|Male and Female|2002|||
0.2|0.6|0.4|22|XII(a) Other specified malignant tumors|59931314|0-14|All Races|Male and Female|2002|||
~|~|~|~|XII(b) Other unspecified malignant tumors|59931314|0-14|All Races|Male and Female|2002|||
149.1|155.4|152.2|9249|All ICCC Groups Combined|60628650|0-14|All Races|Male and Female|2003|||
46.0|49.5|47.7|2884|I Leukemias, myeloproliferative & myelodysplastic diseases|60628650|0-14|All Races|Male and Female|2003|||
34.5|37.5|36.0|2167|I(a) Lymphoid leukemias|60628650|0-14|All Races|Male and Female|2003|||
6.8|8.2|7.5|457|I(b) Acute myeloid leukemias|60628650|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.5|90|I(c) Chronic myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|112|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.2|1.0|58|I(e) Unspecified and other specified leukemias|60628650|0-14|All Races|Male and Female|2003|||
15.2|17.2|16.2|985|II Lymphomas and reticuloendothelial neoplasms|60628650|0-14|All Races|Male and Female|2003|||
5.3|6.5|5.8|360|II(a) Hodgkin lymphomas|60628650|0-14|All Races|Male and Female|2003|||
5.7|7.0|6.3|385|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60628650|0-14|All Races|Male and Female|2003|||
2.3|3.2|2.7|163|II(c) Burkitt lymphoma|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|71|II(d) Miscellaneous lymphoreticular neoplasms|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|II(e) Unspecified lymphomas|60628650|0-14|All Races|Male and Female|2003|||
31.5|34.4|32.9|1991|III CNS and misc intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|149|III(a) Ependymomas and choroid plexus tumor|60628650|0-14|All Races|Male and Female|2003|||
15.4|17.5|16.4|995|III(b) Astrocytomas|60628650|0-14|All Races|Male and Female|2003|||
6.5|7.9|7.2|434|III(c) Intracranial and intraspinal embryonal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.0|6.2|5.6|339|III(d) Other gliomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.1|0.9|52|III(e) Other specified intracranial & intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.4|22|III(f) Unspecified intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
9.9|11.6|10.7|652|IV Neuroblastoma and other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.7|11.4|10.5|642|IV(a) Neuroblastoma and ganglioneuroblastoma|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.9|11.5|10.7|650|IX Soft tissue and other extraosseous sarcomas|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|306|IX(a) Rhabdomyosarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.8|1.3|1.1|64|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IX(c) Kaposi sarcoma|60628650|0-14|All Races|Male and Female|2003|||
3.1|4.1|3.6|220|IX(d) Other specified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|58|IX(e) Unspecified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|Not classified by ICCC|60628650|0-14|All Races|Male and Female|2003|||
3.6|4.6|4.1|249|V Retinoblastoma|60628650|0-14|All Races|Male and Female|2003|||
7.8|9.3|8.6|517|VI Renal tumors|60628650|0-14|All Races|Male and Female|2003|||
7.4|8.9|8.2|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|21|VI(b) Renal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|151|VII Hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
1.7|2.4|2.0|123|VII(a) Hepatoblastoma|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
6.0|7.3|6.6|408|VIII Malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
3.2|4.2|3.7|227|VIII(a) Osteosarcomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(b) Chondrosarcomas|60628650|0-14|All Races|Male and Female|2003|||
1.9|2.6|2.2|137|VIII(c) Ewing tumor and related sarcomas of bone|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|312|X Germ cell, trophoblastic tumors & neoplasms of gonads|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|72|X(a) Intracranial & intraspinal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.4|88|X(b) Malignant extracranial & extragonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|136|X(c) Malignant gonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(d) Gonadal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.7|6.9|6.3|390|XI Other malignant epithelial neoplasms and malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|134|XI(b) Thyroid carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.6|2.3|1.9|119|XI(d) Malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(e) Skin carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.1|1.8|110|XI(f) Other and unspecified carcinomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.0|0.8|47|XII Other and unspecified malignant neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
156.8|163.2|159.9|9742|All ICCC Groups Combined|60651802|0-14|All Races|Male and Female|2004|||
49.4|53.1|51.2|3107|I Leukemias, myeloproliferative & myelodysplastic diseases|60651802|0-14|All Races|Male and Female|2004|||
37.2|40.4|38.8|2347|I(a) Lymphoid leukemias|60651802|0-14|All Races|Male and Female|2004|||
7.3|8.7|8.0|486|I(b) Acute myeloid leukemias|60651802|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|97|I(c) Chronic myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.9|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|84|I(e) Unspecified and other specified leukemias|60651802|0-14|All Races|Male and Female|2004|||
15.1|17.1|16.1|981|II Lymphomas and reticuloendothelial neoplasms|60651802|0-14|All Races|Male and Female|2004|||
4.7|5.9|5.3|324|II(a) Hodgkin lymphomas|60651802|0-14|All Races|Male and Female|2004|||
6.2|7.6|6.9|419|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.4|147|II(c) Burkitt lymphoma|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.3|79|II(d) Miscellaneous lymphoreticular neoplasms|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|II(e) Unspecified lymphomas|60651802|0-14|All Races|Male and Female|2004|||
33.7|36.7|35.1|2125|III CNS and misc intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
2.6|3.4|3.0|181|III(a) Ependymomas and choroid plexus tumor|60651802|0-14|All Races|Male and Female|2004|||
16.5|18.7|17.6|1064|III(b) Astrocytomas|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|471|III(c) Intracranial and intraspinal embryonal tumors|60651802|0-14|All Races|Male and Female|2004|||
4.8|6.0|5.4|325|III(d) Other gliomas|60651802|0-14|All Races|Male and Female|2004|||
0.6|1.1|0.8|49|III(e) Other specified intracranial & intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.4|0.8|0.6|35|III(f) Unspecified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
10.2|11.9|11.1|678|IV Neuroblastoma and other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
10.0|11.7|10.8|663|IV(a) Neuroblastoma and ganglioneuroblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
9.8|11.4|10.6|646|IX Soft tissue and other extraosseous sarcomas|60651802|0-14|All Races|Male and Female|2004|||
4.1|5.2|4.6|282|IX(a) Rhabdomyosarcomas|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.5|1.2|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IX(c) Kaposi sarcoma|60651802|0-14|All Races|Male and Female|2004|||
3.2|4.2|3.6|224|IX(d) Other specified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.8|1.3|1.0|62|IX(e) Unspecified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|Not classified by ICCC|60651802|0-14|All Races|Male and Female|2004|||
3.8|4.9|4.3|266|V Retinoblastoma|60651802|0-14|All Races|Male and Female|2004|||
7.4|8.9|8.1|495|VI Renal tumors|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|472|VI(a) Nephroblastoma and other nonepithelial renal tumors|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60651802|0-14|All Races|Male and Female|2004|||
2.3|3.1|2.7|164|VII Hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.4|145|VII(a) Hepatoblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(b) Hepatic carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
6.5|7.8|7.1|437|VIII Malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
3.6|4.7|4.1|254|VIII(a) Osteosarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.7|2.3|143|VIII(c) Ewing tumor and related sarcomas of bone|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
5.0|6.2|5.6|346|X Germ cell, trophoblastic tumors & neoplasms of gonads|60651802|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|96|X(a) Intracranial & intraspinal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.4|148|X(c) Malignant gonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(d) Gonadal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60651802|0-14|All Races|Male and Female|2004|||
6.5|7.9|7.2|440|XI Other malignant epithelial neoplasms and malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.2|3.1|2.6|162|XI(b) Thyroid carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.4|150|XI(d) Malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|XI(e) Skin carcinomas|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|83|XI(f) Other and unspecified carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.5|0.9|0.7|43|XII Other and unspecified malignant neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
0.3|0.6|0.4|24|XII(b) Other unspecified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
153.0|159.3|156.1|9499|All ICCC Groups Combined|60519046|0-14|All Races|Male and Female|2005|||
47.5|51.1|49.3|2992|I Leukemias, myeloproliferative & myelodysplastic diseases|60519046|0-14|All Races|Male and Female|2005|||
35.9|39.0|37.5|2271|I(a) Lymphoid leukemias|60519046|0-14|All Races|Male and Female|2005|||
6.6|8.0|7.3|445|I(b) Acute myeloid leukemias|60519046|0-14|All Races|Male and Female|2005|||
1.2|1.8|1.4|88|I(c) Chronic myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.4|2.0|1.7|102|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|86|I(e) Unspecified and other specified leukemias|60519046|0-14|All Races|Male and Female|2005|||
15.6|17.7|16.6|1012|II Lymphomas and reticuloendothelial neoplasms|60519046|0-14|All Races|Male and Female|2005|||
5.3|6.5|5.9|360|II(a) Hodgkin lymphomas|60519046|0-14|All Races|Male and Female|2005|||
5.8|7.1|6.4|390|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|0-14|All Races|Male and Female|2005|||
2.2|3.0|2.6|155|II(c) Burkitt lymphoma|60519046|0-14|All Races|Male and Female|2005|||
1.2|1.9|1.5|93|II(d) Miscellaneous lymphoreticular neoplasms|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|II(e) Unspecified lymphomas|60519046|0-14|All Races|Male and Female|2005|||
31.8|34.7|33.3|2009|III CNS and misc intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|200|III(a) Ependymomas and choroid plexus tumor|60519046|0-14|All Races|Male and Female|2005|||
15.7|17.8|16.8|1015|III(b) Astrocytomas|60519046|0-14|All Races|Male and Female|2005|||
6.3|7.7|7.0|422|III(c) Intracranial and intraspinal embryonal tumors|60519046|0-14|All Races|Male and Female|2005|||
4.6|5.7|5.1|307|III(d) Other gliomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|36|III(e) Other specified intracranial & intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
11.0|12.7|11.8|727|IV Neuroblastoma and other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
10.8|12.6|11.7|718|IV(a) Neuroblastoma and ganglioneuroblastoma|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
9.8|11.5|10.6|644|IX Soft tissue and other extraosseous sarcomas|60519046|0-14|All Races|Male and Female|2005|||
4.7|5.9|5.3|320|IX(a) Rhabdomyosarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IX(c) Kaposi sarcoma|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|203|IX(d) Other specified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.6|1.1|0.8|50|IX(e) Unspecified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|18|Not classified by ICCC|60519046|0-14|All Races|Male and Female|2005|||
3.4|4.4|3.9|242|V Retinoblastoma|60519046|0-14|All Races|Male and Female|2005|||
7.5|9.0|8.2|500|VI Renal tumors|60519046|0-14|All Races|Male and Female|2005|||
7.1|8.6|7.8|477|VI(a) Nephroblastoma and other nonepithelial renal tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|145|VII Hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|116|VII(a) Hepatoblastoma|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
6.2|7.5|6.8|416|VIII Malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
3.3|4.2|3.7|227|VIII(a) Osteosarcomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(b) Chondrosarcomas|60519046|0-14|All Races|Male and Female|2005|||
2.1|2.9|2.4|148|VIII(c) Ewing tumor and related sarcomas of bone|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.3|2.0|1.6|100|X(b) Malignant extracranial & extragonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.9|2.6|2.2|138|X(c) Malignant gonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(d) Gonadal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60519046|0-14|All Races|Male and Female|2005|||
6.2|7.5|6.9|420|XI Other malignant epithelial neoplasms and malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.9|2.6|2.2|138|XI(b) Thyroid carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|147|XI(d) Malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(e) Skin carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.5|2.2|1.8|112|XI(f) Other and unspecified carcinomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
156.0|162.3|159.1|9685|All ICCC Groups Combined|60516709|0-14|All Races|Male and Female|2006|||
49.9|53.5|51.7|3143|I Leukemias, myeloproliferative & myelodysplastic diseases|60516709|0-14|All Races|Male and Female|2006|||
37.3|40.5|38.9|2361|I(a) Lymphoid leukemias|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|481|I(b) Acute myeloid leukemias|60516709|0-14|All Races|Male and Female|2006|||
1.5|2.1|1.8|108|I(c) Chronic myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.8|111|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.3|82|I(e) Unspecified and other specified leukemias|60516709|0-14|All Races|Male and Female|2006|||
15.7|17.8|16.8|1017|II Lymphomas and reticuloendothelial neoplasms|60516709|0-14|All Races|Male and Female|2006|||
5.6|6.8|6.2|375|II(a) Hodgkin lymphomas|60516709|0-14|All Races|Male and Female|2006|||
5.8|7.1|6.4|389|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.5|150|II(c) Burkitt lymphoma|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.5|91|II(d) Miscellaneous lymphoreticular neoplasms|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|II(e) Unspecified lymphomas|60516709|0-14|All Races|Male and Female|2006|||
32.7|35.7|34.1|2067|III CNS and misc intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
2.6|3.5|3.1|186|III(a) Ependymomas and choroid plexus tumor|60516709|0-14|All Races|Male and Female|2006|||
15.4|17.5|16.4|994|III(b) Astrocytomas|60516709|0-14|All Races|Male and Female|2006|||
7.0|8.5|7.7|468|III(c) Intracranial and intraspinal embryonal tumors|60516709|0-14|All Races|Male and Female|2006|||
5.2|6.4|5.8|347|III(d) Other gliomas|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
9.5|11.2|10.3|636|IV Neuroblastoma and other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.4|11.1|10.2|630|IV(a) Neuroblastoma and ganglioneuroblastoma|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.9|11.5|10.7|649|IX Soft tissue and other extraosseous sarcomas|60516709|0-14|All Races|Male and Female|2006|||
4.4|5.5|4.9|298|IX(a) Rhabdomyosarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.9|1.4|1.1|68|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IX(c) Kaposi sarcoma|60516709|0-14|All Races|Male and Female|2006|||
3.1|4.0|3.5|215|IX(d) Other specified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|66|IX(e) Unspecified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|Not classified by ICCC|60516709|0-14|All Races|Male and Female|2006|||
3.6|4.6|4.1|253|V Retinoblastoma|60516709|0-14|All Races|Male and Female|2006|||
7.6|9.1|8.3|506|VI Renal tumors|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|21|VI(b) Renal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60516709|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|159|VII Hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
1.8|2.5|2.1|132|VII(a) Hepatoblastoma|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
6.4|7.7|7.0|424|VIII Malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
3.5|4.5|4.0|242|VIII(a) Osteosarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(b) Chondrosarcomas|60516709|0-14|All Races|Male and Female|2006|||
2.0|2.9|2.4|146|VIII(c) Ewing tumor and related sarcomas of bone|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
4.6|5.7|5.1|314|X Germ cell, trophoblastic tumors & neoplasms of gonads|60516709|0-14|All Races|Male and Female|2006|||
1.0|1.6|1.3|77|X(a) Intracranial & intraspinal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.9|1.5|95|X(b) Malignant extracranial & extragonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.7|2.5|2.1|126|X(c) Malignant gonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(d) Gonadal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60516709|0-14|All Races|Male and Female|2006|||
6.9|8.3|7.6|461|XI Other malignant epithelial neoplasms and malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.3|3.1|2.7|163|XI(b) Thyroid carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.0|2.8|2.4|147|XI(d) Malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(e) Skin carcinomas|60516709|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.9|114|XI(f) Other and unspecified carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.5|1.0|0.7|45|XII Other and unspecified malignant neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
159.3|165.8|162.5|9933|All ICCC Groups Combined|60681615|0-14|All Races|Male and Female|2007|||
50.4|54.0|52.2|3183|I Leukemias, myeloproliferative & myelodysplastic diseases|60681615|0-14|All Races|Male and Female|2007|||
38.5|41.7|40.1|2440|I(a) Lymphoid leukemias|60681615|0-14|All Races|Male and Female|2007|||
7.0|8.4|7.7|472|I(b) Acute myeloid leukemias|60681615|0-14|All Races|Male and Female|2007|||
1.4|2.0|1.7|102|I(c) Chronic myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
1.3|1.9|1.6|97|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|72|I(e) Unspecified and other specified leukemias|60681615|0-14|All Races|Male and Female|2007|||
15.7|17.8|16.7|1012|II Lymphomas and reticuloendothelial neoplasms|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|332|II(a) Hodgkin lymphomas|60681615|0-14|All Races|Male and Female|2007|||
6.4|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|0-14|All Races|Male and Female|2007|||
2.3|3.1|2.7|160|II(c) Burkitt lymphoma|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|II(d) Miscellaneous lymphoreticular neoplasms|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|II(e) Unspecified lymphomas|60681615|0-14|All Races|Male and Female|2007|||
34.0|37.0|35.5|2157|III CNS and misc intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
2.5|3.4|2.9|179|III(a) Ependymomas and choroid plexus tumor|60681615|0-14|All Races|Male and Female|2007|||
16.0|18.1|17.1|1036|III(b) Astrocytomas|60681615|0-14|All Races|Male and Female|2007|||
7.0|8.5|7.7|470|III(c) Intracranial and intraspinal embryonal tumors|60681615|0-14|All Races|Male and Female|2007|||
5.9|7.2|6.5|394|III(d) Other gliomas|60681615|0-14|All Races|Male and Female|2007|||
0.6|1.0|0.8|46|III(e) Other specified intracranial & intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
11.0|12.7|11.8|736|IV Neuroblastoma and other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.8|12.5|11.6|724|IV(a) Neuroblastoma and ganglioneuroblastoma|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.2|11.9|11.0|672|IX Soft tissue and other extraosseous sarcomas|60681615|0-14|All Races|Male and Female|2007|||
5.1|6.3|5.7|345|IX(a) Rhabdomyosarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IX(c) Kaposi sarcoma|60681615|0-14|All Races|Male and Female|2007|||
2.9|3.8|3.3|202|IX(d) Other specified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.6|1.1|0.9|52|IX(e) Unspecified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|Not classified by ICCC|60681615|0-14|All Races|Male and Female|2007|||
3.9|4.9|4.4|274|V Retinoblastoma|60681615|0-14|All Races|Male and Female|2007|||
7.9|9.4|8.6|530|VI Renal tumors|60681615|0-14|All Races|Male and Female|2007|||
7.5|8.9|8.2|503|VI(a) Nephroblastoma and other nonepithelial renal tumors|60681615|0-14|All Races|Male and Female|2007|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|159|VII Hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.7|2.3|141|VII(a) Hepatoblastoma|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|VII(b) Hepatic carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
6.2|7.5|6.9|415|VIII Malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
3.2|4.2|3.7|223|VIII(a) Osteosarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(b) Chondrosarcomas|60681615|0-14|All Races|Male and Female|2007|||
2.1|2.9|2.5|151|VIII(c) Ewing tumor and related sarcomas of bone|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60681615|0-14|All Races|Male and Female|2007|||
1.1|1.7|1.4|86|X(a) Intracranial & intraspinal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|157|X(c) Malignant gonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(d) Gonadal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60681615|0-14|All Races|Male and Female|2007|||
6.0|7.3|6.6|404|XI Other malignant epithelial neoplasms and malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.7|2.3|141|XI(b) Thyroid carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.8|2.5|2.1|130|XI(d) Malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(e) Skin carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.4|2.0|1.7|101|XI(f) Other and unspecified carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|0.9|0.7|43|XII Other and unspecified malignant neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.3|0.6|0.4|24|XII(a) Other specified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
162.0|168.5|165.2|10138|All ICCC Groups Combined|60907384|0-14|All Races|Male and Female|2008|||
52.3|56.0|54.1|3321|I Leukemias, myeloproliferative & myelodysplastic diseases|60907384|0-14|All Races|Male and Female|2008|||
39.6|42.8|41.2|2524|I(a) Lymphoid leukemias|60907384|0-14|All Races|Male and Female|2008|||
7.3|8.7|8.0|492|I(b) Acute myeloid leukemias|60907384|0-14|All Races|Male and Female|2008|||
1.8|2.6|2.2|134|I(c) Chronic myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
1.4|2.0|1.7|104|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
0.8|1.4|1.1|67|I(e) Unspecified and other specified leukemias|60907384|0-14|All Races|Male and Female|2008|||
16.2|18.3|17.2|1046|II Lymphomas and reticuloendothelial neoplasms|60907384|0-14|All Races|Male and Female|2008|||
5.7|7.0|6.3|384|II(a) Hodgkin lymphomas|60907384|0-14|All Races|Male and Female|2008|||
6.1|7.5|6.8|410|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|163|II(c) Burkitt lymphoma|60907384|0-14|All Races|Male and Female|2008|||
0.9|1.5|1.2|74|II(d) Miscellaneous lymphoreticular neoplasms|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|II(e) Unspecified lymphomas|60907384|0-14|All Races|Male and Female|2008|||
34.1|37.1|35.6|2174|III CNS and misc intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.1|2.6|162|III(a) Ependymomas and choroid plexus tumor|60907384|0-14|All Races|Male and Female|2008|||
16.6|18.8|17.7|1078|III(b) Astrocytomas|60907384|0-14|All Races|Male and Female|2008|||
7.5|8.9|8.2|502|III(c) Intracranial and intraspinal embryonal tumors|60907384|0-14|All Races|Male and Female|2008|||
5.4|6.7|6.0|366|III(d) Other gliomas|60907384|0-14|All Races|Male and Female|2008|||
0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.5|0.4|22|III(f) Unspecified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
10.1|11.8|11.0|686|IV Neuroblastoma and other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
9.9|11.5|10.7|669|IV(a) Neuroblastoma and ganglioneuroblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|IV(b) Other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
10.3|12.0|11.1|679|IX Soft tissue and other extraosseous sarcomas|60907384|0-14|All Races|Male and Female|2008|||
4.8|5.9|5.3|326|IX(a) Rhabdomyosarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.8|1.3|1.0|62|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|IX(c) Kaposi sarcoma|60907384|0-14|All Races|Male and Female|2008|||
3.0|4.0|3.5|211|IX(d) Other specified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
1.0|1.6|1.3|79|IX(e) Unspecified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.5|0.3|18|Not classified by ICCC|60907384|0-14|All Races|Male and Female|2008|||
3.7|4.8|4.2|268|V Retinoblastoma|60907384|0-14|All Races|Male and Female|2008|||
8.3|9.8|9.0|557|VI Renal tumors|60907384|0-14|All Races|Male and Female|2008|||
7.9|9.3|8.6|532|VI(a) Nephroblastoma and other nonepithelial renal tumors|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.1|2.6|164|VII Hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.6|2.2|140|VII(a) Hepatoblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|24|VII(b) Hepatic carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
6.2|7.6|6.9|416|VIII Malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
3.4|4.4|3.9|233|VIII(a) Osteosarcomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(b) Chondrosarcomas|60907384|0-14|All Races|Male and Female|2008|||
2.1|2.9|2.4|148|VIII(c) Ewing tumor and related sarcomas of bone|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
4.7|5.9|5.3|326|X Germ cell, trophoblastic tumors & neoplasms of gonads|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|89|X(b) Malignant extracranial & extragonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|141|X(c) Malignant gonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(d) Gonadal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60907384|0-14|All Races|Male and Female|2008|||
6.6|8.0|7.3|444|XI Other malignant epithelial neoplasms and malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
0.1|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.0|2.6|158|XI(b) Thyroid carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|140|XI(d) Malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(e) Skin carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.5|2.2|1.8|110|XI(f) Other and unspecified carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.4|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XII(b) Other unspecified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
160.7|167.1|163.8|10066|All ICCC Groups Combined|61087581|0-14|All Races|Male and Female|2009|||
51.0|54.6|52.8|3251|I Leukemias, myeloproliferative & myelodysplastic diseases|61087581|0-14|All Races|Male and Female|2009|||
39.6|42.8|41.2|2539|I(a) Lymphoid leukemias|61087581|0-14|All Races|Male and Female|2009|||
6.6|8.0|7.3|448|I(b) Acute myeloid leukemias|61087581|0-14|All Races|Male and Female|2009|||
1.3|2.0|1.6|99|I(c) Chronic myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
1.2|1.9|1.5|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.4|1.1|70|I(e) Unspecified and other specified leukemias|61087581|0-14|All Races|Male and Female|2009|||
15.9|18.0|16.9|1031|II Lymphomas and reticuloendothelial neoplasms|61087581|0-14|All Races|Male and Female|2009|||
5.2|6.4|5.8|349|II(a) Hodgkin lymphomas|61087581|0-14|All Races|Male and Female|2009|||
6.3|7.7|7.0|424|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|143|II(c) Burkitt lymphoma|61087581|0-14|All Races|Male and Female|2009|||
1.4|2.0|1.7|103|II(d) Miscellaneous lymphoreticular neoplasms|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|II(e) Unspecified lymphomas|61087581|0-14|All Races|Male and Female|2009|||
34.3|37.3|35.8|2192|III CNS and misc intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
2.1|2.9|2.5|155|III(a) Ependymomas and choroid plexus tumor|61087581|0-14|All Races|Male and Female|2009|||
16.9|19.0|17.9|1096|III(b) Astrocytomas|61087581|0-14|All Races|Male and Female|2009|||
7.0|8.4|7.6|468|III(c) Intracranial and intraspinal embryonal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.1|7.4|6.7|409|III(d) Other gliomas|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|30|III(f) Unspecified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
10.0|11.7|10.8|673|IV Neuroblastoma and other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.9|11.5|10.6|663|IV(a) Neuroblastoma and ganglioneuroblastoma|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
10.0|11.7|10.8|661|IX Soft tissue and other extraosseous sarcomas|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.1|4.5|278|IX(a) Rhabdomyosarcomas|61087581|0-14|All Races|Male and Female|2009|||
1.0|1.6|1.3|79|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IX(c) Kaposi sarcoma|61087581|0-14|All Races|Male and Female|2009|||
3.3|4.3|3.8|232|IX(d) Other specified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|72|IX(e) Unspecified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|19|Not classified by ICCC|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.1|4.5|284|V Retinoblastoma|61087581|0-14|All Races|Male and Female|2009|||
8.5|10.0|9.2|573|VI Renal tumors|61087581|0-14|All Races|Male and Female|2009|||
7.9|9.4|8.6|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|36|VI(b) Renal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61087581|0-14|All Races|Male and Female|2009|||
1.8|2.6|2.2|137|VII Hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
1.5|2.2|1.9|116|VII(a) Hepatoblastoma|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
6.4|7.7|7.0|426|VIII Malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
3.5|4.5|4.0|241|VIII(a) Osteosarcomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(b) Chondrosarcomas|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|144|VIII(c) Ewing tumor and related sarcomas of bone|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.6|0.4|23|VIII(d) Other specified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
4.9|6.1|5.5|334|X Germ cell, trophoblastic tumors & neoplasms of gonads|61087581|0-14|All Races|Male and Female|2009|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|74|X(b) Malignant extracranial & extragonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
2.2|3.0|2.6|160|X(c) Malignant gonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(d) Gonadal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.5|7.9|7.2|436|XI Other malignant epithelial neoplasms and malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61087581|0-14|All Races|Male and Female|2009|||
2.5|3.4|2.9|177|XI(b) Thyroid carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|25|XI(c) Nasopharyngeal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.3|2.0|1.6|99|XI(d) Malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(e) Skin carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.6|2.3|1.9|115|XI(f) Other and unspecified carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.6|1.0|0.8|49|XII Other and unspecified malignant neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|21|XII(a) Other specified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|28|XII(b) Other unspecified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
167.7|174.3|171.0|10512|All ICCC Groups Combined|61202423|0-14|All Races|Male and Female|2010|||
52.5|56.2|54.3|3347|I Leukemias, myeloproliferative & myelodysplastic diseases|61202423|0-14|All Races|Male and Female|2010|||
39.4|42.6|41.0|2529|I(a) Lymphoid leukemias|61202423|0-14|All Races|Male and Female|2010|||
7.1|8.5|7.8|478|I(b) Acute myeloid leukemias|61202423|0-14|All Races|Male and Female|2010|||
1.6|2.3|1.9|118|I(c) Chronic myeloproliferative diseases|61202423|0-14|All Races|Male and Female|2010|||
1.6|2.3|1.9|117|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61202423|0-14|All Races|Male and Female|2010|||
1.4|2.1|1.7|105|I(e) Unspecified and other specified leukemias|61202423|0-14|All Races|Male and Female|2010|||
19.0|21.3|20.1|1229|II Lymphomas and reticuloendothelial neoplasms|61202423|0-14|All Races|Male and Female|2010|||
4.8|5.9|5.3|324|II(a) Hodgkin lymphomas|61202423|0-14|All Races|Male and Female|2010|||
6.5|7.9|7.2|437|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61202423|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|150|II(c) Burkitt lymphoma|61202423|0-14|All Races|Male and Female|2010|||
4.5|5.6|5.0|308|II(d) Miscellaneous lymphoreticular neoplasms|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|II(e) Unspecified lymphomas|61202423|0-14|All Races|Male and Female|2010|||
35.3|38.3|36.8|2257|III CNS and misc intracranial and intraspinal neoplasms|61202423|0-14|All Races|Male and Female|2010|||
2.9|3.8|3.3|205|III(a) Ependymomas and choroid plexus tumor|61202423|0-14|All Races|Male and Female|2010|||
17.8|20.0|18.9|1157|III(b) Astrocytomas|61202423|0-14|All Races|Male and Female|2010|||
6.7|8.1|7.4|455|III(c) Intracranial and intraspinal embryonal tumors|61202423|0-14|All Races|Male and Female|2010|||
5.6|6.8|6.2|378|III(d) Other gliomas|61202423|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.6|39|III(e) Other specified intracranial & intraspinal neoplasms|61202423|0-14|All Races|Male and Female|2010|||
0.2|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|61202423|0-14|All Races|Male and Female|2010|||
10.4|12.1|11.2|697|IV Neuroblastoma and other peripheral nervous cell tumors|61202423|0-14|All Races|Male and Female|2010|||
10.2|11.9|11.0|686|IV(a) Neuroblastoma and ganglioneuroblastoma|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61202423|0-14|All Races|Male and Female|2010|||
10.8|12.6|11.7|715|IX Soft tissue and other extraosseous sarcomas|61202423|0-14|All Races|Male and Female|2010|||
5.0|6.2|5.6|344|IX(a) Rhabdomyosarcomas|61202423|0-14|All Races|Male and Female|2010|||
0.6|1.1|0.8|50|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|IX(c) Kaposi sarcoma|61202423|0-14|All Races|Male and Female|2010|||
3.4|4.5|3.9|240|IX(d) Other specified soft tissue sarcomas|61202423|0-14|All Races|Male and Female|2010|||
1.1|1.6|1.3|81|IX(e) Unspecified soft tissue sarcomas|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|Not classified by ICCC|61202423|0-14|All Races|Male and Female|2010|||
4.1|5.1|4.6|284|V Retinoblastoma|61202423|0-14|All Races|Male and Female|2010|||
7.8|9.2|8.5|526|VI Renal tumors|61202423|0-14|All Races|Male and Female|2010|||
7.4|8.9|8.1|506|VI(a) Nephroblastoma and other nonepithelial renal tumors|61202423|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61202423|0-14|All Races|Male and Female|2010|||
2.6|3.5|3.0|186|VII Hepatic tumors|61202423|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|156|VII(a) Hepatoblastoma|61202423|0-14|All Races|Male and Female|2010|||
0.3|0.7|0.5|29|VII(b) Hepatic carcinomas|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61202423|0-14|All Races|Male and Female|2010|||
6.1|7.4|6.7|410|VIII Malignant bone tumors|61202423|0-14|All Races|Male and Female|2010|||
3.2|4.2|3.7|225|VIII(a) Osteosarcomas|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(b) Chondrosarcomas|61202423|0-14|All Races|Male and Female|2010|||
2.0|2.8|2.4|143|VIII(c) Ewing tumor and related sarcomas of bone|61202423|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|21|VIII(d) Other specified malignant bone tumors|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61202423|0-14|All Races|Male and Female|2010|||
5.6|6.8|6.2|378|X Germ cell, trophoblastic tumors & neoplasms of gonads|61202423|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|111|X(a) Intracranial & intraspinal germ cell tumors|61202423|0-14|All Races|Male and Female|2010|||
1.1|1.7|1.4|84|X(b) Malignant extracranial & extragonadal germ cell tumors|61202423|0-14|All Races|Male and Female|2010|||
2.2|3.0|2.6|159|X(c) Malignant gonadal germ cell tumors|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|X(d) Gonadal carcinomas|61202423|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|16|X(e) Other and unspecified malignant gonadal tumors|61202423|0-14|All Races|Male and Female|2010|||
6.4|7.8|7.1|429|XI Other malignant epithelial neoplasms and malignant melanomas|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61202423|0-14|All Races|Male and Female|2010|||
2.5|3.3|2.9|175|XI(b) Thyroid carcinomas|61202423|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|61202423|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|109|XI(d) Malignant melanomas|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(e) Skin carcinomas|61202423|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|109|XI(f) Other and unspecified carcinomas|61202423|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.6|40|XII Other and unspecified malignant neoplasms|61202423|0-14|All Races|Male and Female|2010|||
0.3|0.6|0.4|25|XII(a) Other specified malignant tumors|61202423|0-14|All Races|Male and Female|2010|||
~|~|~|~|XII(b) Other unspecified malignant tumors|61202423|0-14|All Races|Male and Female|2010|||
167.7|174.2|170.9|10499|All ICCC Groups Combined|61176726|0-14|All Races|Male and Female|2011|||
52.5|56.2|54.4|3346|I Leukemias, myeloproliferative & myelodysplastic diseases|61176726|0-14|All Races|Male and Female|2011|||
40.4|43.6|42.0|2586|I(a) Lymphoid leukemias|61176726|0-14|All Races|Male and Female|2011|||
7.0|8.4|7.7|472|I(b) Acute myeloid leukemias|61176726|0-14|All Races|Male and Female|2011|||
1.5|2.2|1.8|112|I(c) Chronic myeloproliferative diseases|61176726|0-14|All Races|Male and Female|2011|||
1.1|1.7|1.3|83|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61176726|0-14|All Races|Male and Female|2011|||
1.2|1.9|1.5|93|I(e) Unspecified and other specified leukemias|61176726|0-14|All Races|Male and Female|2011|||
19.3|21.6|20.4|1246|II Lymphomas and reticuloendothelial neoplasms|61176726|0-14|All Races|Male and Female|2011|||
4.6|5.8|5.2|316|II(a) Hodgkin lymphomas|61176726|0-14|All Races|Male and Female|2011|||
5.8|7.1|6.4|390|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61176726|0-14|All Races|Male and Female|2011|||
2.3|3.1|2.7|162|II(c) Burkitt lymphoma|61176726|0-14|All Races|Male and Female|2011|||
5.3|6.6|5.9|364|II(d) Miscellaneous lymphoreticular neoplasms|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|II(e) Unspecified lymphomas|61176726|0-14|All Races|Male and Female|2011|||
34.7|37.8|36.2|2221|III CNS and misc intracranial and intraspinal neoplasms|61176726|0-14|All Races|Male and Female|2011|||
3.0|3.9|3.4|211|III(a) Ependymomas and choroid plexus tumor|61176726|0-14|All Races|Male and Female|2011|||
17.3|19.5|18.4|1127|III(b) Astrocytomas|61176726|0-14|All Races|Male and Female|2011|||
6.4|7.7|7.0|433|III(c) Intracranial and intraspinal embryonal tumors|61176726|0-14|All Races|Male and Female|2011|||
5.7|7.0|6.3|386|III(d) Other gliomas|61176726|0-14|All Races|Male and Female|2011|||
0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|61176726|0-14|All Races|Male and Female|2011|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|61176726|0-14|All Races|Male and Female|2011|||
10.5|12.2|11.3|701|IV Neuroblastoma and other peripheral nervous cell tumors|61176726|0-14|All Races|Male and Female|2011|||
10.3|12.0|11.1|688|IV(a) Neuroblastoma and ganglioneuroblastoma|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61176726|0-14|All Races|Male and Female|2011|||
10.3|12.0|11.1|683|IX Soft tissue and other extraosseous sarcomas|61176726|0-14|All Races|Male and Female|2011|||
4.6|5.8|5.2|320|IX(a) Rhabdomyosarcomas|61176726|0-14|All Races|Male and Female|2011|||
0.8|1.3|1.0|64|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|IX(c) Kaposi sarcoma|61176726|0-14|All Races|Male and Female|2011|||
3.3|4.3|3.8|230|IX(d) Other specified soft tissue sarcomas|61176726|0-14|All Races|Male and Female|2011|||
0.9|1.4|1.1|67|IX(e) Unspecified soft tissue sarcomas|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|Not classified by ICCC|61176726|0-14|All Races|Male and Female|2011|||
3.7|4.8|4.2|263|V Retinoblastoma|61176726|0-14|All Races|Male and Female|2011|||
8.3|9.8|9.0|557|VI Renal tumors|61176726|0-14|All Races|Male and Female|2011|||
7.9|9.4|8.6|534|VI(a) Nephroblastoma and other nonepithelial renal tumors|61176726|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.4|22|VI(b) Renal carcinomas|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61176726|0-14|All Races|Male and Female|2011|||
2.7|3.6|3.2|196|VII Hepatic tumors|61176726|0-14|All Races|Male and Female|2011|||
2.3|3.1|2.7|167|VII(a) Hepatoblastoma|61176726|0-14|All Races|Male and Female|2011|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61176726|0-14|All Races|Male and Female|2011|||
6.7|8.1|7.4|451|VIII Malignant bone tumors|61176726|0-14|All Races|Male and Female|2011|||
3.6|4.7|4.1|250|VIII(a) Osteosarcomas|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(b) Chondrosarcomas|61176726|0-14|All Races|Male and Female|2011|||
2.4|3.3|2.8|171|VIII(c) Ewing tumor and related sarcomas of bone|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61176726|0-14|All Races|Male and Female|2011|||
4.6|5.7|5.1|314|X Germ cell, trophoblastic tumors & neoplasms of gonads|61176726|0-14|All Races|Male and Female|2011|||
1.2|1.9|1.5|93|X(a) Intracranial & intraspinal germ cell tumors|61176726|0-14|All Races|Male and Female|2011|||
1.0|1.5|1.2|75|X(b) Malignant extracranial & extragonadal germ cell tumors|61176726|0-14|All Races|Male and Female|2011|||
1.8|2.6|2.2|132|X(c) Malignant gonadal germ cell tumors|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(d) Gonadal carcinomas|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61176726|0-14|All Races|Male and Female|2011|||
7.1|8.5|7.7|471|XI Other malignant epithelial neoplasms and malignant melanomas|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61176726|0-14|All Races|Male and Female|2011|||
2.9|3.8|3.3|203|XI(b) Thyroid carcinomas|61176726|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|61176726|0-14|All Races|Male and Female|2011|||
1.7|2.4|2.1|125|XI(d) Malignant melanomas|61176726|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(e) Skin carcinomas|61176726|0-14|All Races|Male and Female|2011|||
1.4|2.1|1.8|107|XI(f) Other and unspecified carcinomas|61176726|0-14|All Races|Male and Female|2011|||
0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|61176726|0-14|All Races|Male and Female|2011|||
0.2|0.4|0.3|17|XII(a) Other specified malignant tumors|61176726|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.4|22|XII(b) Other unspecified malignant tumors|61176726|0-14|All Races|Male and Female|2011|||
166.9|173.4|170.1|10430|All ICCC Groups Combined|61127458|0-14|All Races|Male and Female|2012|||
50.8|54.4|52.6|3231|I Leukemias, myeloproliferative & myelodysplastic diseases|61127458|0-14|All Races|Male and Female|2012|||
38.8|41.9|40.3|2480|I(a) Lymphoid leukemias|61127458|0-14|All Races|Male and Female|2012|||
6.5|7.9|7.2|439|I(b) Acute myeloid leukemias|61127458|0-14|All Races|Male and Female|2012|||
1.4|2.1|1.7|104|I(c) Chronic myeloproliferative diseases|61127458|0-14|All Races|Male and Female|2012|||
1.4|2.0|1.7|102|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61127458|0-14|All Races|Male and Female|2012|||
1.4|2.1|1.7|106|I(e) Unspecified and other specified leukemias|61127458|0-14|All Races|Male and Female|2012|||
20.6|23.0|21.8|1330|II Lymphomas and reticuloendothelial neoplasms|61127458|0-14|All Races|Male and Female|2012|||
5.2|6.4|5.8|351|II(a) Hodgkin lymphomas|61127458|0-14|All Races|Male and Female|2012|||
6.8|8.2|7.5|456|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61127458|0-14|All Races|Male and Female|2012|||
2.0|2.8|2.3|143|II(c) Burkitt lymphoma|61127458|0-14|All Races|Male and Female|2012|||
5.2|6.4|5.8|356|II(d) Miscellaneous lymphoreticular neoplasms|61127458|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|24|II(e) Unspecified lymphomas|61127458|0-14|All Races|Male and Female|2012|||
34.1|37.1|35.6|2180|III CNS and misc intracranial and intraspinal neoplasms|61127458|0-14|All Races|Male and Female|2012|||
2.5|3.4|2.9|181|III(a) Ependymomas and choroid plexus tumor|61127458|0-14|All Races|Male and Female|2012|||
17.8|20.0|18.9|1157|III(b) Astrocytomas|61127458|0-14|All Races|Male and Female|2012|||
6.5|7.8|7.1|438|III(c) Intracranial and intraspinal embryonal tumors|61127458|0-14|All Races|Male and Female|2012|||
4.7|5.9|5.3|322|III(d) Other gliomas|61127458|0-14|All Races|Male and Female|2012|||
0.4|0.8|0.6|37|III(e) Other specified intracranial & intraspinal neoplasms|61127458|0-14|All Races|Male and Female|2012|||
0.5|1.0|0.7|45|III(f) Unspecified intracranial and intraspinal neoplasms|61127458|0-14|All Races|Male and Female|2012|||
10.7|12.4|11.5|709|IV Neuroblastoma and other peripheral nervous cell tumors|61127458|0-14|All Races|Male and Female|2012|||
10.4|12.1|11.3|695|IV(a) Neuroblastoma and ganglioneuroblastoma|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61127458|0-14|All Races|Male and Female|2012|||
10.3|12.0|11.1|681|IX Soft tissue and other extraosseous sarcomas|61127458|0-14|All Races|Male and Female|2012|||
4.5|5.6|5.0|309|IX(a) Rhabdomyosarcomas|61127458|0-14|All Races|Male and Female|2012|||
0.9|1.5|1.2|72|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|IX(c) Kaposi sarcoma|61127458|0-14|All Races|Male and Female|2012|||
3.2|4.2|3.7|223|IX(d) Other specified soft tissue sarcomas|61127458|0-14|All Races|Male and Female|2012|||
1.0|1.5|1.2|75|IX(e) Unspecified soft tissue sarcomas|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|Not classified by ICCC|61127458|0-14|All Races|Male and Female|2012|||
3.9|5.0|4.4|272|V Retinoblastoma|61127458|0-14|All Races|Male and Female|2012|||
7.9|9.4|8.6|531|VI Renal tumors|61127458|0-14|All Races|Male and Female|2012|||
7.5|8.9|8.2|506|VI(a) Nephroblastoma and other nonepithelial renal tumors|61127458|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61127458|0-14|All Races|Male and Female|2012|||
2.9|3.8|3.3|204|VII Hepatic tumors|61127458|0-14|All Races|Male and Female|2012|||
2.4|3.3|2.8|174|VII(a) Hepatoblastoma|61127458|0-14|All Races|Male and Female|2012|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61127458|0-14|All Races|Male and Female|2012|||
6.7|8.0|7.3|445|VIII Malignant bone tumors|61127458|0-14|All Races|Male and Female|2012|||
3.9|5.0|4.4|269|VIII(a) Osteosarcomas|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(b) Chondrosarcomas|61127458|0-14|All Races|Male and Female|2012|||
1.9|2.6|2.2|136|VIII(c) Ewing tumor and related sarcomas of bone|61127458|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61127458|0-14|All Races|Male and Female|2012|||
4.6|5.8|5.2|317|X Germ cell, trophoblastic tumors & neoplasms of gonads|61127458|0-14|All Races|Male and Female|2012|||
1.1|1.7|1.4|84|X(a) Intracranial & intraspinal germ cell tumors|61127458|0-14|All Races|Male and Female|2012|||
1.2|1.9|1.5|93|X(b) Malignant extracranial & extragonadal germ cell tumors|61127458|0-14|All Races|Male and Female|2012|||
1.7|2.5|2.1|126|X(c) Malignant gonadal germ cell tumors|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(d) Gonadal carcinomas|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61127458|0-14|All Races|Male and Female|2012|||
7.0|8.4|7.7|466|XI Other malignant epithelial neoplasms and malignant melanomas|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61127458|0-14|All Races|Male and Female|2012|||
2.8|3.8|3.3|199|XI(b) Thyroid carcinomas|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61127458|0-14|All Races|Male and Female|2012|||
1.6|2.3|1.9|117|XI(d) Malignant melanomas|61127458|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(e) Skin carcinomas|61127458|0-14|All Races|Male and Female|2012|||
1.6|2.3|2.0|119|XI(f) Other and unspecified carcinomas|61127458|0-14|All Races|Male and Female|2012|||
0.6|1.1|0.8|52|XII Other and unspecified malignant neoplasms|61127458|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|25|XII(a) Other specified malignant tumors|61127458|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|61127458|0-14|All Races|Male and Female|2012|||
169.5|176.1|172.8|10571|All ICCC Groups Combined|61087762|0-14|All Races|Male and Female|2013|||
49.5|53.1|51.3|3143|I Leukemias, myeloproliferative & myelodysplastic diseases|61087762|0-14|All Races|Male and Female|2013|||
36.6|39.7|38.1|2337|I(a) Lymphoid leukemias|61087762|0-14|All Races|Male and Female|2013|||
7.2|8.6|7.9|481|I(b) Acute myeloid leukemias|61087762|0-14|All Races|Male and Female|2013|||
1.3|2.0|1.7|101|I(c) Chronic myeloproliferative diseases|61087762|0-14|All Races|Male and Female|2013|||
1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61087762|0-14|All Races|Male and Female|2013|||
1.8|2.6|2.2|132|I(e) Unspecified and other specified leukemias|61087762|0-14|All Races|Male and Female|2013|||
20.7|23.0|21.8|1331|II Lymphomas and reticuloendothelial neoplasms|61087762|0-14|All Races|Male and Female|2013|||
5.0|6.2|5.5|337|II(a) Hodgkin lymphomas|61087762|0-14|All Races|Male and Female|2013|||
6.7|8.1|7.3|448|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087762|0-14|All Races|Male and Female|2013|||
2.0|2.7|2.3|142|II(c) Burkitt lymphoma|61087762|0-14|All Races|Male and Female|2013|||
5.8|7.0|6.4|390|II(d) Miscellaneous lymphoreticular neoplasms|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|II(e) Unspecified lymphomas|61087762|0-14|All Races|Male and Female|2013|||
35.5|38.6|37.1|2266|III CNS and misc intracranial and intraspinal neoplasms|61087762|0-14|All Races|Male and Female|2013|||
2.7|3.6|3.2|194|III(a) Ependymomas and choroid plexus tumor|61087762|0-14|All Races|Male and Female|2013|||
18.5|20.7|19.6|1196|III(b) Astrocytomas|61087762|0-14|All Races|Male and Female|2013|||
6.3|7.6|6.9|422|III(c) Intracranial and intraspinal embryonal tumors|61087762|0-14|All Races|Male and Female|2013|||
5.6|6.9|6.2|380|III(d) Other gliomas|61087762|0-14|All Races|Male and Female|2013|||
0.5|1.0|0.7|45|III(e) Other specified intracranial & intraspinal neoplasms|61087762|0-14|All Races|Male and Female|2013|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|61087762|0-14|All Races|Male and Female|2013|||
11.4|13.1|12.2|751|IV Neuroblastoma and other peripheral nervous cell tumors|61087762|0-14|All Races|Male and Female|2013|||
11.1|12.8|11.9|731|IV(a) Neuroblastoma and ganglioneuroblastoma|61087762|0-14|All Races|Male and Female|2013|||
0.2|0.5|0.3|20|IV(b) Other peripheral nervous cell tumors|61087762|0-14|All Races|Male and Female|2013|||
10.4|12.0|11.2|683|IX Soft tissue and other extraosseous sarcomas|61087762|0-14|All Races|Male and Female|2013|||
4.7|5.9|5.3|322|IX(a) Rhabdomyosarcomas|61087762|0-14|All Races|Male and Female|2013|||
0.9|1.5|1.2|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|IX(c) Kaposi sarcoma|61087762|0-14|All Races|Male and Female|2013|||
3.2|4.2|3.7|226|IX(d) Other specified soft tissue sarcomas|61087762|0-14|All Races|Male and Female|2013|||
0.8|1.3|1.0|61|IX(e) Unspecified soft tissue sarcomas|61087762|0-14|All Races|Male and Female|2013|||
0.1|0.4|0.3|16|Not classified by ICCC|61087762|0-14|All Races|Male and Female|2013|||
3.9|4.9|4.4|269|V Retinoblastoma|61087762|0-14|All Races|Male and Female|2013|||
8.2|9.8|9.0|552|VI Renal tumors|61087762|0-14|All Races|Male and Female|2013|||
7.8|9.3|8.5|525|VI(a) Nephroblastoma and other nonepithelial renal tumors|61087762|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|24|VI(b) Renal carcinomas|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61087762|0-14|All Races|Male and Female|2013|||
2.5|3.4|2.9|179|VII Hepatic tumors|61087762|0-14|All Races|Male and Female|2013|||
2.1|2.9|2.5|151|VII(a) Hepatoblastoma|61087762|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61087762|0-14|All Races|Male and Female|2013|||
6.7|8.1|7.4|450|VIII Malignant bone tumors|61087762|0-14|All Races|Male and Female|2013|||
3.3|4.3|3.8|230|VIII(a) Osteosarcomas|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(b) Chondrosarcomas|61087762|0-14|All Races|Male and Female|2013|||
2.5|3.3|2.9|175|VIII(c) Ewing tumor and related sarcomas of bone|61087762|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|27|VIII(d) Other specified malignant bone tumors|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61087762|0-14|All Races|Male and Female|2013|||
5.2|6.4|5.8|354|X Germ cell, trophoblastic tumors & neoplasms of gonads|61087762|0-14|All Races|Male and Female|2013|||
1.4|2.1|1.7|104|X(a) Intracranial & intraspinal germ cell tumors|61087762|0-14|All Races|Male and Female|2013|||
1.1|1.6|1.3|81|X(b) Malignant extracranial & extragonadal germ cell tumors|61087762|0-14|All Races|Male and Female|2013|||
2.1|2.9|2.4|148|X(c) Malignant gonadal germ cell tumors|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(d) Gonadal carcinomas|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61087762|0-14|All Races|Male and Female|2013|||
8.1|9.6|8.8|537|XI Other malignant epithelial neoplasms and malignant melanomas|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61087762|0-14|All Races|Male and Female|2013|||
3.1|4.1|3.6|219|XI(b) Thyroid carcinomas|61087762|0-14|All Races|Male and Female|2013|||
0.2|0.5|0.4|22|XI(c) Nasopharyngeal carcinomas|61087762|0-14|All Races|Male and Female|2013|||
1.8|2.5|2.1|130|XI(d) Malignant melanomas|61087762|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(e) Skin carcinomas|61087762|0-14|All Races|Male and Female|2013|||
2.1|2.9|2.5|153|XI(f) Other and unspecified carcinomas|61087762|0-14|All Races|Male and Female|2013|||
0.5|0.9|0.7|40|XII Other and unspecified malignant neoplasms|61087762|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|24|XII(a) Other specified malignant tumors|61087762|0-14|All Races|Male and Female|2013|||
0.1|0.4|0.3|16|XII(b) Other unspecified malignant tumors|61087762|0-14|All Races|Male and Female|2013|||
173.2|179.9|176.5|10802|All ICCC Groups Combined|61078836|0-14|All Races|Male and Female|2014|||
50.5|54.2|52.3|3206|I Leukemias, myeloproliferative & myelodysplastic diseases|61078836|0-14|All Races|Male and Female|2014|||
37.6|40.7|39.1|2398|I(a) Lymphoid leukemias|61078836|0-14|All Races|Male and Female|2014|||
7.2|8.7|7.9|486|I(b) Acute myeloid leukemias|61078836|0-14|All Races|Male and Female|2014|||
1.3|1.9|1.6|97|I(c) Chronic myeloproliferative diseases|61078836|0-14|All Races|Male and Female|2014|||
1.3|2.0|1.6|100|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61078836|0-14|All Races|Male and Female|2014|||
1.7|2.4|2.0|125|I(e) Unspecified and other specified leukemias|61078836|0-14|All Races|Male and Female|2014|||
22.4|24.8|23.6|1438|II Lymphomas and reticuloendothelial neoplasms|61078836|0-14|All Races|Male and Female|2014|||
5.0|6.2|5.5|337|II(a) Hodgkin lymphomas|61078836|0-14|All Races|Male and Female|2014|||
7.7|9.2|8.4|514|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61078836|0-14|All Races|Male and Female|2014|||
2.4|3.2|2.8|170|II(c) Burkitt lymphoma|61078836|0-14|All Races|Male and Female|2014|||
5.9|7.2|6.5|399|II(d) Miscellaneous lymphoreticular neoplasms|61078836|0-14|All Races|Male and Female|2014|||
0.2|0.5|0.3|18|II(e) Unspecified lymphomas|61078836|0-14|All Races|Male and Female|2014|||
35.3|38.4|36.8|2253|III CNS and misc intracranial and intraspinal neoplasms|61078836|0-14|All Races|Male and Female|2014|||
2.8|3.7|3.3|200|III(a) Ependymomas and choroid plexus tumor|61078836|0-14|All Races|Male and Female|2014|||
17.9|20.1|19.0|1161|III(b) Astrocytomas|61078836|0-14|All Races|Male and Female|2014|||
6.7|8.1|7.4|453|III(c) Intracranial and intraspinal embryonal tumors|61078836|0-14|All Races|Male and Female|2014|||
5.2|6.4|5.8|352|III(d) Other gliomas|61078836|0-14|All Races|Male and Female|2014|||
0.6|1.1|0.8|51|III(e) Other specified intracranial & intraspinal neoplasms|61078836|0-14|All Races|Male and Female|2014|||
0.4|0.8|0.6|36|III(f) Unspecified intracranial and intraspinal neoplasms|61078836|0-14|All Races|Male and Female|2014|||
11.1|12.9|12.0|735|IV Neuroblastoma and other peripheral nervous cell tumors|61078836|0-14|All Races|Male and Female|2014|||
10.9|12.6|11.7|722|IV(a) Neuroblastoma and ganglioneuroblastoma|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61078836|0-14|All Races|Male and Female|2014|||
10.4|12.1|11.3|689|IX Soft tissue and other extraosseous sarcomas|61078836|0-14|All Races|Male and Female|2014|||
4.4|5.5|4.9|302|IX(a) Rhabdomyosarcomas|61078836|0-14|All Races|Male and Female|2014|||
1.0|1.5|1.2|75|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|IX(c) Kaposi sarcoma|61078836|0-14|All Races|Male and Female|2014|||
3.4|4.4|3.9|237|IX(d) Other specified soft tissue sarcomas|61078836|0-14|All Races|Male and Female|2014|||
1.0|1.5|1.2|74|IX(e) Unspecified soft tissue sarcomas|61078836|0-14|All Races|Male and Female|2014|||
0.2|0.5|0.3|20|Not classified by ICCC|61078836|0-14|All Races|Male and Female|2014|||
3.8|4.9|4.3|268|V Retinoblastoma|61078836|0-14|All Races|Male and Female|2014|||
8.4|10.0|9.2|563|VI Renal tumors|61078836|0-14|All Races|Male and Female|2014|||
8.0|9.5|8.7|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|61078836|0-14|All Races|Male and Female|2014|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61078836|0-14|All Races|Male and Female|2014|||
2.6|3.5|3.0|187|VII Hepatic tumors|61078836|0-14|All Races|Male and Female|2014|||
2.2|3.1|2.6|161|VII(a) Hepatoblastoma|61078836|0-14|All Races|Male and Female|2014|||
0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61078836|0-14|All Races|Male and Female|2014|||
7.2|8.7|7.9|483|VIII Malignant bone tumors|61078836|0-14|All Races|Male and Female|2014|||
3.9|5.0|4.4|267|VIII(a) Osteosarcomas|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|VIII(b) Chondrosarcomas|61078836|0-14|All Races|Male and Female|2014|||
2.3|3.2|2.7|166|VIII(c) Ewing tumor and related sarcomas of bone|61078836|0-14|All Races|Male and Female|2014|||
0.3|0.7|0.5|29|VIII(d) Other specified malignant bone tumors|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61078836|0-14|All Races|Male and Female|2014|||
5.2|6.4|5.7|351|X Germ cell, trophoblastic tumors & neoplasms of gonads|61078836|0-14|All Races|Male and Female|2014|||
1.2|1.8|1.5|90|X(a) Intracranial & intraspinal germ cell tumors|61078836|0-14|All Races|Male and Female|2014|||
1.3|2.0|1.6|101|X(b) Malignant extracranial & extragonadal germ cell tumors|61078836|0-14|All Races|Male and Female|2014|||
1.9|2.7|2.3|139|X(c) Malignant gonadal germ cell tumors|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|X(d) Gonadal carcinomas|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61078836|0-14|All Races|Male and Female|2014|||
8.6|10.2|9.4|570|XI Other malignant epithelial neoplasms and malignant melanomas|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61078836|0-14|All Races|Male and Female|2014|||
3.4|4.5|3.9|239|XI(b) Thyroid carcinomas|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61078836|0-14|All Races|Male and Female|2014|||
1.9|2.6|2.2|136|XI(d) Malignant melanomas|61078836|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(e) Skin carcinomas|61078836|0-14|All Races|Male and Female|2014|||
2.4|3.2|2.8|170|XI(f) Other and unspecified carcinomas|61078836|0-14|All Races|Male and Female|2014|||
0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|61078836|0-14|All Races|Male and Female|2014|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61078836|0-14|All Races|Male and Female|2014|||
0.1|0.4|0.3|16|XII(b) Other unspecified malignant tumors|61078836|0-14|All Races|Male and Female|2014|||
175.7|182.4|179.0|10953|All ICCC Groups Combined|61030138|0-14|All Races|Male and Female|2015|||
53.0|56.8|54.9|3363|I Leukemias, myeloproliferative & myelodysplastic diseases|61030138|0-14|All Races|Male and Female|2015|||
39.9|43.2|41.5|2544|I(a) Lymphoid leukemias|61030138|0-14|All Races|Male and Female|2015|||
7.2|8.7|7.9|486|I(b) Acute myeloid leukemias|61030138|0-14|All Races|Male and Female|2015|||
1.6|2.3|1.9|116|I(c) Chronic myeloproliferative diseases|61030138|0-14|All Races|Male and Female|2015|||
1.2|1.9|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61030138|0-14|All Races|Male and Female|2015|||
1.7|2.4|2.0|124|I(e) Unspecified and other specified leukemias|61030138|0-14|All Races|Male and Female|2015|||
22.1|24.6|23.3|1421|II Lymphomas and reticuloendothelial neoplasms|61030138|0-14|All Races|Male and Female|2015|||
5.4|6.6|6.0|361|II(a) Hodgkin lymphomas|61030138|0-14|All Races|Male and Female|2015|||
6.9|8.2|7.5|458|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61030138|0-14|All Races|Male and Female|2015|||
2.2|3.0|2.5|155|II(c) Burkitt lymphoma|61030138|0-14|All Races|Male and Female|2015|||
6.4|7.7|7.0|430|II(d) Miscellaneous lymphoreticular neoplasms|61030138|0-14|All Races|Male and Female|2015|||
0.2|0.4|0.3|17|II(e) Unspecified lymphomas|61030138|0-14|All Races|Male and Female|2015|||
34.2|37.2|35.7|2180|III CNS and misc intracranial and intraspinal neoplasms|61030138|0-14|All Races|Male and Female|2015|||
2.7|3.6|3.1|192|III(a) Ependymomas and choroid plexus tumor|61030138|0-14|All Races|Male and Female|2015|||
17.1|19.3|18.2|1111|III(b) Astrocytomas|61030138|0-14|All Races|Male and Female|2015|||
6.6|8.0|7.3|447|III(c) Intracranial and intraspinal embryonal tumors|61030138|0-14|All Races|Male and Female|2015|||
5.4|6.6|6.0|363|III(d) Other gliomas|61030138|0-14|All Races|Male and Female|2015|||
0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|61030138|0-14|All Races|Male and Female|2015|||
0.3|0.6|0.4|25|III(f) Unspecified intracranial and intraspinal neoplasms|61030138|0-14|All Races|Male and Female|2015|||
11.4|13.2|12.3|759|IV Neuroblastoma and other peripheral nervous cell tumors|61030138|0-14|All Races|Male and Female|2015|||
11.2|13.0|12.1|746|IV(a) Neuroblastoma and ganglioneuroblastoma|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61030138|0-14|All Races|Male and Female|2015|||
10.5|12.2|11.3|690|IX Soft tissue and other extraosseous sarcomas|61030138|0-14|All Races|Male and Female|2015|||
4.7|5.9|5.3|322|IX(a) Rhabdomyosarcomas|61030138|0-14|All Races|Male and Female|2015|||
0.8|1.4|1.1|67|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|IX(c) Kaposi sarcoma|61030138|0-14|All Races|Male and Female|2015|||
3.3|4.3|3.8|229|IX(d) Other specified soft tissue sarcomas|61030138|0-14|All Races|Male and Female|2015|||
0.9|1.5|1.2|71|IX(e) Unspecified soft tissue sarcomas|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|Not classified by ICCC|61030138|0-14|All Races|Male and Female|2015|||
4.4|5.5|4.9|305|V Retinoblastoma|61030138|0-14|All Races|Male and Female|2015|||
9.0|10.6|9.8|603|VI Renal tumors|61030138|0-14|All Races|Male and Female|2015|||
8.6|10.2|9.4|577|VI(a) Nephroblastoma and other nonepithelial renal tumors|61030138|0-14|All Races|Male and Female|2015|||
0.3|0.6|0.4|24|VI(b) Renal carcinomas|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61030138|0-14|All Races|Male and Female|2015|||
2.8|3.7|3.2|200|VII Hepatic tumors|61030138|0-14|All Races|Male and Female|2015|||
2.4|3.3|2.8|173|VII(a) Hepatoblastoma|61030138|0-14|All Races|Male and Female|2015|||
0.3|0.6|0.4|26|VII(b) Hepatic carcinomas|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61030138|0-14|All Races|Male and Female|2015|||
6.9|8.3|7.5|457|VIII Malignant bone tumors|61030138|0-14|All Races|Male and Female|2015|||
3.4|4.5|3.9|238|VIII(a) Osteosarcomas|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|VIII(b) Chondrosarcomas|61030138|0-14|All Races|Male and Female|2015|||
2.3|3.1|2.7|164|VIII(c) Ewing tumor and related sarcomas of bone|61030138|0-14|All Races|Male and Female|2015|||
0.4|0.7|0.5|32|VIII(d) Other specified malignant bone tumors|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61030138|0-14|All Races|Male and Female|2015|||
4.9|6.1|5.5|336|X Germ cell, trophoblastic tumors & neoplasms of gonads|61030138|0-14|All Races|Male and Female|2015|||
1.3|2.0|1.6|100|X(a) Intracranial & intraspinal germ cell tumors|61030138|0-14|All Races|Male and Female|2015|||
1.1|1.7|1.4|84|X(b) Malignant extracranial & extragonadal germ cell tumors|61030138|0-14|All Races|Male and Female|2015|||
1.9|2.6|2.2|136|X(c) Malignant gonadal germ cell tumors|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|X(d) Gonadal carcinomas|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61030138|0-14|All Races|Male and Female|2015|||
8.8|10.4|9.6|583|XI Other malignant epithelial neoplasms and malignant melanomas|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61030138|0-14|All Races|Male and Female|2015|||
3.0|4.0|3.5|212|XI(b) Thyroid carcinomas|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61030138|0-14|All Races|Male and Female|2015|||
1.7|2.5|2.1|127|XI(d) Malignant melanomas|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|XI(e) Skin carcinomas|61030138|0-14|All Races|Male and Female|2015|||
3.2|4.2|3.7|224|XI(f) Other and unspecified carcinomas|61030138|0-14|All Races|Male and Female|2015|||
0.5|1.0|0.7|46|XII Other and unspecified malignant neoplasms|61030138|0-14|All Races|Male and Female|2015|||
0.4|0.7|0.5|32|XII(a) Other specified malignant tumors|61030138|0-14|All Races|Male and Female|2015|||
~|~|~|~|XII(b) Other unspecified malignant tumors|61030138|0-14|All Races|Male and Female|2015|||
171.5|174.4|173.0|52273|All ICCC Groups Combined|301711217|0-14|All Races|Male and Female|2015-2019|||
52.3|54.0|53.1|16089|I Leukemias, myeloproliferative & myelodysplastic diseases|301711217|0-14|All Races|Male and Female|2015-2019|||
39.6|41.1|40.3|12221|I(a) Lymphoid leukemias|301711217|0-14|All Races|Male and Female|2015-2019|||
7.5|8.1|7.8|2350|I(b) Acute myeloid leukemias|301711217|0-14|All Races|Male and Female|2015-2019|||
1.5|1.8|1.6|492|I(c) Chronic myeloproliferative diseases|301711217|0-14|All Races|Male and Female|2015-2019|||
1.2|1.5|1.3|401|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|301711217|0-14|All Races|Male and Female|2015-2019|||
1.9|2.2|2.1|625|I(e) Unspecified and other specified leukemias|301711217|0-14|All Races|Male and Female|2015-2019|||
21.6|22.7|22.2|6685|II Lymphomas and reticuloendothelial neoplasms|301711217|0-14|All Races|Male and Female|2015-2019|||
5.6|6.1|5.8|1756|II(a) Hodgkin lymphomas|301711217|0-14|All Races|Male and Female|2015-2019|||
7.4|8.0|7.7|2320|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|301711217|0-14|All Races|Male and Female|2015-2019|||
2.3|2.6|2.4|733|II(c) Burkitt lymphoma|301711217|0-14|All Races|Male and Female|2015-2019|||
5.7|6.3|6.0|1818|II(d) Miscellaneous lymphoreticular neoplasms|301711217|0-14|All Races|Male and Female|2015-2019|||
0.1|0.2|0.2|58|II(e) Unspecified lymphomas|301711217|0-14|All Races|Male and Female|2015-2019|||
32.3|33.6|33.0|9955|III CNS and misc intracranial and intraspinal neoplasms|301711217|0-14|All Races|Male and Female|2015-2019|||
2.8|3.2|3.0|894|III(a) Ependymomas and choroid plexus tumor|301711217|0-14|All Races|Male and Female|2015-2019|||
16.3|17.2|16.8|5066|III(b) Astrocytomas|301711217|0-14|All Races|Male and Female|2015-2019|||
5.9|6.5|6.2|1876|III(c) Intracranial and intraspinal embryonal tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
5.6|6.1|5.8|1761|III(d) Other gliomas|301711217|0-14|All Races|Male and Female|2015-2019|||
0.6|0.8|0.7|200|III(e) Other specified intracranial & intraspinal neoplasms|301711217|0-14|All Races|Male and Female|2015-2019|||
0.4|0.6|0.5|158|III(f) Unspecified intracranial and intraspinal neoplasms|301711217|0-14|All Races|Male and Female|2015-2019|||
11.2|11.9|11.6|3498|IV Neuroblastoma and other peripheral nervous cell tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
11.0|11.8|11.4|3450|IV(a) Neuroblastoma and ganglioneuroblastoma|301711217|0-14|All Races|Male and Female|2015-2019|||
0.1|0.2|0.2|48|IV(b) Other peripheral nervous cell tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
10.7|11.5|11.1|3356|IX Soft tissue and other extraosseous sarcomas|301711217|0-14|All Races|Male and Female|2015-2019|||
4.9|5.4|5.2|1567|IX(a) Rhabdomyosarcomas|301711217|0-14|All Races|Male and Female|2015-2019|||
0.9|1.1|1.0|304|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|301711217|0-14|All Races|Male and Female|2015-2019|||
~|~|~|~|IX(c) Kaposi sarcoma|301711217|0-14|All Races|Male and Female|2015-2019|||
3.4|3.8|3.6|1091|IX(d) Other specified soft tissue sarcomas|301711217|0-14|All Races|Male and Female|2015-2019|||
1.2|1.4|1.3|390|IX(e) Unspecified soft tissue sarcomas|301711217|0-14|All Races|Male and Female|2015-2019|||
1.5|1.8|1.7|506|Not classified by ICCC|301711217|0-14|All Races|Male and Female|2015-2019|||
4.0|4.5|4.2|1283|V Retinoblastoma|301711217|0-14|All Races|Male and Female|2015-2019|||
8.3|9.0|8.7|2624|VI Renal tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
7.9|8.5|8.2|2483|VI(a) Nephroblastoma and other nonepithelial renal tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
0.4|0.5|0.4|130|VI(b) Renal carcinomas|301711217|0-14|All Races|Male and Female|2015-2019|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
2.9|3.3|3.1|934|VII Hepatic tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
2.5|2.9|2.7|812|VII(a) Hepatoblastoma|301711217|0-14|All Races|Male and Female|2015-2019|||
0.3|0.4|0.4|110|VII(b) Hepatic carcinomas|301711217|0-14|All Races|Male and Female|2015-2019|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
7.5|8.1|7.8|2343|VIII Malignant bone tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
4.1|4.5|4.3|1297|VIII(a) Osteosarcomas|301711217|0-14|All Races|Male and Female|2015-2019|||
0.1|0.3|0.2|59|VIII(b) Chondrosarcomas|301711217|0-14|All Races|Male and Female|2015-2019|||
2.5|2.8|2.7|801|VIII(c) Ewing tumor and related sarcomas of bone|301711217|0-14|All Races|Male and Female|2015-2019|||
0.4|0.5|0.4|128|VIII(d) Other specified malignant bone tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
0.1|0.2|0.2|58|VIII(e) Unspecified malignant bone tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
5.5|6.0|5.7|1726|X Germ cell, trophoblastic tumors & neoplasms of gonads|301711217|0-14|All Races|Male and Female|2015-2019|||
1.5|1.8|1.7|500|X(a) Intracranial & intraspinal germ cell tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
1.2|1.5|1.4|413|X(b) Malignant extracranial & extragonadal germ cell tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
2.2|2.5|2.4|713|X(c) Malignant gonadal germ cell tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
0.1|0.1|0.1|30|X(d) Gonadal carcinomas|301711217|0-14|All Races|Male and Female|2015-2019|||
0.2|0.3|0.2|70|X(e) Other and unspecified malignant gonadal tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
9.7|10.4|10.0|3023|XI Other malignant epithelial neoplasms and malignant melanomas|301711217|0-14|All Races|Male and Female|2015-2019|||
0.1|0.2|0.2|52|XI(a) Adrenocortical carcinomas|301711217|0-14|All Races|Male and Female|2015-2019|||
3.4|3.9|3.6|1100|XI(b) Thyroid carcinomas|301711217|0-14|All Races|Male and Female|2015-2019|||
0.1|0.2|0.2|57|XI(c) Nasopharyngeal carcinomas|301711217|0-14|All Races|Male and Female|2015-2019|||
1.6|2.0|1.8|541|XI(d) Malignant melanomas|301711217|0-14|All Races|Male and Female|2015-2019|||
~|~|~|~|XI(e) Skin carcinomas|301711217|0-14|All Races|Male and Female|2015-2019|||
3.9|4.4|4.2|1259|XI(f) Other and unspecified carcinomas|301711217|0-14|All Races|Male and Female|2015-2019|||
0.7|0.9|0.8|251|XII Other and unspecified malignant neoplasms|301711217|0-14|All Races|Male and Female|2015-2019|||
0.4|0.6|0.5|147|XII(a) Other specified malignant tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
0.3|0.4|0.3|104|XII(b) Other unspecified malignant tumors|301711217|0-14|All Races|Male and Female|2015-2019|||
174.2|180.9|177.5|10856|All ICCC Groups Combined|61021294|0-14|All Races|Male and Female|2016|||
53.6|57.4|55.5|3399|I Leukemias, myeloproliferative & myelodysplastic diseases|61021294|0-14|All Races|Male and Female|2016|||
40.1|43.3|41.7|2554|I(a) Lymphoid leukemias|61021294|0-14|All Races|Male and Female|2016|||
7.4|8.9|8.1|498|I(b) Acute myeloid leukemias|61021294|0-14|All Races|Male and Female|2016|||
1.8|2.5|2.1|129|I(c) Chronic myeloproliferative diseases|61021294|0-14|All Races|Male and Female|2016|||
1.2|1.8|1.5|90|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61021294|0-14|All Races|Male and Female|2016|||
1.7|2.5|2.1|128|I(e) Unspecified and other specified leukemias|61021294|0-14|All Races|Male and Female|2016|||
21.2|23.6|22.4|1364|II Lymphomas and reticuloendothelial neoplasms|61021294|0-14|All Races|Male and Female|2016|||
5.2|6.4|5.8|352|II(a) Hodgkin lymphomas|61021294|0-14|All Races|Male and Female|2016|||
7.7|9.2|8.5|515|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61021294|0-14|All Races|Male and Female|2016|||
2.0|2.8|2.4|146|II(c) Burkitt lymphoma|61021294|0-14|All Races|Male and Female|2016|||
5.0|6.2|5.5|339|II(d) Miscellaneous lymphoreticular neoplasms|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|II(e) Unspecified lymphomas|61021294|0-14|All Races|Male and Female|2016|||
34.0|37.0|35.5|2168|III CNS and misc intracranial and intraspinal neoplasms|61021294|0-14|All Races|Male and Female|2016|||
2.4|3.3|2.9|175|III(a) Ependymomas and choroid plexus tumor|61021294|0-14|All Races|Male and Female|2016|||
16.3|18.5|17.4|1062|III(b) Astrocytomas|61021294|0-14|All Races|Male and Female|2016|||
6.2|7.5|6.8|418|III(c) Intracranial and intraspinal embryonal tumors|61021294|0-14|All Races|Male and Female|2016|||
6.3|7.7|7.0|425|III(d) Other gliomas|61021294|0-14|All Races|Male and Female|2016|||
0.6|1.1|0.8|51|III(e) Other specified intracranial & intraspinal neoplasms|61021294|0-14|All Races|Male and Female|2016|||
0.4|0.8|0.6|37|III(f) Unspecified intracranial and intraspinal neoplasms|61021294|0-14|All Races|Male and Female|2016|||
10.7|12.4|11.5|711|IV Neuroblastoma and other peripheral nervous cell tumors|61021294|0-14|All Races|Male and Female|2016|||
10.6|12.3|11.4|703|IV(a) Neuroblastoma and ganglioneuroblastoma|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61021294|0-14|All Races|Male and Female|2016|||
10.5|12.2|11.3|692|IX Soft tissue and other extraosseous sarcomas|61021294|0-14|All Races|Male and Female|2016|||
5.1|6.3|5.7|347|IX(a) Rhabdomyosarcomas|61021294|0-14|All Races|Male and Female|2016|||
0.7|1.2|0.9|58|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|IX(c) Kaposi sarcoma|61021294|0-14|All Races|Male and Female|2016|||
3.2|4.1|3.6|221|IX(d) Other specified soft tissue sarcomas|61021294|0-14|All Races|Male and Female|2016|||
0.8|1.4|1.1|65|IX(e) Unspecified soft tissue sarcomas|61021294|0-14|All Races|Male and Female|2016|||
0.2|0.5|0.3|19|Not classified by ICCC|61021294|0-14|All Races|Male and Female|2016|||
3.8|4.8|4.3|264|V Retinoblastoma|61021294|0-14|All Races|Male and Female|2016|||
8.0|9.4|8.7|533|VI Renal tumors|61021294|0-14|All Races|Male and Female|2016|||
7.4|8.9|8.1|501|VI(a) Nephroblastoma and other nonepithelial renal tumors|61021294|0-14|All Races|Male and Female|2016|||
0.3|0.7|0.5|30|VI(b) Renal carcinomas|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61021294|0-14|All Races|Male and Female|2016|||
2.7|3.6|3.1|192|VII Hepatic tumors|61021294|0-14|All Races|Male and Female|2016|||
2.4|3.3|2.9|176|VII(a) Hepatoblastoma|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|VII(b) Hepatic carcinomas|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61021294|0-14|All Races|Male and Female|2016|||
7.4|8.9|8.1|494|VIII Malignant bone tumors|61021294|0-14|All Races|Male and Female|2016|||
3.9|4.9|4.4|266|VIII(a) Osteosarcomas|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|VIII(b) Chondrosarcomas|61021294|0-14|All Races|Male and Female|2016|||
2.5|3.4|3.0|180|VIII(c) Ewing tumor and related sarcomas of bone|61021294|0-14|All Races|Male and Female|2016|||
0.3|0.7|0.5|30|VIII(d) Other specified malignant bone tumors|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61021294|0-14|All Races|Male and Female|2016|||
5.3|6.6|5.9|361|X Germ cell, trophoblastic tumors & neoplasms of gonads|61021294|0-14|All Races|Male and Female|2016|||
1.5|2.2|1.9|114|X(a) Intracranial & intraspinal germ cell tumors|61021294|0-14|All Races|Male and Female|2016|||
1.0|1.6|1.3|81|X(b) Malignant extracranial & extragonadal germ cell tumors|61021294|0-14|All Races|Male and Female|2016|||
2.1|2.9|2.5|150|X(c) Malignant gonadal germ cell tumors|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|X(d) Gonadal carcinomas|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61021294|0-14|All Races|Male and Female|2016|||
9.2|10.8|10.0|608|XI Other malignant epithelial neoplasms and malignant melanomas|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61021294|0-14|All Races|Male and Female|2016|||
3.0|4.0|3.5|211|XI(b) Thyroid carcinomas|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61021294|0-14|All Races|Male and Female|2016|||
1.6|2.3|1.9|116|XI(d) Malignant melanomas|61021294|0-14|All Races|Male and Female|2016|||
~|~|~|~|XI(e) Skin carcinomas|61021294|0-14|All Races|Male and Female|2016|||
3.7|4.8|4.2|256|XI(f) Other and unspecified carcinomas|61021294|0-14|All Races|Male and Female|2016|||
0.6|1.1|0.8|51|XII Other and unspecified malignant neoplasms|61021294|0-14|All Races|Male and Female|2016|||
0.4|0.8|0.5|33|XII(a) Other specified malignant tumors|61021294|0-14|All Races|Male and Female|2016|||
0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|61021294|0-14|All Races|Male and Female|2016|||
169.9|176.6|173.2|10592|All ICCC Groups Combined|61008778|0-14|All Races|Male and Female|2017|||
50.2|53.8|52.0|3185|I Leukemias, myeloproliferative & myelodysplastic diseases|61008778|0-14|All Races|Male and Female|2017|||
37.8|40.9|39.3|2413|I(a) Lymphoid leukemias|61008778|0-14|All Races|Male and Female|2017|||
7.0|8.4|7.6|467|I(b) Acute myeloid leukemias|61008778|0-14|All Races|Male and Female|2017|||
1.4|2.0|1.7|102|I(c) Chronic myeloproliferative diseases|61008778|0-14|All Races|Male and Female|2017|||
1.0|1.6|1.3|80|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61008778|0-14|All Races|Male and Female|2017|||
1.7|2.4|2.0|123|I(e) Unspecified and other specified leukemias|61008778|0-14|All Races|Male and Female|2017|||
21.3|23.7|22.5|1369|II Lymphomas and reticuloendothelial neoplasms|61008778|0-14|All Races|Male and Female|2017|||
5.2|6.4|5.8|353|II(a) Hodgkin lymphomas|61008778|0-14|All Races|Male and Female|2017|||
6.6|8.0|7.3|443|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61008778|0-14|All Races|Male and Female|2017|||
2.2|3.1|2.6|160|II(c) Burkitt lymphoma|61008778|0-14|All Races|Male and Female|2017|||
6.0|7.3|6.6|404|II(d) Miscellaneous lymphoreticular neoplasms|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|II(e) Unspecified lymphomas|61008778|0-14|All Races|Male and Female|2017|||
35.7|38.8|37.3|2276|III CNS and misc intracranial and intraspinal neoplasms|61008778|0-14|All Races|Male and Female|2017|||
3.0|4.0|3.5|212|III(a) Ependymomas and choroid plexus tumor|61008778|0-14|All Races|Male and Female|2017|||
17.9|20.1|19.0|1161|III(b) Astrocytomas|61008778|0-14|All Races|Male and Female|2017|||
6.2|7.6|6.9|420|III(c) Intracranial and intraspinal embryonal tumors|61008778|0-14|All Races|Male and Female|2017|||
6.1|7.4|6.7|411|III(d) Other gliomas|61008778|0-14|All Races|Male and Female|2017|||
0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|61008778|0-14|All Races|Male and Female|2017|||
0.4|0.8|0.6|37|III(f) Unspecified intracranial and intraspinal neoplasms|61008778|0-14|All Races|Male and Female|2017|||
10.1|11.8|10.9|668|IV Neuroblastoma and other peripheral nervous cell tumors|61008778|0-14|All Races|Male and Female|2017|||
10.0|11.6|10.8|660|IV(a) Neuroblastoma and ganglioneuroblastoma|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61008778|0-14|All Races|Male and Female|2017|||
10.2|11.9|11.0|672|IX Soft tissue and other extraosseous sarcomas|61008778|0-14|All Races|Male and Female|2017|||
4.7|5.9|5.3|322|IX(a) Rhabdomyosarcomas|61008778|0-14|All Races|Male and Female|2017|||
0.7|1.1|0.9|53|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|IX(c) Kaposi sarcoma|61008778|0-14|All Races|Male and Female|2017|||
2.8|3.7|3.3|198|IX(d) Other specified soft tissue sarcomas|61008778|0-14|All Races|Male and Female|2017|||
1.3|2.0|1.6|99|IX(e) Unspecified soft tissue sarcomas|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|Not classified by ICCC|61008778|0-14|All Races|Male and Female|2017|||
3.7|4.7|4.2|255|V Retinoblastoma|61008778|0-14|All Races|Male and Female|2017|||
7.8|9.2|8.5|521|VI Renal tumors|61008778|0-14|All Races|Male and Female|2017|||
7.3|8.7|8.0|490|VI(a) Nephroblastoma and other nonepithelial renal tumors|61008778|0-14|All Races|Male and Female|2017|||
0.3|0.7|0.5|29|VI(b) Renal carcinomas|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61008778|0-14|All Races|Male and Female|2017|||
2.4|3.3|2.8|172|VII Hepatic tumors|61008778|0-14|All Races|Male and Female|2017|||
2.0|2.8|2.4|148|VII(a) Hepatoblastoma|61008778|0-14|All Races|Male and Female|2017|||
0.2|0.5|0.3|20|VII(b) Hepatic carcinomas|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61008778|0-14|All Races|Male and Female|2017|||
6.9|8.3|7.5|460|VIII Malignant bone tumors|61008778|0-14|All Races|Male and Female|2017|||
4.0|5.0|4.5|273|VIII(a) Osteosarcomas|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|VIII(b) Chondrosarcomas|61008778|0-14|All Races|Male and Female|2017|||
2.0|2.8|2.4|145|VIII(c) Ewing tumor and related sarcomas of bone|61008778|0-14|All Races|Male and Female|2017|||
0.2|0.5|0.3|21|VIII(d) Other specified malignant bone tumors|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61008778|0-14|All Races|Male and Female|2017|||
5.6|6.8|6.2|377|X Germ cell, trophoblastic tumors & neoplasms of gonads|61008778|0-14|All Races|Male and Female|2017|||
1.5|2.3|1.9|114|X(a) Intracranial & intraspinal germ cell tumors|61008778|0-14|All Races|Male and Female|2017|||
1.2|1.8|1.5|90|X(b) Malignant extracranial & extragonadal germ cell tumors|61008778|0-14|All Races|Male and Female|2017|||
2.0|2.8|2.4|146|X(c) Malignant gonadal germ cell tumors|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|X(d) Gonadal carcinomas|61008778|0-14|All Races|Male and Female|2017|||
0.2|0.5|0.4|22|X(e) Other and unspecified malignant gonadal tumors|61008778|0-14|All Races|Male and Female|2017|||
8.5|10.0|9.2|562|XI Other malignant epithelial neoplasms and malignant melanomas|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61008778|0-14|All Races|Male and Female|2017|||
2.8|3.7|3.2|198|XI(b) Thyroid carcinomas|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61008778|0-14|All Races|Male and Female|2017|||
1.1|1.7|1.4|83|XI(d) Malignant melanomas|61008778|0-14|All Races|Male and Female|2017|||
~|~|~|~|XI(e) Skin carcinomas|61008778|0-14|All Races|Male and Female|2017|||
3.7|4.7|4.2|254|XI(f) Other and unspecified carcinomas|61008778|0-14|All Races|Male and Female|2017|||
0.8|1.4|1.1|65|XII Other and unspecified malignant neoplasms|61008778|0-14|All Races|Male and Female|2017|||
0.4|0.9|0.6|38|XII(a) Other specified malignant tumors|61008778|0-14|All Races|Male and Female|2017|||
0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|61008778|0-14|All Races|Male and Female|2017|||
168.7|175.3|172.0|10388|All ICCC Groups Combined|60304658|0-14|All Races|Male and Female|2018|||
51.5|55.2|53.4|3229|I Leukemias, myeloproliferative & myelodysplastic diseases|60304658|0-14|All Races|Male and Female|2018|||
39.5|42.8|41.1|2492|I(a) Lymphoid leukemias|60304658|0-14|All Races|Male and Female|2018|||
6.9|8.3|7.6|456|I(b) Acute myeloid leukemias|60304658|0-14|All Races|Male and Female|2018|||
1.0|1.6|1.3|79|I(c) Chronic myeloproliferative diseases|60304658|0-14|All Races|Male and Female|2018|||
0.8|1.4|1.1|65|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60304658|0-14|All Races|Male and Female|2018|||
1.9|2.7|2.3|137|I(e) Unspecified and other specified leukemias|60304658|0-14|All Races|Male and Female|2018|||
21.0|23.4|22.1|1336|II Lymphomas and reticuloendothelial neoplasms|60304658|0-14|All Races|Male and Female|2018|||
5.4|6.7|6.0|364|II(a) Hodgkin lymphomas|60304658|0-14|All Races|Male and Female|2018|||
7.3|8.8|8.0|485|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60304658|0-14|All Races|Male and Female|2018|||
1.9|2.6|2.2|135|II(c) Burkitt lymphoma|60304658|0-14|All Races|Male and Female|2018|||
5.1|6.3|5.7|341|II(d) Miscellaneous lymphoreticular neoplasms|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|II(e) Unspecified lymphomas|60304658|0-14|All Races|Male and Female|2018|||
28.4|31.1|29.7|1795|III CNS and misc intracranial and intraspinal neoplasms|60304658|0-14|All Races|Male and Female|2018|||
2.3|3.2|2.7|166|III(a) Ependymomas and choroid plexus tumor|60304658|0-14|All Races|Male and Female|2018|||
14.4|16.3|15.3|926|III(b) Astrocytomas|60304658|0-14|All Races|Male and Female|2018|||
4.9|6.1|5.5|331|III(c) Intracranial and intraspinal embryonal tumors|60304658|0-14|All Races|Male and Female|2018|||
4.5|5.6|5.0|303|III(d) Other gliomas|60304658|0-14|All Races|Male and Female|2018|||
0.4|0.8|0.6|37|III(e) Other specified intracranial & intraspinal neoplasms|60304658|0-14|All Races|Male and Female|2018|||
0.4|0.8|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60304658|0-14|All Races|Male and Female|2018|||
10.7|12.4|11.5|695|IV Neuroblastoma and other peripheral nervous cell tumors|60304658|0-14|All Races|Male and Female|2018|||
10.5|12.3|11.4|684|IV(a) Neuroblastoma and ganglioneuroblastoma|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60304658|0-14|All Races|Male and Female|2018|||
10.1|11.8|10.9|660|IX Soft tissue and other extraosseous sarcomas|60304658|0-14|All Races|Male and Female|2018|||
4.3|5.5|4.9|295|IX(a) Rhabdomyosarcomas|60304658|0-14|All Races|Male and Female|2018|||
0.8|1.4|1.1|65|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|IX(c) Kaposi sarcoma|60304658|0-14|All Races|Male and Female|2018|||
3.3|4.3|3.8|230|IX(d) Other specified soft tissue sarcomas|60304658|0-14|All Races|Male and Female|2018|||
0.9|1.4|1.1|68|IX(e) Unspecified soft tissue sarcomas|60304658|0-14|All Races|Male and Female|2018|||
3.2|4.2|3.7|221|Not classified by ICCC|60304658|0-14|All Races|Male and Female|2018|||
3.5|4.6|4.0|241|V Retinoblastoma|60304658|0-14|All Races|Male and Female|2018|||
7.9|9.4|8.6|520|VI Renal tumors|60304658|0-14|All Races|Male and Female|2018|||
7.4|8.9|8.1|490|VI(a) Nephroblastoma and other nonepithelial renal tumors|60304658|0-14|All Races|Male and Female|2018|||
0.3|0.6|0.4|27|VI(b) Renal carcinomas|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60304658|0-14|All Races|Male and Female|2018|||
2.6|3.5|3.1|184|VII Hepatic tumors|60304658|0-14|All Races|Male and Female|2018|||
2.2|3.1|2.6|159|VII(a) Hepatoblastoma|60304658|0-14|All Races|Male and Female|2018|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60304658|0-14|All Races|Male and Female|2018|||
7.3|8.8|8.0|486|VIII Malignant bone tumors|60304658|0-14|All Races|Male and Female|2018|||
3.7|4.8|4.3|257|VIII(a) Osteosarcomas|60304658|0-14|All Races|Male and Female|2018|||
0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60304658|0-14|All Races|Male and Female|2018|||
2.5|3.4|2.9|176|VIII(c) Ewing tumor and related sarcomas of bone|60304658|0-14|All Races|Male and Female|2018|||
0.2|0.6|0.4|23|VIII(d) Other specified malignant bone tumors|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60304658|0-14|All Races|Male and Female|2018|||
5.0|6.2|5.6|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60304658|0-14|All Races|Male and Female|2018|||
1.1|1.7|1.4|84|X(a) Intracranial & intraspinal germ cell tumors|60304658|0-14|All Races|Male and Female|2018|||
1.1|1.7|1.4|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60304658|0-14|All Races|Male and Female|2018|||
2.1|3.0|2.5|153|X(c) Malignant gonadal germ cell tumors|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|X(d) Gonadal carcinomas|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60304658|0-14|All Races|Male and Female|2018|||
9.7|11.4|10.5|638|XI Other malignant epithelial neoplasms and malignant melanomas|60304658|0-14|All Races|Male and Female|2018|||
0.2|0.5|0.3|20|XI(a) Adrenocortical carcinomas|60304658|0-14|All Races|Male and Female|2018|||
3.6|4.7|4.1|250|XI(b) Thyroid carcinomas|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60304658|0-14|All Races|Male and Female|2018|||
1.4|2.1|1.7|105|XI(d) Malignant melanomas|60304658|0-14|All Races|Male and Female|2018|||
~|~|~|~|XI(e) Skin carcinomas|60304658|0-14|All Races|Male and Female|2018|||
3.6|4.7|4.1|250|XI(f) Other and unspecified carcinomas|60304658|0-14|All Races|Male and Female|2018|||
0.5|1.0|0.7|45|XII Other and unspecified malignant neoplasms|60304658|0-14|All Races|Male and Female|2018|||
0.2|0.5|0.3|17|XII(a) Other specified malignant tumors|60304658|0-14|All Races|Male and Female|2018|||
0.3|0.7|0.5|28|XII(b) Other unspecified malignant tumors|60304658|0-14|All Races|Male and Female|2018|||
159.8|166.3|163.0|9790|All ICCC Groups Combined|60033795|0-14|All Races|Male and Female|2019|||
48.4|52.0|50.2|3021|I Leukemias, myeloproliferative & myelodysplastic diseases|60033795|0-14|All Races|Male and Female|2019|||
36.6|39.8|38.2|2299|I(a) Lymphoid leukemias|60033795|0-14|All Races|Male and Female|2019|||
6.9|8.3|7.6|457|I(b) Acute myeloid leukemias|60033795|0-14|All Races|Male and Female|2019|||
0.9|1.4|1.1|67|I(c) Chronic myeloproliferative diseases|60033795|0-14|All Races|Male and Female|2019|||
1.0|1.6|1.3|75|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60033795|0-14|All Races|Male and Female|2019|||
1.7|2.4|2.0|123|I(e) Unspecified and other specified leukemias|60033795|0-14|All Races|Male and Female|2019|||
19.2|21.5|20.3|1222|II Lymphomas and reticuloendothelial neoplasms|60033795|0-14|All Races|Male and Female|2019|||
4.9|6.1|5.5|332|II(a) Hodgkin lymphomas|60033795|0-14|All Races|Male and Female|2019|||
6.5|7.9|7.1|430|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60033795|0-14|All Races|Male and Female|2019|||
1.9|2.7|2.3|139|II(c) Burkitt lymphoma|60033795|0-14|All Races|Male and Female|2019|||
4.7|5.8|5.2|312|II(d) Miscellaneous lymphoreticular neoplasms|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|II(e) Unspecified lymphomas|60033795|0-14|All Races|Male and Female|2019|||
25.3|28.0|26.6|1600|III CNS and misc intracranial and intraspinal neoplasms|60033795|0-14|All Races|Male and Female|2019|||
2.3|3.1|2.7|160|III(a) Ependymomas and choroid plexus tumor|60033795|0-14|All Races|Male and Female|2019|||
12.9|14.8|13.8|831|III(b) Astrocytomas|60033795|0-14|All Races|Male and Female|2019|||
4.0|5.1|4.5|270|III(c) Intracranial and intraspinal embryonal tumors|60033795|0-14|All Races|Male and Female|2019|||
4.0|5.1|4.5|270|III(d) Other gliomas|60033795|0-14|All Races|Male and Female|2019|||
0.4|0.8|0.6|36|III(e) Other specified intracranial & intraspinal neoplasms|60033795|0-14|All Races|Male and Female|2019|||
0.4|0.8|0.6|33|III(f) Unspecified intracranial and intraspinal neoplasms|60033795|0-14|All Races|Male and Female|2019|||
10.6|12.4|11.5|685|IV Neuroblastoma and other peripheral nervous cell tumors|60033795|0-14|All Races|Male and Female|2019|||
10.5|12.2|11.3|677|IV(a) Neuroblastoma and ganglioneuroblastoma|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60033795|0-14|All Races|Male and Female|2019|||
10.2|11.9|11.0|661|IX Soft tissue and other extraosseous sarcomas|60033795|0-14|All Races|Male and Female|2019|||
4.3|5.4|4.8|291|IX(a) Rhabdomyosarcomas|60033795|0-14|All Races|Male and Female|2019|||
0.8|1.4|1.1|63|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|IX(c) Kaposi sarcoma|60033795|0-14|All Races|Male and Female|2019|||
3.2|4.2|3.7|220|IX(d) Other specified soft tissue sarcomas|60033795|0-14|All Races|Male and Female|2019|||
1.2|1.8|1.5|87|IX(e) Unspecified soft tissue sarcomas|60033795|0-14|All Races|Male and Female|2019|||
3.6|4.6|4.1|246|Not classified by ICCC|60033795|0-14|All Races|Male and Female|2019|||
3.4|4.4|3.9|231|V Retinoblastoma|60033795|0-14|All Races|Male and Female|2019|||
7.1|8.5|7.8|466|VI Renal tumors|60033795|0-14|All Races|Male and Female|2019|||
6.7|8.1|7.4|444|VI(a) Nephroblastoma and other nonepithelial renal tumors|60033795|0-14|All Races|Male and Female|2019|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60033795|0-14|All Races|Male and Female|2019|||
2.8|3.7|3.2|192|VII Hepatic tumors|60033795|0-14|All Races|Male and Female|2019|||
2.3|3.1|2.7|161|VII(a) Hepatoblastoma|60033795|0-14|All Races|Male and Female|2019|||
0.3|0.7|0.4|27|VII(b) Hepatic carcinomas|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60033795|0-14|All Races|Male and Female|2019|||
6.9|8.3|7.6|459|VIII Malignant bone tumors|60033795|0-14|All Races|Male and Female|2019|||
3.9|5.0|4.4|268|VIII(a) Osteosarcomas|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|VIII(b) Chondrosarcomas|60033795|0-14|All Races|Male and Female|2019|||
2.0|2.8|2.4|142|VIII(c) Ewing tumor and related sarcomas of bone|60033795|0-14|All Races|Male and Female|2019|||
0.2|0.6|0.4|22|VIII(d) Other specified malignant bone tumors|60033795|0-14|All Races|Male and Female|2019|||
0.2|0.5|0.3|20|VIII(e) Unspecified malignant bone tumors|60033795|0-14|All Races|Male and Female|2019|||
4.8|6.0|5.4|322|X Germ cell, trophoblastic tumors & neoplasms of gonads|60033795|0-14|All Races|Male and Female|2019|||
1.2|1.9|1.5|91|X(a) Intracranial & intraspinal germ cell tumors|60033795|0-14|All Races|Male and Female|2019|||
1.0|1.6|1.3|76|X(b) Malignant extracranial & extragonadal germ cell tumors|60033795|0-14|All Races|Male and Female|2019|||
1.8|2.6|2.2|132|X(c) Malignant gonadal germ cell tumors|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|X(d) Gonadal carcinomas|60033795|0-14|All Races|Male and Female|2019|||
0.2|0.5|0.3|19|X(e) Other and unspecified malignant gonadal tumors|60033795|0-14|All Races|Male and Female|2019|||
9.8|11.5|10.6|640|XI Other malignant epithelial neoplasms and malignant melanomas|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60033795|0-14|All Races|Male and Female|2019|||
3.4|4.4|3.9|233|XI(b) Thyroid carcinomas|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60033795|0-14|All Races|Male and Female|2019|||
1.5|2.2|1.8|110|XI(d) Malignant melanomas|60033795|0-14|All Races|Male and Female|2019|||
~|~|~|~|XI(e) Skin carcinomas|60033795|0-14|All Races|Male and Female|2019|||
4.1|5.2|4.6|277|XI(f) Other and unspecified carcinomas|60033795|0-14|All Races|Male and Female|2019|||
0.6|1.0|0.8|45|XII Other and unspecified malignant neoplasms|60033795|0-14|All Races|Male and Female|2019|||
0.3|0.7|0.5|27|XII(a) Other specified malignant tumors|60033795|0-14|All Races|Male and Female|2019|||
0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|60033795|0-14|All Races|Male and Female|2019|||
155.8|161.3|158.5|12490|All ICCC Groups Combined|78936986|0-19|All Races|Male and Female|1999|155.5|161.0|158.2
39.1|41.9|40.5|3196|I Leukemias, myeloproliferative & myelodysplastic diseases|78936986|0-19|All Races|Male and Female|1999|39.1|41.9|40.5
28.8|31.2|30.0|2369|I(a) Lymphoid leukemias|78936986|0-19|All Races|Male and Female|1999|28.8|31.2|30.0
7.4|8.6|8.0|628|I(b) Acute myeloid leukemias|78936986|0-19|All Races|Male and Female|1999|7.3|8.6|8.0
0.8|1.3|1.0|82|I(c) Chronic myeloproliferative diseases|78936986|0-19|All Races|Male and Female|1999|0.8|1.3|1.0
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78936986|0-19|All Races|Male and Female|1999|~|~|~
1.1|1.6|1.3|105|I(e) Unspecified and other specified leukemias|78936986|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
22.2|24.4|23.3|1833|II Lymphomas and reticuloendothelial neoplasms|78936986|0-19|All Races|Male and Female|1999|22.2|24.3|23.2
11.1|12.7|11.9|934|II(a) Hodgkin lymphomas|78936986|0-19|All Races|Male and Female|1999|11.1|12.6|11.8
7.1|8.3|7.6|603|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78936986|0-19|All Races|Male and Female|1999|7.0|8.3|7.6
2.1|2.8|2.4|189|II(c) Burkitt lymphoma|78936986|0-19|All Races|Male and Female|1999|2.1|2.8|2.4
0.5|0.9|0.7|56|II(d) Miscellaneous lymphoreticular neoplasms|78936986|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
0.5|0.9|0.6|51|II(e) Unspecified lymphomas|78936986|0-19|All Races|Male and Female|1999|0.5|0.8|0.6
27.6|30.0|28.8|2272|III CNS and misc intracranial and intraspinal neoplasms|78936986|0-19|All Races|Male and Female|1999|27.6|30.0|28.8
2.3|3.0|2.6|207|III(a) Ependymomas and choroid plexus tumor|78936986|0-19|All Races|Male and Female|1999|2.3|3.0|2.6
12.9|14.5|13.7|1081|III(b) Astrocytomas|78936986|0-19|All Races|Male and Female|1999|12.9|14.5|13.7
6.1|7.2|6.6|524|III(c) Intracranial and intraspinal embryonal tumors|78936986|0-19|All Races|Male and Female|1999|6.1|7.2|6.6
4.2|5.2|4.7|373|III(d) Other gliomas|78936986|0-19|All Races|Male and Female|1999|4.3|5.2|4.7
0.4|0.7|0.5|40|III(e) Other specified intracranial & intraspinal neoplasms|78936986|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
0.4|0.8|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|78936986|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
7.6|8.9|8.3|648|IV Neuroblastoma and other peripheral nervous cell tumors|78936986|0-19|All Races|Male and Female|1999|7.6|8.9|8.2
7.4|8.6|8.0|625|IV(a) Neuroblastoma and ganglioneuroblastoma|78936986|0-19|All Races|Male and Female|1999|7.3|8.6|7.9
0.2|0.4|0.3|23|IV(b) Other peripheral nervous cell tumors|78936986|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
10.2|11.7|10.9|860|IX Soft tissue and other extraosseous sarcomas|78936986|0-19|All Races|Male and Female|1999|10.2|11.6|10.9
4.1|5.0|4.5|358|IX(a) Rhabdomyosarcomas|78936986|0-19|All Races|Male and Female|1999|4.1|5.0|4.5
0.9|1.4|1.1|88|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78936986|0-19|All Races|Male and Female|1999|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|78936986|0-19|All Races|Male and Female|1999|~|~|~
3.5|4.4|4.0|312|IX(d) Other specified soft tissue sarcomas|78936986|0-19|All Races|Male and Female|1999|3.5|4.4|4.0
1.0|1.5|1.3|99|IX(e) Unspecified soft tissue sarcomas|78936986|0-19|All Races|Male and Female|1999|1.0|1.5|1.3
0.2|0.4|0.3|22|Not classified by ICCC|78936986|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
2.8|3.6|3.2|248|V Retinoblastoma|78936986|0-19|All Races|Male and Female|1999|2.8|3.6|3.1
5.8|6.9|6.4|501|VI Renal tumors|78936986|0-19|All Races|Male and Female|1999|5.8|6.9|6.3
5.3|6.4|5.8|457|VI(a) Nephroblastoma and other nonepithelial renal tumors|78936986|0-19|All Races|Male and Female|1999|5.3|6.3|5.8
0.4|0.7|0.5|40|VI(b) Renal carcinomas|78936986|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|78936986|0-19|All Races|Male and Female|1999|~|~|~
1.7|2.3|2.0|154|VII Hepatic tumors|78936986|0-19|All Races|Male and Female|1999|1.7|2.3|2.0
1.1|1.6|1.3|102|VII(a) Hepatoblastoma|78936986|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
0.5|0.9|0.6|51|VII(b) Hepatic carcinomas|78936986|0-19|All Races|Male and Female|1999|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78936986|0-19|All Races|Male and Female|1999|~|~|~
8.2|9.5|8.8|695|VIII Malignant bone tumors|78936986|0-19|All Races|Male and Female|1999|8.2|9.5|8.8
4.6|5.6|5.1|401|VIII(a) Osteosarcomas|78936986|0-19|All Races|Male and Female|1999|4.6|5.6|5.1
0.2|0.5|0.4|28|VIII(b) Chondrosarcomas|78936986|0-19|All Races|Male and Female|1999|0.2|0.5|0.4
2.4|3.1|2.7|214|VIII(c) Ewing tumor and related sarcomas of bone|78936986|0-19|All Races|Male and Female|1999|2.4|3.1|2.7
0.4|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|78936986|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|78936986|0-19|All Races|Male and Female|1999|~|~|~
9.4|10.8|10.1|791|X Germ cell, trophoblastic tumors & neoplasms of gonads|78936986|0-19|All Races|Male and Female|1999|9.3|10.7|10.0
1.1|1.7|1.4|110|X(a) Intracranial & intraspinal germ cell tumors|78936986|0-19|All Races|Male and Female|1999|1.1|1.7|1.4
1.1|1.7|1.4|107|X(b) Malignant extracranial & extragonadal germ cell tumors|78936986|0-19|All Races|Male and Female|1999|1.1|1.6|1.4
6.1|7.2|6.7|523|X(c) Malignant gonadal germ cell tumors|78936986|0-19|All Races|Male and Female|1999|6.1|7.2|6.6
0.3|0.6|0.4|32|X(d) Gonadal carcinomas|78936986|0-19|All Races|Male and Female|1999|0.3|0.6|0.4
0.1|0.4|0.2|19|X(e) Other and unspecified malignant gonadal tumors|78936986|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
14.5|16.2|15.3|1205|XI Other malignant epithelial neoplasms and malignant melanomas|78936986|0-19|All Races|Male and Female|1999|14.4|16.2|15.3
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|78936986|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
5.3|6.4|5.9|461|XI(b) Thyroid carcinomas|78936986|0-19|All Races|Male and Female|1999|5.3|6.4|5.8
0.4|0.7|0.5|42|XI(c) Nasopharyngeal carcinomas|78936986|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
4.3|5.3|4.7|373|XI(d) Malignant melanomas|78936986|0-19|All Races|Male and Female|1999|4.3|5.2|4.7
~|~|~|~|XI(e) Skin carcinomas|78936986|0-19|All Races|Male and Female|1999|~|~|~
3.4|4.3|3.9|303|XI(f) Other and unspecified carcinomas|78936986|0-19|All Races|Male and Female|1999|3.4|4.3|3.8
0.6|1.1|0.8|65|XII Other and unspecified malignant neoplasms|78936986|0-19|All Races|Male and Female|1999|0.6|1.0|0.8
0.1|0.3|0.2|17|XII(a) Other specified malignant tumors|78936986|0-19|All Races|Male and Female|1999|0.1|0.3|0.2
0.4|0.8|0.6|48|XII(b) Other unspecified malignant tumors|78936986|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
161.1|166.7|163.9|13004|All ICCC Groups Combined|79474943|0-19|All Races|Male and Female|2000|160.8|166.5|163.6
39.9|42.8|41.3|3273|I Leukemias, myeloproliferative & myelodysplastic diseases|79474943|0-19|All Races|Male and Female|2000|39.8|42.6|41.2
30.6|33.1|31.8|2516|I(a) Lymphoid leukemias|79474943|0-19|All Races|Male and Female|2000|30.4|32.9|31.7
6.6|7.8|7.1|567|I(b) Acute myeloid leukemias|79474943|0-19|All Races|Male and Female|2000|6.6|7.7|7.1
0.7|1.1|0.9|72|I(c) Chronic myeloproliferative diseases|79474943|0-19|All Races|Male and Female|2000|0.7|1.1|0.9
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|79474943|0-19|All Races|Male and Female|2000|~|~|~
1.1|1.6|1.3|107|I(e) Unspecified and other specified leukemias|79474943|0-19|All Races|Male and Female|2000|1.1|1.6|1.3
23.8|26.0|24.9|1978|II Lymphomas and reticuloendothelial neoplasms|79474943|0-19|All Races|Male and Female|2000|23.8|26.0|24.9
11.6|13.1|12.3|981|II(a) Hodgkin lymphomas|79474943|0-19|All Races|Male and Female|2000|11.6|13.1|12.3
7.6|8.8|8.2|652|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|79474943|0-19|All Races|Male and Female|2000|7.6|8.9|8.2
2.3|3.1|2.7|213|II(c) Burkitt lymphoma|79474943|0-19|All Races|Male and Female|2000|2.3|3.1|2.7
0.8|1.2|1.0|79|II(d) Miscellaneous lymphoreticular neoplasms|79474943|0-19|All Races|Male and Female|2000|0.8|1.2|1.0
0.5|0.9|0.7|53|II(e) Unspecified lymphomas|79474943|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
29.0|31.4|30.2|2399|III CNS and misc intracranial and intraspinal neoplasms|79474943|0-19|All Races|Male and Female|2000|29.0|31.4|30.2
2.0|2.7|2.3|184|III(a) Ependymomas and choroid plexus tumor|79474943|0-19|All Races|Male and Female|2000|2.0|2.7|2.3
14.9|16.7|15.8|1253|III(b) Astrocytomas|79474943|0-19|All Races|Male and Female|2000|14.9|16.7|15.8
5.9|7.0|6.4|509|III(c) Intracranial and intraspinal embryonal tumors|79474943|0-19|All Races|Male and Female|2000|5.9|7.0|6.4
4.1|5.0|4.6|362|III(d) Other gliomas|79474943|0-19|All Races|Male and Female|2000|4.1|5.0|4.6
0.3|0.7|0.5|38|III(e) Other specified intracranial & intraspinal neoplasms|79474943|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
0.5|0.9|0.7|53|III(f) Unspecified intracranial and intraspinal neoplasms|79474943|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
7.1|8.3|7.7|607|IV Neuroblastoma and other peripheral nervous cell tumors|79474943|0-19|All Races|Male and Female|2000|7.0|8.3|7.6
7.0|8.2|7.5|595|IV(a) Neuroblastoma and ganglioneuroblastoma|79474943|0-19|All Races|Male and Female|2000|6.9|8.1|7.5
~|~|~|~|IV(b) Other peripheral nervous cell tumors|79474943|0-19|All Races|Male and Female|2000|~|~|~
11.2|12.7|11.9|948|IX Soft tissue and other extraosseous sarcomas|79474943|0-19|All Races|Male and Female|2000|11.2|12.7|11.9
4.4|5.4|4.9|385|IX(a) Rhabdomyosarcomas|79474943|0-19|All Races|Male and Female|2000|4.4|5.4|4.8
1.0|1.4|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|79474943|0-19|All Races|Male and Female|2000|1.0|1.4|1.2
~|~|~|~|IX(c) Kaposi sarcoma|79474943|0-19|All Races|Male and Female|2000|~|~|~
4.1|5.0|4.5|360|IX(d) Other specified soft tissue sarcomas|79474943|0-19|All Races|Male and Female|2000|4.1|5.0|4.5
1.1|1.6|1.3|105|IX(e) Unspecified soft tissue sarcomas|79474943|0-19|All Races|Male and Female|2000|1.1|1.6|1.3
0.1|0.3|0.2|17|Not classified by ICCC|79474943|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
2.9|3.7|3.3|258|V Retinoblastoma|79474943|0-19|All Races|Male and Female|2000|2.9|3.7|3.2
6.3|7.5|6.9|544|VI Renal tumors|79474943|0-19|All Races|Male and Female|2000|6.3|7.4|6.8
5.8|7.0|6.4|504|VI(a) Nephroblastoma and other nonepithelial renal tumors|79474943|0-19|All Races|Male and Female|2000|5.8|6.9|6.3
0.3|0.7|0.5|38|VI(b) Renal carcinomas|79474943|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|79474943|0-19|All Races|Male and Female|2000|~|~|~
1.6|2.2|1.9|146|VII Hepatic tumors|79474943|0-19|All Races|Male and Female|2000|1.6|2.2|1.8
1.2|1.7|1.4|114|VII(a) Hepatoblastoma|79474943|0-19|All Races|Male and Female|2000|1.2|1.7|1.4
0.3|0.5|0.4|30|VII(b) Hepatic carcinomas|79474943|0-19|All Races|Male and Female|2000|0.3|0.5|0.4
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|79474943|0-19|All Races|Male and Female|2000|~|~|~
7.7|9.0|8.3|664|VIII Malignant bone tumors|79474943|0-19|All Races|Male and Female|2000|7.7|9.0|8.4
4.2|5.2|4.7|374|VIII(a) Osteosarcomas|79474943|0-19|All Races|Male and Female|2000|4.2|5.2|4.7
~|~|~|~|VIII(b) Chondrosarcomas|79474943|0-19|All Races|Male and Female|2000|~|~|~
2.7|3.4|3.0|241|VIII(c) Ewing tumor and related sarcomas of bone|79474943|0-19|All Races|Male and Female|2000|2.7|3.4|3.0
0.1|0.4|0.2|19|VIII(d) Other specified malignant bone tumors|79474943|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|79474943|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
10.1|11.6|10.8|860|X Germ cell, trophoblastic tumors & neoplasms of gonads|79474943|0-19|All Races|Male and Female|2000|10.1|11.6|10.8
1.4|2.0|1.7|134|X(a) Intracranial & intraspinal germ cell tumors|79474943|0-19|All Races|Male and Female|2000|1.4|2.0|1.7
1.1|1.7|1.4|109|X(b) Malignant extracranial & extragonadal germ cell tumors|79474943|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
6.5|7.7|7.1|562|X(c) Malignant gonadal germ cell tumors|79474943|0-19|All Races|Male and Female|2000|6.5|7.7|7.1
0.3|0.6|0.5|37|X(d) Gonadal carcinomas|79474943|0-19|All Races|Male and Female|2000|0.3|0.6|0.5
0.1|0.4|0.2|18|X(e) Other and unspecified malignant gonadal tumors|79474943|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
14.8|16.5|15.6|1245|XI Other malignant epithelial neoplasms and malignant melanomas|79474943|0-19|All Races|Male and Female|2000|14.8|16.6|15.7
0.2|0.5|0.3|25|XI(a) Adrenocortical carcinomas|79474943|0-19|All Races|Male and Female|2000|0.2|0.5|0.3
5.2|6.2|5.7|451|XI(b) Thyroid carcinomas|79474943|0-19|All Races|Male and Female|2000|5.2|6.2|5.7
0.4|0.7|0.5|42|XI(c) Nasopharyngeal carcinomas|79474943|0-19|All Races|Male and Female|2000|0.4|0.7|0.5
4.7|5.7|5.2|412|XI(d) Malignant melanomas|79474943|0-19|All Races|Male and Female|2000|4.7|5.7|5.2
~|~|~|~|XI(e) Skin carcinomas|79474943|0-19|All Races|Male and Female|2000|~|~|~
3.5|4.3|3.9|309|XI(f) Other and unspecified carcinomas|79474943|0-19|All Races|Male and Female|2000|3.5|4.3|3.9
0.6|1.0|0.8|65|XII Other and unspecified malignant neoplasms|79474943|0-19|All Races|Male and Female|2000|0.6|1.0|0.8
~|~|~|~|XII(a) Other specified malignant tumors|79474943|0-19|All Races|Male and Female|2000|~|~|~
0.5|0.8|0.6|50|XII(b) Other unspecified malignant tumors|79474943|0-19|All Races|Male and Female|2000|0.5|0.8|0.6
167.6|173.3|170.4|13639|All ICCC Groups Combined|80042731|0-19|All Races|Male and Female|2001|167.5|173.3|170.4
44.2|47.1|45.6|3634|I Leukemias, myeloproliferative & myelodysplastic diseases|80042731|0-19|All Races|Male and Female|2001|43.9|46.9|45.4
31.6|34.2|32.9|2610|I(a) Lymphoid leukemias|80042731|0-19|All Races|Male and Female|2001|31.4|33.9|32.6
7.1|8.4|7.7|620|I(b) Acute myeloid leukemias|80042731|0-19|All Races|Male and Female|2001|7.1|8.4|7.7
1.9|2.6|2.3|182|I(c) Chronic myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001|2.0|2.6|2.3
1.2|1.8|1.5|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001|1.2|1.8|1.5
1.1|1.6|1.3|104|I(e) Unspecified and other specified leukemias|80042731|0-19|All Races|Male and Female|2001|1.1|1.6|1.3
23.6|25.8|24.6|1981|II Lymphomas and reticuloendothelial neoplasms|80042731|0-19|All Races|Male and Female|2001|23.7|25.9|24.7
11.7|13.3|12.5|1007|II(a) Hodgkin lymphomas|80042731|0-19|All Races|Male and Female|2001|11.8|13.4|12.6
8.0|9.3|8.7|695|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80042731|0-19|All Races|Male and Female|2001|8.0|9.4|8.7
1.9|2.5|2.2|174|II(c) Burkitt lymphoma|80042731|0-19|All Races|Male and Female|2001|1.9|2.5|2.2
0.6|1.0|0.8|66|II(d) Miscellaneous lymphoreticular neoplasms|80042731|0-19|All Races|Male and Female|2001|0.6|1.0|0.8
0.3|0.7|0.5|39|II(e) Unspecified lymphomas|80042731|0-19|All Races|Male and Female|2001|0.3|0.7|0.5
28.9|31.3|30.1|2400|III CNS and misc intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|28.8|31.2|30.0
2.1|2.8|2.5|197|III(a) Ependymomas and choroid plexus tumor|80042731|0-19|All Races|Male and Female|2001|2.1|2.8|2.5
14.2|15.9|15.1|1203|III(b) Astrocytomas|80042731|0-19|All Races|Male and Female|2001|14.2|15.9|15.0
6.0|7.1|6.5|518|III(c) Intracranial and intraspinal embryonal tumors|80042731|0-19|All Races|Male and Female|2001|5.9|7.1|6.5
4.6|5.6|5.1|404|III(d) Other gliomas|80042731|0-19|All Races|Male and Female|2001|4.6|5.6|5.0
0.5|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|0.5|0.8|0.6
0.2|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
8.2|9.5|8.8|707|IV Neuroblastoma and other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001|8.2|9.5|8.8
8.0|9.3|8.7|692|IV(a) Neuroblastoma and ganglioneuroblastoma|80042731|0-19|All Races|Male and Female|2001|8.0|9.3|8.6
~|~|~|~|IV(b) Other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
11.2|12.7|11.9|955|IX Soft tissue and other extraosseous sarcomas|80042731|0-19|All Races|Male and Female|2001|11.2|12.7|11.9
4.5|5.5|5.0|400|IX(a) Rhabdomyosarcomas|80042731|0-19|All Races|Male and Female|2001|4.5|5.5|5.0
1.2|1.7|1.4|116|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80042731|0-19|All Races|Male and Female|2001|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|80042731|0-19|All Races|Male and Female|2001|~|~|~
3.7|4.6|4.1|333|IX(d) Other specified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001|3.7|4.6|4.2
1.0|1.5|1.3|103|IX(e) Unspecified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001|1.1|1.6|1.3
0.1|0.4|0.2|19|Not classified by ICCC|80042731|0-19|All Races|Male and Female|2001|0.1|0.4|0.2
2.9|3.7|3.3|265|V Retinoblastoma|80042731|0-19|All Races|Male and Female|2001|2.9|3.7|3.3
6.2|7.4|6.8|539|VI Renal tumors|80042731|0-19|All Races|Male and Female|2001|6.2|7.3|6.7
5.7|6.8|6.2|493|VI(a) Nephroblastoma and other nonepithelial renal tumors|80042731|0-19|All Races|Male and Female|2001|5.6|6.7|6.2
0.4|0.7|0.5|43|VI(b) Renal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
1.5|2.1|1.8|145|VII Hepatic tumors|80042731|0-19|All Races|Male and Female|2001|1.5|2.1|1.8
1.0|1.5|1.3|101|VII(a) Hepatoblastoma|80042731|0-19|All Races|Male and Female|2001|1.0|1.5|1.3
0.4|0.7|0.5|43|VII(b) Hepatic carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
8.8|10.2|9.5|766|VIII Malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|8.9|10.3|9.6
4.7|5.7|5.2|418|VIII(a) Osteosarcomas|80042731|0-19|All Races|Male and Female|2001|4.7|5.7|5.2
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
3.0|3.8|3.4|272|VIII(c) Ewing tumor and related sarcomas of bone|80042731|0-19|All Races|Male and Female|2001|3.0|3.8|3.4
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
9.7|11.1|10.4|835|X Germ cell, trophoblastic tumors & neoplasms of gonads|80042731|0-19|All Races|Male and Female|2001|9.7|11.2|10.4
1.3|1.9|1.6|128|X(a) Intracranial & intraspinal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
1.3|1.9|1.6|128|X(b) Malignant extracranial & extragonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
6.0|7.1|6.6|528|X(c) Malignant gonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|6.0|7.2|6.6
0.2|0.5|0.3|27|X(d) Gonadal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
0.2|0.4|0.3|24|X(e) Other and unspecified malignant gonadal tumors|80042731|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
15.5|17.3|16.4|1322|XI Other malignant epithelial neoplasms and malignant melanomas|80042731|0-19|All Races|Male and Female|2001|15.6|17.4|16.5
0.1|0.4|0.2|18|XI(a) Adrenocortical carcinomas|80042731|0-19|All Races|Male and Female|2001|0.1|0.4|0.2
5.3|6.3|5.8|466|XI(b) Thyroid carcinomas|80042731|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
0.4|0.7|0.5|43|XI(c) Nasopharyngeal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
5.3|6.3|5.8|466|XI(d) Malignant melanomas|80042731|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
~|~|~|~|XI(e) Skin carcinomas|80042731|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.0|324|XI(f) Other and unspecified carcinomas|80042731|0-19|All Races|Male and Female|2001|3.6|4.5|4.0
0.7|1.1|0.9|71|XII Other and unspecified malignant neoplasms|80042731|0-19|All Races|Male and Female|2001|0.7|1.1|0.9
0.3|0.5|0.4|30|XII(a) Other specified malignant tumors|80042731|0-19|All Races|Male and Female|2001|0.3|0.5|0.4
0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
168.0|173.7|170.9|13733|All ICCC Groups Combined|80317363|0-19|All Races|Male and Female|2002|168.1|173.9|171.0
43.3|46.3|44.8|3582|I Leukemias, myeloproliferative & myelodysplastic diseases|80317363|0-19|All Races|Male and Female|2002|43.1|46.1|44.6
30.6|33.1|31.9|2540|I(a) Lymphoid leukemias|80317363|0-19|All Races|Male and Female|2002|30.4|32.9|31.6
7.5|8.8|8.1|655|I(b) Acute myeloid leukemias|80317363|0-19|All Races|Male and Female|2002|7.5|8.8|8.2
1.8|2.4|2.1|169|I(c) Chronic myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002|1.8|2.4|2.1
1.2|1.8|1.5|120|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002|1.2|1.8|1.5
1.0|1.5|1.2|98|I(e) Unspecified and other specified leukemias|80317363|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
23.5|25.7|24.6|1990|II Lymphomas and reticuloendothelial neoplasms|80317363|0-19|All Races|Male and Female|2002|23.7|25.9|24.8
11.6|13.2|12.4|1005|II(a) Hodgkin lymphomas|80317363|0-19|All Races|Male and Female|2002|11.8|13.3|12.5
7.6|8.9|8.2|664|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80317363|0-19|All Races|Male and Female|2002|7.7|8.9|8.3
2.4|3.1|2.7|220|II(c) Burkitt lymphoma|80317363|0-19|All Races|Male and Female|2002|2.4|3.1|2.7
0.7|1.1|0.9|73|II(d) Miscellaneous lymphoreticular neoplasms|80317363|0-19|All Races|Male and Female|2002|0.7|1.1|0.9
0.2|0.5|0.3|28|II(e) Unspecified lymphomas|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
30.2|32.7|31.4|2515|III CNS and misc intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002|30.1|32.6|31.3
2.6|3.3|2.9|236|III(a) Ependymomas and choroid plexus tumor|80317363|0-19|All Races|Male and Female|2002|2.6|3.3|2.9
14.6|16.3|15.4|1236|III(b) Astrocytomas|80317363|0-19|All Races|Male and Female|2002|14.5|16.3|15.4
5.8|6.9|6.4|507|III(c) Intracranial and intraspinal embryonal tumors|80317363|0-19|All Races|Male and Female|2002|5.8|6.9|6.3
5.0|6.1|5.5|443|III(d) Other gliomas|80317363|0-19|All Races|Male and Female|2002|5.0|6.1|5.5
0.6|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002|0.6|0.9|0.7
0.3|0.6|0.4|34|III(f) Unspecified intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
7.8|9.1|8.5|678|IV Neuroblastoma and other peripheral nervous cell tumors|80317363|0-19|All Races|Male and Female|2002|7.8|9.1|8.4
7.6|8.9|8.2|659|IV(a) Neuroblastoma and ganglioneuroblastoma|80317363|0-19|All Races|Male and Female|2002|7.6|8.9|8.2
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|80317363|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
11.0|12.6|11.8|948|IX Soft tissue and other extraosseous sarcomas|80317363|0-19|All Races|Male and Female|2002|11.1|12.6|11.8
4.4|5.4|4.9|390|IX(a) Rhabdomyosarcomas|80317363|0-19|All Races|Male and Female|2002|4.4|5.4|4.9
0.9|1.4|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80317363|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
~|~|~|~|IX(c) Kaposi sarcoma|80317363|0-19|All Races|Male and Female|2002|~|~|~
4.3|5.3|4.8|386|IX(d) Other specified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002|4.3|5.3|4.8
0.8|1.2|1.0|78|IX(e) Unspecified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002|0.8|1.2|1.0
0.2|0.5|0.3|26|Not classified by ICCC|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
2.5|3.2|2.8|225|V Retinoblastoma|80317363|0-19|All Races|Male and Female|2002|2.4|3.2|2.8
6.0|7.1|6.5|520|VI Renal tumors|80317363|0-19|All Races|Male and Female|2002|5.9|7.1|6.5
5.5|6.6|6.1|482|VI(a) Nephroblastoma and other nonepithelial renal tumors|80317363|0-19|All Races|Male and Female|2002|5.5|6.6|6.0
0.3|0.6|0.5|37|VI(b) Renal carcinomas|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|80317363|0-19|All Races|Male and Female|2002|~|~|~
1.4|2.0|1.7|136|VII Hepatic tumors|80317363|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
0.9|1.4|1.2|93|VII(a) Hepatoblastoma|80317363|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
0.4|0.7|0.5|42|VII(b) Hepatic carcinomas|80317363|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80317363|0-19|All Races|Male and Female|2002|~|~|~
8.5|9.8|9.1|741|VIII Malignant bone tumors|80317363|0-19|All Races|Male and Female|2002|8.6|9.9|9.2
4.4|5.4|4.9|398|VIII(a) Osteosarcomas|80317363|0-19|All Races|Male and Female|2002|4.5|5.5|5.0
0.3|0.6|0.5|38|VIII(b) Chondrosarcomas|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
2.7|3.5|3.1|250|VIII(c) Ewing tumor and related sarcomas of bone|80317363|0-19|All Races|Male and Female|2002|2.7|3.5|3.1
0.4|0.7|0.5|43|VIII(d) Other specified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002|~|~|~
10.3|11.8|11.0|892|X Germ cell, trophoblastic tumors & neoplasms of gonads|80317363|0-19|All Races|Male and Female|2002|10.4|11.9|11.1
1.4|1.9|1.6|132|X(a) Intracranial & intraspinal germ cell tumors|80317363|0-19|All Races|Male and Female|2002|1.4|1.9|1.6
1.3|1.8|1.5|125|X(b) Malignant extracranial & extragonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002|1.3|1.9|1.6
6.6|7.8|7.2|582|X(c) Malignant gonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002|6.7|7.9|7.2
0.2|0.5|0.4|29|X(d) Gonadal carcinomas|80317363|0-19|All Races|Male and Female|2002|0.2|0.5|0.4
0.2|0.4|0.3|24|X(e) Other and unspecified malignant gonadal tumors|80317363|0-19|All Races|Male and Female|2002|0.2|0.4|0.3
16.4|18.3|17.3|1406|XI Other malignant epithelial neoplasms and malignant melanomas|80317363|0-19|All Races|Male and Female|2002|16.6|18.4|17.5
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|80317363|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
5.3|6.4|5.8|474|XI(b) Thyroid carcinomas|80317363|0-19|All Races|Male and Female|2002|5.4|6.5|5.9
0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|80317363|0-19|All Races|Male and Female|2002|0.5|0.8|0.6
6.0|7.1|6.5|528|XI(d) Malignant melanomas|80317363|0-19|All Races|Male and Female|2002|6.0|7.2|6.6
~|~|~|~|XI(e) Skin carcinomas|80317363|0-19|All Races|Male and Female|2002|~|~|~
3.6|4.5|4.0|328|XI(f) Other and unspecified carcinomas|80317363|0-19|All Races|Male and Female|2002|3.7|4.6|4.1
0.7|1.2|0.9|74|XII Other and unspecified malignant neoplasms|80317363|0-19|All Races|Male and Female|2002|0.7|1.2|0.9
0.3|0.6|0.5|38|XII(a) Other specified malignant tumors|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
0.3|0.6|0.4|36|XII(b) Other unspecified malignant tumors|80317363|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
165.0|170.6|167.8|13701|All ICCC Groups Combined|81425816|0-19|All Races|Male and Female|2003|165.5|171.1|168.3
42.1|45.0|43.5|3528|I Leukemias, myeloproliferative & myelodysplastic diseases|81425816|0-19|All Races|Male and Female|2003|41.9|44.8|43.3
29.5|31.9|30.7|2477|I(a) Lymphoid leukemias|81425816|0-19|All Races|Male and Female|2003|29.2|31.6|30.4
7.2|8.4|7.8|639|I(b) Acute myeloid leukemias|81425816|0-19|All Races|Male and Female|2003|7.3|8.5|7.8
2.0|2.7|2.3|191|I(c) Chronic myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|2.0|2.7|2.3
1.4|2.0|1.7|138|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|1.4|2.0|1.7
0.8|1.3|1.0|83|I(e) Unspecified and other specified leukemias|81425816|0-19|All Races|Male and Female|2003|0.8|1.3|1.0
23.2|25.3|24.2|1987|II Lymphomas and reticuloendothelial neoplasms|81425816|0-19|All Races|Male and Female|2003|23.3|25.5|24.4
11.7|13.2|12.4|1024|II(a) Hodgkin lymphomas|81425816|0-19|All Races|Male and Female|2003|11.8|13.4|12.6
7.5|8.7|8.1|661|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81425816|0-19|All Races|Male and Female|2003|7.5|8.8|8.1
2.3|3.0|2.6|212|II(c) Burkitt lymphoma|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.7|1.1|0.9|74|II(d) Miscellaneous lymphoreticular neoplasms|81425816|0-19|All Races|Male and Female|2003|0.7|1.1|0.9
0.1|0.3|0.2|16|II(e) Unspecified lymphomas|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
29.0|31.4|30.2|2448|III CNS and misc intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|28.9|31.3|30.1
2.0|2.6|2.3|186|III(a) Ependymomas and choroid plexus tumor|81425816|0-19|All Races|Male and Female|2003|2.0|2.6|2.3
14.5|16.2|15.3|1247|III(b) Astrocytomas|81425816|0-19|All Races|Male and Female|2003|14.5|16.2|15.3
5.6|6.7|6.1|493|III(c) Intracranial and intraspinal embryonal tumors|81425816|0-19|All Races|Male and Female|2003|5.5|6.6|6.1
4.7|5.7|5.2|423|III(d) Other gliomas|81425816|0-19|All Races|Male and Female|2003|4.7|5.7|5.2
0.7|1.1|0.8|68|III(e) Other specified intracranial & intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.6|1.1|0.8
0.3|0.5|0.4|31|III(f) Unspecified intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.3|0.5|0.4
7.6|8.9|8.2|668|IV Neuroblastoma and other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|7.6|8.9|8.2
7.4|8.7|8.0|653|IV(a) Neuroblastoma and ganglioneuroblastoma|81425816|0-19|All Races|Male and Female|2003|7.4|8.7|8.0
~|~|~|~|IV(b) Other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
11.5|13.0|12.2|1000|IX Soft tissue and other extraosseous sarcomas|81425816|0-19|All Races|Male and Female|2003|11.5|13.1|12.3
4.3|5.3|4.8|389|IX(a) Rhabdomyosarcomas|81425816|0-19|All Races|Male and Female|2003|4.3|5.3|4.8
1.2|1.8|1.5|120|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81425816|0-19|All Races|Male and Female|2003|1.2|1.8|1.5
~|~|~|~|IX(c) Kaposi sarcoma|81425816|0-19|All Races|Male and Female|2003|~|~|~
4.2|5.2|4.7|386|IX(d) Other specified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|4.3|5.2|4.7
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|1.0|1.5|1.3
0.1|0.4|0.2|19|Not classified by ICCC|81425816|0-19|All Races|Male and Female|2003|0.1|0.4|0.2
2.7|3.5|3.1|250|V Retinoblastoma|81425816|0-19|All Races|Male and Female|2003|2.7|3.5|3.1
6.2|7.3|6.7|544|VI Renal tumors|81425816|0-19|All Races|Male and Female|2003|6.1|7.3|6.7
5.6|6.7|6.1|495|VI(a) Nephroblastoma and other nonepithelial renal tumors|81425816|0-19|All Races|Male and Female|2003|5.6|6.6|6.1
0.4|0.7|0.5|45|VI(b) Renal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.4|0.7|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
1.8|2.5|2.1|173|VII Hepatic tumors|81425816|0-19|All Races|Male and Female|2003|1.8|2.5|2.1
1.3|1.8|1.5|123|VII(a) Hepatoblastoma|81425816|0-19|All Races|Male and Female|2003|1.3|1.8|1.5
0.5|0.8|0.6|50|VII(b) Hepatic carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
8.0|9.3|8.7|714|VIII Malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|8.1|9.4|8.8
4.8|5.8|5.3|436|VIII(a) Osteosarcomas|81425816|0-19|All Races|Male and Female|2003|4.9|5.9|5.4
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.2|2.9|2.6|212|VIII(c) Ewing tumor and related sarcomas of bone|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.2|0.5|0.3|28|VIII(d) Other specified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.3
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
9.6|11.0|10.3|848|X Germ cell, trophoblastic tumors & neoplasms of gonads|81425816|0-19|All Races|Male and Female|2003|9.7|11.1|10.4
1.1|1.6|1.4|112|X(a) Intracranial & intraspinal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.1|1.7|1.4
1.2|1.8|1.5|121|X(b) Malignant extracranial & extragonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.2|1.8|1.5
6.1|7.3|6.7|553|X(c) Malignant gonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|6.2|7.4|6.8
0.2|0.5|0.3|29|X(d) Gonadal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
0.3|0.6|0.4|33|X(e) Other and unspecified malignant gonadal tumors|81425816|0-19|All Races|Male and Female|2003|0.3|0.6|0.4
16.5|18.3|17.3|1434|XI Other malignant epithelial neoplasms and malignant melanomas|81425816|0-19|All Races|Male and Female|2003|16.7|18.5|17.6
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.2
5.7|6.7|6.2|512|XI(b) Thyroid carcinomas|81425816|0-19|All Races|Male and Female|2003|5.8|6.9|6.3
0.5|0.9|0.7|54|XI(c) Nasopharyngeal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.9|0.7
5.4|6.5|5.9|491|XI(d) Malignant melanomas|81425816|0-19|All Races|Male and Female|2003|5.5|6.6|6.0
~|~|~|~|XI(e) Skin carcinomas|81425816|0-19|All Races|Male and Female|2003|~|~|~
3.8|4.7|4.2|348|XI(f) Other and unspecified carcinomas|81425816|0-19|All Races|Male and Female|2003|3.8|4.7|4.3
0.9|1.3|1.1|88|XII Other and unspecified malignant neoplasms|81425816|0-19|All Races|Male and Female|2003|0.9|1.3|1.1
0.3|0.7|0.5|40|XII(a) Other specified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.4|0.7|0.5
0.4|0.8|0.6|48|XII(b) Other unspecified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.4|0.8|0.6
171.6|177.3|174.4|14330|All ICCC Groups Combined|81754354|0-19|All Races|Male and Female|2004|172.4|178.2|175.3
44.8|47.8|46.3|3773|I Leukemias, myeloproliferative & myelodysplastic diseases|81754354|0-19|All Races|Male and Female|2004|44.7|47.6|46.2
32.0|34.5|33.2|2700|I(a) Lymphoid leukemias|81754354|0-19|All Races|Male and Female|2004|31.8|34.3|33.0
7.6|8.9|8.2|677|I(b) Acute myeloid leukemias|81754354|0-19|All Races|Male and Female|2004|7.7|8.9|8.3
1.9|2.5|2.2|182|I(c) Chronic myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.9|2.6|2.2
1.1|1.7|1.4|113|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.1|1.7|1.4
1.0|1.5|1.2|101|I(e) Unspecified and other specified leukemias|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
23.1|25.2|24.2|2000|II Lymphomas and reticuloendothelial neoplasms|81754354|0-19|All Races|Male and Female|2004|23.4|25.6|24.5
11.1|12.6|11.9|990|II(a) Hodgkin lymphomas|81754354|0-19|All Races|Male and Female|2004|11.4|12.9|12.1
7.9|9.2|8.6|706|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|0-19|All Races|Male and Female|2004|8.0|9.3|8.6
2.0|2.7|2.3|191|II(c) Burkitt lymphoma|81754354|0-19|All Races|Male and Female|2004|2.0|2.7|2.3
0.8|1.3|1.0|86|II(d) Miscellaneous lymphoreticular neoplasms|81754354|0-19|All Races|Male and Female|2004|0.8|1.3|1.1
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
30.9|33.4|32.2|2618|III CNS and misc intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|30.8|33.3|32.0
2.4|3.1|2.7|224|III(a) Ependymomas and choroid plexus tumor|81754354|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
15.6|17.4|16.5|1346|III(b) Astrocytomas|81754354|0-19|All Races|Male and Female|2004|15.6|17.4|16.5
6.0|7.2|6.6|533|III(c) Intracranial and intraspinal embryonal tumors|81754354|0-19|All Races|Male and Female|2004|6.0|7.1|6.5
4.6|5.6|5.1|413|III(d) Other gliomas|81754354|0-19|All Races|Male and Female|2004|4.6|5.6|5.1
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.5|0.9|0.7
0.4|0.7|0.5|43|III(f) Unspecified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
7.9|9.1|8.5|695|IV Neuroblastoma and other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|7.9|9.2|8.5
7.6|8.8|8.2|672|IV(a) Neuroblastoma and ganglioneuroblastoma|81754354|0-19|All Races|Male and Female|2004|7.6|8.9|8.2
0.2|0.4|0.3|23|IV(b) Other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.4|0.3
11.3|12.8|12.0|991|IX Soft tissue and other extraosseous sarcomas|81754354|0-19|All Races|Male and Female|2004|11.4|12.9|12.1
3.9|4.8|4.3|351|IX(a) Rhabdomyosarcomas|81754354|0-19|All Races|Male and Female|2004|3.9|4.8|4.3
1.1|1.6|1.4|113|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81754354|0-19|All Races|Male and Female|2004|1.1|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81754354|0-19|All Races|Male and Female|2004|~|~|~
4.6|5.6|5.1|423|IX(d) Other specified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
1.0|1.5|1.2|100|IX(e) Unspecified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
0.2|0.4|0.3|25|Not classified by ICCC|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
2.9|3.6|3.2|266|V Retinoblastoma|81754354|0-19|All Races|Male and Female|2004|2.9|3.7|3.3
6.0|7.1|6.5|530|VI Renal tumors|81754354|0-19|All Races|Male and Female|2004|5.9|7.1|6.5
5.4|6.5|5.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|81754354|0-19|All Races|Male and Female|2004|5.4|6.4|5.9
0.4|0.8|0.6|47|VI(b) Renal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
2.1|2.8|2.4|197|VII Hepatic tumors|81754354|0-19|All Races|Male and Female|2004|2.1|2.8|2.4
1.5|2.1|1.8|145|VII(a) Hepatoblastoma|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
0.4|0.8|0.6|48|VII(b) Hepatic carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
8.4|9.7|9.1|750|VIII Malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|8.5|9.9|9.2
4.7|5.7|5.1|426|VIII(a) Osteosarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
0.4|0.7|0.5|42|VIII(b) Chondrosarcomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
2.4|3.1|2.7|227|VIII(c) Ewing tumor and related sarcomas of bone|81754354|0-19|All Races|Male and Female|2004|2.4|3.2|2.8
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
10.4|11.9|11.1|927|X Germ cell, trophoblastic tumors & neoplasms of gonads|81754354|0-19|All Races|Male and Female|2004|10.6|12.1|11.3
1.5|2.1|1.8|148|X(a) Intracranial & intraspinal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.3
6.7|7.9|7.3|609|X(c) Malignant gonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|6.9|8.1|7.4
0.3|0.6|0.4|33|X(d) Gonadal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
16.9|18.8|17.8|1486|XI Other malignant epithelial neoplasms and malignant melanomas|81754354|0-19|All Races|Male and Female|2004|17.3|19.1|18.2
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|81754354|0-19|All Races|Male and Female|2004|0.1|0.4|0.2
6.3|7.4|6.8|569|XI(b) Thyroid carcinomas|81754354|0-19|All Races|Male and Female|2004|6.4|7.6|7.0
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
5.9|7.0|6.4|537|XI(d) Malignant melanomas|81754354|0-19|All Races|Male and Female|2004|6.0|7.1|6.6
~|~|~|~|XI(e) Skin carcinomas|81754354|0-19|All Races|Male and Female|2004|~|~|~
3.3|4.1|3.7|308|XI(f) Other and unspecified carcinomas|81754354|0-19|All Races|Male and Female|2004|3.4|4.2|3.8
0.7|1.1|0.9|72|XII Other and unspecified malignant neoplasms|81754354|0-19|All Races|Male and Female|2004|0.7|1.1|0.9
0.2|0.5|0.4|29|XII(a) Other specified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.4
0.4|0.7|0.5|43|XII(b) Other unspecified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
170.0|175.7|172.8|14283|All ICCC Groups Combined|82005260|0-19|All Races|Male and Female|2005|171.3|177.1|174.2
43.1|46.1|44.6|3651|I Leukemias, myeloproliferative & myelodysplastic diseases|82005260|0-19|All Races|Male and Female|2005|43.1|46.0|44.5
30.8|33.3|32.0|2613|I(a) Lymphoid leukemias|82005260|0-19|All Races|Male and Female|2005|30.7|33.1|31.9
7.0|8.2|7.5|624|I(b) Acute myeloid leukemias|82005260|0-19|All Races|Male and Female|2005|7.0|8.2|7.6
1.8|2.4|2.1|174|I(c) Chronic myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.8|2.5|2.1
1.4|1.9|1.6|133|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
1.1|1.6|1.3|107|I(e) Unspecified and other specified leukemias|82005260|0-19|All Races|Male and Female|2005|1.1|1.6|1.3
24.8|27.0|25.9|2157|II Lymphomas and reticuloendothelial neoplasms|82005260|0-19|All Races|Male and Female|2005|25.2|27.4|26.3
12.0|13.5|12.7|1071|II(a) Hodgkin lymphomas|82005260|0-19|All Races|Male and Female|2005|12.3|13.9|13.1
8.4|9.7|9.0|748|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|0-19|All Races|Male and Female|2005|8.5|9.8|9.1
2.2|2.9|2.5|205|II(c) Burkitt lymphoma|82005260|0-19|All Races|Male and Female|2005|2.2|2.9|2.5
1.0|1.5|1.3|104|II(d) Miscellaneous lymphoreticular neoplasms|82005260|0-19|All Races|Male and Female|2005|1.0|1.5|1.3
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.4
29.2|31.6|30.4|2480|III CNS and misc intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|29.1|31.5|30.2
2.6|3.3|2.9|241|III(a) Ependymomas and choroid plexus tumor|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
14.7|16.4|15.5|1271|III(b) Astrocytomas|82005260|0-19|All Races|Male and Female|2005|14.7|16.4|15.5
5.4|6.5|5.9|480|III(c) Intracranial and intraspinal embryonal tumors|82005260|0-19|All Races|Male and Female|2005|5.3|6.4|5.9
4.4|5.4|4.9|397|III(d) Other gliomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.3|4.8
0.5|0.8|0.6|53|III(e) Other specified intracranial & intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.5
8.4|9.7|9.1|746|IV Neuroblastoma and other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|8.5|9.8|9.1
8.2|9.5|8.8|727|IV(a) Neuroblastoma and ganglioneuroblastoma|82005260|0-19|All Races|Male and Female|2005|8.2|9.5|8.9
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.4|0.2
11.6|13.1|12.3|1018|IX Soft tissue and other extraosseous sarcomas|82005260|0-19|All Races|Male and Female|2005|11.7|13.2|12.4
4.4|5.4|4.9|398|IX(a) Rhabdomyosarcomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.4|4.9
1.2|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82005260|0-19|All Races|Male and Female|2005|~|~|~
4.4|5.4|4.9|408|IX(d) Other specified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|4.5|5.5|5.0
0.9|1.4|1.1|91|IX(e) Unspecified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|0.9|1.4|1.1
0.2|0.4|0.3|23|Not classified by ICCC|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|3.0|244|V Retinoblastoma|82005260|0-19|All Races|Male and Female|2005|2.6|3.4|3.0
6.1|7.3|6.7|547|VI Renal tumors|82005260|0-19|All Races|Male and Female|2005|6.1|7.3|6.7
5.5|6.6|6.0|493|VI(a) Nephroblastoma and other nonepithelial renal tumors|82005260|0-19|All Races|Male and Female|2005|5.5|6.6|6.0
0.4|0.8|0.6|50|VI(b) Renal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
1.7|2.3|2.0|166|VII Hepatic tumors|82005260|0-19|All Races|Male and Female|2005|1.7|2.4|2.0
1.2|1.7|1.4|117|VII(a) Hepatoblastoma|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|82005260|0-19|All Races|Male and Female|2005|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
8.3|9.5|8.9|738|VIII Malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|8.4|9.7|9.0
4.6|5.5|5.0|418|VIII(a) Osteosarcomas|82005260|0-19|All Races|Male and Female|2005|4.6|5.6|5.1
0.2|0.4|0.3|23|VIII(b) Chondrosarcomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|3.0|244|VIII(c) Ewing tumor and related sarcomas of bone|82005260|0-19|All Races|Male and Female|2005|2.6|3.4|3.0
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
10.7|12.2|11.4|962|X Germ cell, trophoblastic tumors & neoplasms of gonads|82005260|0-19|All Races|Male and Female|2005|11.0|12.5|11.7
1.3|1.9|1.6|133|X(a) Intracranial & intraspinal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
1.3|1.9|1.6|134|X(b) Malignant extracranial & extragonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
6.9|8.1|7.5|635|X(c) Malignant gonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|7.2|8.4|7.7
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
16.6|18.4|17.5|1477|XI Other malignant epithelial neoplasms and malignant melanomas|82005260|0-19|All Races|Male and Female|2005|17.1|19.0|18.0
~|~|~|~|XI(a) Adrenocortical carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
5.7|6.7|6.2|523|XI(b) Thyroid carcinomas|82005260|0-19|All Races|Male and Female|2005|5.8|6.9|6.4
0.3|0.5|0.4|33|XI(c) Nasopharyngeal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
6.0|7.1|6.5|550|XI(d) Malignant melanomas|82005260|0-19|All Races|Male and Female|2005|6.2|7.3|6.7
~|~|~|~|XI(e) Skin carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
3.8|4.6|4.2|352|XI(f) Other and unspecified carcinomas|82005260|0-19|All Races|Male and Female|2005|3.9|4.8|4.3
0.7|1.1|0.9|74|XII Other and unspecified malignant neoplasms|82005260|0-19|All Races|Male and Female|2005|0.7|1.1|0.9
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.4|0.7|0.5|42|XII(b) Other unspecified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.4|0.7|0.5
170.5|176.2|173.4|14390|All ICCC Groups Combined|82324418|0-19|All Races|Male and Female|2006|172.0|177.7|174.8
45.6|48.6|47.1|3868|I Leukemias, myeloproliferative & myelodysplastic diseases|82324418|0-19|All Races|Male and Female|2006|45.5|48.5|47.0
32.1|34.6|33.3|2726|I(a) Lymphoid leukemias|82324418|0-19|All Races|Male and Female|2006|31.9|34.4|33.1
7.6|8.8|8.2|682|I(b) Acute myeloid leukemias|82324418|0-19|All Races|Male and Female|2006|7.7|8.9|8.3
2.1|2.8|2.4|204|I(c) Chronic myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|2.1|2.8|2.5
1.4|2.0|1.7|140|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|1.4|2.0|1.7
1.2|1.7|1.4|116|I(e) Unspecified and other specified leukemias|82324418|0-19|All Races|Male and Female|2006|1.2|1.7|1.4
24.1|26.2|25.1|2107|II Lymphomas and reticuloendothelial neoplasms|82324418|0-19|All Races|Male and Female|2006|24.5|26.7|25.6
11.8|13.3|12.5|1058|II(a) Hodgkin lymphomas|82324418|0-19|All Races|Male and Female|2006|12.1|13.6|12.9
8.1|9.4|8.7|728|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|0-19|All Races|Male and Female|2006|8.2|9.5|8.8
2.1|2.8|2.4|199|II(c) Burkitt lymphoma|82324418|0-19|All Races|Male and Female|2006|2.1|2.8|2.4
1.0|1.5|1.2|99|II(d) Miscellaneous lymphoreticular neoplasms|82324418|0-19|All Races|Male and Female|2006|1.0|1.5|1.2
0.2|0.4|0.3|23|II(e) Unspecified lymphomas|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
30.2|32.6|31.4|2571|III CNS and misc intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|30.0|32.5|31.2
2.5|3.2|2.8|234|III(a) Ependymomas and choroid plexus tumor|82324418|0-19|All Races|Male and Female|2006|2.5|3.2|2.8
14.6|16.3|15.5|1271|III(b) Astrocytomas|82324418|0-19|All Races|Male and Female|2006|14.6|16.3|15.4
5.8|6.9|6.4|519|III(c) Intracranial and intraspinal embryonal tumors|82324418|0-19|All Races|Male and Female|2006|5.8|6.9|6.3
5.0|6.0|5.5|449|III(d) Other gliomas|82324418|0-19|All Races|Male and Female|2006|5.0|6.0|5.5
0.4|0.8|0.6|48|III(e) Other specified intracranial & intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.4|0.8|0.6
0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
7.3|8.6|7.9|653|IV Neuroblastoma and other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|7.3|8.6|7.9
7.2|8.4|7.7|638|IV(a) Neuroblastoma and ganglioneuroblastoma|82324418|0-19|All Races|Male and Female|2006|7.2|8.4|7.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
11.0|12.5|11.8|976|IX Soft tissue and other extraosseous sarcomas|82324418|0-19|All Races|Male and Female|2006|11.1|12.6|11.9
4.1|5.1|4.6|377|IX(a) Rhabdomyosarcomas|82324418|0-19|All Races|Male and Female|2006|4.1|5.1|4.6
1.1|1.6|1.3|110|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82324418|0-19|All Races|Male and Female|2006|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82324418|0-19|All Races|Male and Female|2006|~|~|~
4.1|5.0|4.6|381|IX(d) Other specified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|4.2|5.1|4.6
1.0|1.5|1.2|103|IX(e) Unspecified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|1.0|1.5|1.3
0.2|0.4|0.3|24|Not classified by ICCC|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
2.7|3.5|3.1|254|V Retinoblastoma|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.1
6.2|7.3|6.7|552|VI Renal tumors|82324418|0-19|All Races|Male and Female|2006|6.2|7.3|6.7
5.5|6.5|6.0|487|VI(a) Nephroblastoma and other nonepithelial renal tumors|82324418|0-19|All Races|Male and Female|2006|5.4|6.5|5.9
0.5|0.9|0.7|59|VI(b) Renal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
2.0|2.6|2.3|191|VII Hepatic tumors|82324418|0-19|All Races|Male and Female|2006|2.0|2.7|2.3
1.4|1.9|1.6|134|VII(a) Hepatoblastoma|82324418|0-19|All Races|Male and Female|2006|1.4|1.9|1.6
0.5|0.8|0.6|53|VII(b) Hepatic carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
8.6|10.0|9.3|775|VIII Malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|8.8|10.1|9.4
4.9|5.9|5.4|449|VIII(a) Osteosarcomas|82324418|0-19|All Races|Male and Female|2006|5.0|6.0|5.5
0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
2.7|3.4|3.0|251|VIII(c) Ewing tumor and related sarcomas of bone|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.0
0.4|0.7|0.5|44|VIII(d) Other specified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
9.6|11.0|10.3|872|X Germ cell, trophoblastic tumors & neoplasms of gonads|82324418|0-19|All Races|Male and Female|2006|9.9|11.3|10.6
1.3|1.8|1.5|126|X(a) Intracranial & intraspinal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
1.3|1.8|1.5|129|X(b) Malignant extracranial & extragonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.9|1.6
5.9|6.9|6.4|546|X(c) Malignant gonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.2|6.6
0.4|0.7|0.5|42|X(d) Gonadal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.2|0.5|0.3|29|X(e) Other and unspecified malignant gonadal tumors|82324418|0-19|All Races|Male and Female|2006|0.2|0.5|0.4
16.5|18.2|17.3|1474|XI Other malignant epithelial neoplasms and malignant melanomas|82324418|0-19|All Races|Male and Female|2006|17.0|18.8|17.9
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
6.2|7.3|6.7|574|XI(b) Thyroid carcinomas|82324418|0-19|All Races|Male and Female|2006|6.4|7.6|7.0
0.5|0.8|0.6|54|XI(c) Nasopharyngeal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
4.9|5.9|5.4|461|XI(d) Malignant melanomas|82324418|0-19|All Races|Male and Female|2006|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|82324418|0-19|All Races|Male and Female|2006|~|~|~
3.8|4.7|4.3|362|XI(f) Other and unspecified carcinomas|82324418|0-19|All Races|Male and Female|2006|4.0|4.9|4.4
0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|82324418|0-19|All Races|Male and Female|2006|0.7|1.1|0.9
0.4|0.7|0.5|41|XII(a) Other specified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.3|0.5|0.4|32|XII(b) Other unspecified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.3|0.5|0.4
174.6|180.3|177.4|14826|All ICCC Groups Combined|82749431|0-19|All Races|Male and Female|2007|176.3|182.1|179.2
45.9|48.9|47.4|3919|I Leukemias, myeloproliferative & myelodysplastic diseases|82749431|0-19|All Races|Male and Female|2007|45.9|48.9|47.4
33.0|35.6|34.3|2819|I(a) Lymphoid leukemias|82749431|0-19|All Races|Male and Female|2007|32.8|35.3|34.1
7.4|8.6|8.0|666|I(b) Acute myeloid leukemias|82749431|0-19|All Races|Male and Female|2007|7.4|8.7|8.0
2.2|2.9|2.6|217|I(c) Chronic myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|2.3|3.0|2.6
1.2|1.8|1.5|123|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|1.2|1.8|1.5
0.9|1.4|1.1|94|I(e) Unspecified and other specified leukemias|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
24.0|26.1|25.0|2113|II Lymphomas and reticuloendothelial neoplasms|82749431|0-19|All Races|Male and Female|2007|24.5|26.6|25.5
11.4|12.9|12.1|1038|II(a) Hodgkin lymphomas|82749431|0-19|All Races|Male and Female|2007|11.8|13.3|12.5
8.2|9.4|8.8|734|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|0-19|All Races|Male and Female|2007|8.2|9.5|8.9
2.3|3.0|2.6|214|II(c) Burkitt lymphoma|82749431|0-19|All Races|Male and Female|2007|2.3|3.0|2.6
0.9|1.4|1.1|92|II(d) Miscellaneous lymphoreticular neoplasms|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
30.9|33.3|32.1|2641|III CNS and misc intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|30.7|33.2|31.9
2.2|2.9|2.5|210|III(a) Ependymomas and choroid plexus tumor|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.5
15.3|17.1|16.2|1336|III(b) Astrocytomas|82749431|0-19|All Races|Male and Female|2007|15.3|17.0|16.1
5.9|7.1|6.5|531|III(c) Intracranial and intraspinal embryonal tumors|82749431|0-19|All Races|Male and Female|2007|5.9|7.0|6.4
5.2|6.3|5.7|468|III(d) Other gliomas|82749431|0-19|All Races|Male and Female|2007|5.2|6.2|5.7
0.5|0.9|0.7|58|III(e) Other specified intracranial & intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.5
8.4|9.7|9.0|754|IV Neuroblastoma and other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|8.5|9.8|9.1
8.2|9.5|8.8|735|IV(a) Neuroblastoma and ganglioneuroblastoma|82749431|0-19|All Races|Male and Female|2007|8.3|9.5|8.9
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|0.1|0.4|0.2
11.8|13.3|12.6|1050|IX Soft tissue and other extraosseous sarcomas|82749431|0-19|All Races|Male and Female|2007|11.9|13.5|12.7
4.7|5.7|5.2|426|IX(a) Rhabdomyosarcomas|82749431|0-19|All Races|Male and Female|2007|4.7|5.7|5.1
1.1|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82749431|0-19|All Races|Male and Female|2007|~|~|~
4.3|5.3|4.8|403|IX(d) Other specified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|4.4|5.4|4.9
1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|1.0|1.5|1.2
0.1|0.3|0.2|18|Not classified by ICCC|82749431|0-19|All Races|Male and Female|2007|0.1|0.3|0.2
2.9|3.7|3.3|274|V Retinoblastoma|82749431|0-19|All Races|Male and Female|2007|2.9|3.7|3.3
6.4|7.5|6.9|570|VI Renal tumors|82749431|0-19|All Races|Male and Female|2007|6.3|7.5|6.9
5.7|6.8|6.2|514|VI(a) Nephroblastoma and other nonepithelial renal tumors|82749431|0-19|All Races|Male and Female|2007|5.7|6.8|6.2
0.5|0.8|0.6|54|VI(b) Renal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
2.0|2.6|2.3|193|VII Hepatic tumors|82749431|0-19|All Races|Male and Female|2007|2.0|2.7|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|82749431|0-19|All Races|Male and Female|2007|1.4|2.0|1.7
0.4|0.8|0.6|51|VII(b) Hepatic carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
8.2|9.5|8.8|736|VIII Malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|8.3|9.6|8.9
4.3|5.2|4.7|394|VIII(a) Osteosarcomas|82749431|0-19|All Races|Male and Female|2007|4.3|5.3|4.8
0.2|0.5|0.4|31|VIII(b) Chondrosarcomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
2.7|3.5|3.1|256|VIII(c) Ewing tumor and related sarcomas of bone|82749431|0-19|All Races|Male and Female|2007|2.7|3.5|3.1
0.3|0.6|0.4|34|VIII(d) Other specified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
10.5|11.9|11.2|960|X Germ cell, trophoblastic tumors & neoplasms of gonads|82749431|0-19|All Races|Male and Female|2007|10.9|12.4|11.6
1.4|1.9|1.6|135|X(a) Intracranial & intraspinal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.4|1.9|1.6
1.1|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
7.0|8.1|7.5|649|X(c) Malignant gonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|7.3|8.5|7.8
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
0.2|0.4|0.3|26|X(e) Other and unspecified malignant gonadal tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.3
16.9|18.7|17.8|1528|XI Other malignant epithelial neoplasms and malignant melanomas|82749431|0-19|All Races|Male and Female|2007|17.6|19.4|18.5
~|~|~|~|XI(a) Adrenocortical carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
6.8|8.0|7.4|639|XI(b) Thyroid carcinomas|82749431|0-19|All Races|Male and Female|2007|7.1|8.3|7.7
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
4.9|5.9|5.4|462|XI(d) Malignant melanomas|82749431|0-19|All Races|Male and Female|2007|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
3.7|4.6|4.1|353|XI(f) Other and unspecified carcinomas|82749431|0-19|All Races|Male and Female|2007|3.8|4.7|4.3
0.6|1.0|0.8|70|XII Other and unspecified malignant neoplasms|82749431|0-19|All Races|Male and Female|2007|0.7|1.1|0.8
0.2|0.5|0.4|30|XII(a) Other specified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.3|0.6|0.5|40|XII(b) Other unspecified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.7|0.5
176.7|182.4|179.5|15070|All ICCC Groups Combined|83118264|0-19|All Races|Male and Female|2008|178.4|184.2|181.3
47.6|50.6|49.1|4077|I Leukemias, myeloproliferative & myelodysplastic diseases|83118264|0-19|All Races|Male and Female|2008|47.6|50.6|49.1
33.9|36.5|35.2|2912|I(a) Lymphoid leukemias|83118264|0-19|All Races|Male and Female|2008|33.8|36.3|35.0
7.7|9.0|8.3|701|I(b) Acute myeloid leukemias|83118264|0-19|All Races|Male and Female|2008|7.8|9.1|8.4
2.5|3.2|2.8|239|I(c) Chronic myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|2.5|3.3|2.9
1.3|1.9|1.6|132|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|1.3|1.9|1.6
0.9|1.4|1.1|93|I(e) Unspecified and other specified leukemias|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
24.5|26.7|25.6|2164|II Lymphomas and reticuloendothelial neoplasms|83118264|0-19|All Races|Male and Female|2008|24.9|27.2|26.0
12.2|13.7|13.0|1108|II(a) Hodgkin lymphomas|83118264|0-19|All Races|Male and Female|2008|12.6|14.1|13.3
8.2|9.4|8.8|739|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|0-19|All Races|Male and Female|2008|8.3|9.6|8.9
2.2|2.9|2.6|212|II(c) Burkitt lymphoma|83118264|0-19|All Races|Male and Female|2008|2.2|2.9|2.6
0.7|1.2|0.9|78|II(d) Miscellaneous lymphoreticular neoplasms|83118264|0-19|All Races|Male and Female|2008|0.7|1.2|0.9
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
31.2|33.7|32.4|2684|III CNS and misc intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|31.1|33.5|32.3
2.0|2.7|2.3|195|III(a) Ependymomas and choroid plexus tumor|83118264|0-19|All Races|Male and Female|2008|2.0|2.7|2.3
15.6|17.3|16.4|1361|III(b) Astrocytomas|83118264|0-19|All Races|Male and Female|2008|15.5|17.3|16.4
6.2|7.3|6.8|558|III(c) Intracranial and intraspinal embryonal tumors|83118264|0-19|All Races|Male and Female|2008|6.2|7.3|6.7
5.3|6.3|5.8|479|III(d) Other gliomas|83118264|0-19|All Races|Male and Female|2008|5.3|6.3|5.8
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.5|0.9|0.7
0.3|0.5|0.4|32|III(f) Unspecified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
7.8|9.1|8.4|705|IV Neuroblastoma and other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|7.9|9.1|8.5
7.5|8.7|8.1|677|IV(a) Neuroblastoma and ganglioneuroblastoma|83118264|0-19|All Races|Male and Female|2008|7.5|8.8|8.1
0.2|0.5|0.3|28|IV(b) Other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
11.6|13.1|12.3|1033|IX Soft tissue and other extraosseous sarcomas|83118264|0-19|All Races|Male and Female|2008|11.7|13.2|12.4
4.6|5.6|5.1|425|IX(a) Rhabdomyosarcomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
0.9|1.4|1.1|95|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|83118264|0-19|All Races|Male and Female|2008|~|~|~
4.1|5.0|4.6|385|IX(d) Other specified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|4.2|5.1|4.6
1.2|1.8|1.5|126|IX(e) Unspecified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|1.3|1.8|1.5
0.2|0.4|0.3|24|Not classified by ICCC|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
2.8|3.6|3.2|268|V Retinoblastoma|83118264|0-19|All Races|Male and Female|2008|2.8|3.6|3.2
6.7|7.8|7.2|601|VI Renal tumors|83118264|0-19|All Races|Male and Female|2008|6.7|7.8|7.2
5.9|7.0|6.5|537|VI(a) Nephroblastoma and other nonepithelial renal tumors|83118264|0-19|All Races|Male and Female|2008|5.9|7.0|6.5
0.5|0.9|0.7|61|VI(b) Renal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.6|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
1.9|2.6|2.3|190|VII Hepatic tumors|83118264|0-19|All Races|Male and Female|2008|2.0|2.6|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|83118264|0-19|All Races|Male and Female|2008|1.4|2.0|1.7
0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
8.2|9.5|8.8|739|VIII Malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|8.3|9.6|8.9
4.5|5.5|5.0|415|VIII(a) Osteosarcomas|83118264|0-19|All Races|Male and Female|2008|4.5|5.5|5.0
0.3|0.6|0.4|34|VIII(b) Chondrosarcomas|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
2.4|3.2|2.8|232|VIII(c) Ewing tumor and related sarcomas of bone|83118264|0-19|All Races|Male and Female|2008|2.4|3.2|2.8
0.3|0.6|0.4|35|VIII(d) Other specified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
0.2|0.4|0.3|23|VIII(e) Unspecified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
10.3|11.7|11.0|945|X Germ cell, trophoblastic tumors & neoplasms of gonads|83118264|0-19|All Races|Male and Female|2008|10.7|12.1|11.4
1.5|2.1|1.8|147|X(a) Intracranial & intraspinal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.5|2.1|1.8
1.2|1.7|1.4|123|X(b) Malignant extracranial & extragonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.2|1.8|1.5
6.7|7.8|7.3|630|X(c) Malignant gonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|7.0|8.2|7.6
0.2|0.5|0.3|30|X(d) Gonadal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.4
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
17.4|19.2|18.3|1575|XI Other malignant epithelial neoplasms and malignant melanomas|83118264|0-19|All Races|Male and Female|2008|18.0|19.9|18.9
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|83118264|0-19|All Races|Male and Female|2008|0.1|0.4|0.2
7.6|8.8|8.2|707|XI(b) Thyroid carcinomas|83118264|0-19|All Races|Male and Female|2008|7.9|9.2|8.5
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.7|0.6
4.5|5.4|4.9|422|XI(d) Malignant melanomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
~|~|~|~|XI(e) Skin carcinomas|83118264|0-19|All Races|Male and Female|2008|~|~|~
3.9|4.8|4.4|375|XI(f) Other and unspecified carcinomas|83118264|0-19|All Races|Male and Female|2008|4.1|5.0|4.5
0.6|1.0|0.8|65|XII Other and unspecified malignant neoplasms|83118264|0-19|All Races|Male and Female|2008|0.6|1.0|0.8
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
0.3|0.5|0.4|33|XII(b) Other unspecified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
175.8|181.5|178.6|15008|All ICCC Groups Combined|83280391|0-19|All Races|Male and Female|2009|177.3|183.1|180.2
46.1|49.1|47.6|3965|I Leukemias, myeloproliferative & myelodysplastic diseases|83280391|0-19|All Races|Male and Female|2009|46.1|49.1|47.6
33.6|36.2|34.9|2894|I(a) Lymphoid leukemias|83280391|0-19|All Races|Male and Female|2009|33.5|36.0|34.8
7.1|8.2|7.6|641|I(b) Acute myeloid leukemias|83280391|0-19|All Races|Male and Female|2009|7.1|8.3|7.7
2.1|2.7|2.4|203|I(c) Chronic myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|2.1|2.8|2.4
1.3|1.8|1.5|130|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|1.3|1.9|1.6
0.9|1.4|1.2|97|I(e) Unspecified and other specified leukemias|83280391|0-19|All Races|Male and Female|2009|0.9|1.4|1.2
24.3|26.4|25.3|2148|II Lymphomas and reticuloendothelial neoplasms|83280391|0-19|All Races|Male and Female|2009|24.7|26.9|25.8
11.9|13.4|12.6|1081|II(a) Hodgkin lymphomas|83280391|0-19|All Races|Male and Female|2009|12.2|13.8|13.0
8.2|9.5|8.9|745|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|0-19|All Races|Male and Female|2009|8.3|9.6|8.9
1.9|2.6|2.2|184|II(c) Burkitt lymphoma|83280391|0-19|All Races|Male and Female|2009|1.9|2.6|2.2
1.1|1.6|1.3|112|II(d) Miscellaneous lymphoreticular neoplasms|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.3
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
31.1|33.5|32.3|2677|III CNS and misc intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|30.9|33.4|32.1
2.1|2.8|2.4|203|III(a) Ependymomas and choroid plexus tumor|83280391|0-19|All Races|Male and Female|2009|2.1|2.8|2.4
15.6|17.3|16.4|1363|III(b) Astrocytomas|83280391|0-19|All Races|Male and Female|2009|15.5|17.3|16.4
5.8|6.9|6.4|525|III(c) Intracranial and intraspinal embryonal tumors|83280391|0-19|All Races|Male and Female|2009|5.8|6.9|6.3
5.5|6.6|6.1|501|III(d) Other gliomas|83280391|0-19|All Races|Male and Female|2009|5.5|6.6|6.0
0.4|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
0.3|0.6|0.4|36|III(f) Unspecified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.3|0.6|0.4
7.7|8.9|8.3|691|IV Neuroblastoma and other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|7.7|8.9|8.3
7.4|8.7|8.0|668|IV(a) Neuroblastoma and ganglioneuroblastoma|83280391|0-19|All Races|Male and Female|2009|7.4|8.7|8.0
0.2|0.4|0.3|23|IV(b) Other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
11.5|13.0|12.2|1027|IX Soft tissue and other extraosseous sarcomas|83280391|0-19|All Races|Male and Female|2009|11.6|13.1|12.3
3.8|4.7|4.3|356|IX(a) Rhabdomyosarcomas|83280391|0-19|All Races|Male and Female|2009|3.8|4.7|4.3
1.3|1.9|1.6|132|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83280391|0-19|All Races|Male and Female|2009|1.3|1.9|1.6
~|~|~|~|IX(c) Kaposi sarcoma|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.5|5.5|5.0|418|IX(d) Other specified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|4.5|5.5|5.0
1.1|1.6|1.4|114|IX(e) Unspecified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.4
0.2|0.5|0.3|27|Not classified by ICCC|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
3.0|3.8|3.4|284|V Retinoblastoma|83280391|0-19|All Races|Male and Female|2009|3.0|3.8|3.4
6.8|8.0|7.4|615|VI Renal tumors|83280391|0-19|All Races|Male and Female|2009|6.8|8.0|7.4
6.0|7.1|6.6|545|VI(a) Nephroblastoma and other nonepithelial renal tumors|83280391|0-19|All Races|Male and Female|2009|6.0|7.1|6.5
0.6|1.0|0.8|68|VI(b) Renal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
1.7|2.3|2.0|167|VII Hepatic tumors|83280391|0-19|All Races|Male and Female|2009|1.7|2.3|2.0
1.1|1.7|1.4|116|VII(a) Hepatoblastoma|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
8.4|9.7|9.0|757|VIII Malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|8.5|9.8|9.1
4.6|5.6|5.1|425|VIII(a) Osteosarcomas|83280391|0-19|All Races|Male and Female|2009|4.6|5.6|5.1
0.2|0.5|0.3|27|VIII(b) Chondrosarcomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
2.6|3.3|2.9|247|VIII(c) Ewing tumor and related sarcomas of bone|83280391|0-19|All Races|Male and Female|2009|2.6|3.4|3.0
0.3|0.7|0.5|41|VIII(d) Other specified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.5
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.1|0.3|0.2
10.9|12.3|11.6|995|X Germ cell, trophoblastic tumors & neoplasms of gonads|83280391|0-19|All Races|Male and Female|2009|11.2|12.7|11.9
1.4|2.0|1.7|142|X(a) Intracranial & intraspinal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.4|2.0|1.7
1.1|1.6|1.4|116|X(b) Malignant extracranial & extragonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
7.0|8.2|7.6|655|X(c) Malignant gonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|7.3|8.5|7.9
0.5|0.8|0.6|53|X(d) Gonadal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.8|0.6
0.2|0.5|0.3|29|X(e) Other and unspecified malignant gonadal tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
17.4|19.3|18.3|1579|XI Other malignant epithelial neoplasms and malignant melanomas|83280391|0-19|All Races|Male and Female|2009|18.0|19.9|19.0
0.2|0.4|0.2|21|XI(a) Adrenocortical carcinomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
7.8|9.0|8.4|721|XI(b) Thyroid carcinomas|83280391|0-19|All Races|Male and Female|2009|8.0|9.3|8.7
0.5|0.9|0.7|59|XI(c) Nasopharyngeal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.9|0.7
4.0|4.9|4.4|381|XI(d) Malignant melanomas|83280391|0-19|All Races|Male and Female|2009|4.1|5.1|4.6
~|~|~|~|XI(e) Skin carcinomas|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.1|5.0|4.5|388|XI(f) Other and unspecified carcinomas|83280391|0-19|All Races|Male and Female|2009|4.2|5.1|4.7
0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|83280391|0-19|All Races|Male and Female|2009|0.7|1.1|0.9
0.2|0.5|0.4|31|XII(a) Other specified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.3|0.5|0.4
0.4|0.7|0.5|45|XII(b) Other unspecified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.5
179.8|185.6|182.7|15297|All ICCC Groups Combined|83184292|0-19|All Races|Male and Female|2010|181.0|186.8|183.9
47.6|50.7|49.1|4091|I Leukemias, myeloproliferative & myelodysplastic diseases|83184292|0-19|All Races|Male and Female|2010|47.7|50.7|49.2
33.4|36.0|34.7|2877|I(a) Lymphoid leukemias|83184292|0-19|All Races|Male and Female|2010|33.3|35.9|34.6
7.8|9.0|8.4|702|I(b) Acute myeloid leukemias|83184292|0-19|All Races|Male and Female|2010|7.8|9.1|8.4
2.4|3.1|2.7|227|I(c) Chronic myeloproliferative diseases|83184292|0-19|All Races|Male and Female|2010|2.4|3.1|2.7
1.5|2.1|1.8|150|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83184292|0-19|All Races|Male and Female|2010|1.5|2.1|1.8
1.4|1.9|1.6|135|I(e) Unspecified and other specified leukemias|83184292|0-19|All Races|Male and Female|2010|1.4|1.9|1.6
26.5|28.8|27.6|2329|II Lymphomas and reticuloendothelial neoplasms|83184292|0-19|All Races|Male and Female|2010|26.9|29.2|28.0
11.4|12.9|12.2|1037|II(a) Hodgkin lymphomas|83184292|0-19|All Races|Male and Female|2010|11.7|13.2|12.5
8.1|9.3|8.7|727|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83184292|0-19|All Races|Male and Female|2010|8.1|9.4|8.7
2.1|2.8|2.4|200|II(c) Burkitt lymphoma|83184292|0-19|All Races|Male and Female|2010|2.1|2.8|2.4
3.6|4.5|4.1|336|II(d) Miscellaneous lymphoreticular neoplasms|83184292|0-19|All Races|Male and Female|2010|3.6|4.5|4.0
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|83184292|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
31.5|34.0|32.8|2715|III CNS and misc intracranial and intraspinal neoplasms|83184292|0-19|All Races|Male and Female|2010|31.4|33.9|32.6
2.5|3.3|2.9|239|III(a) Ependymomas and choroid plexus tumor|83184292|0-19|All Races|Male and Female|2010|2.5|3.3|2.9
16.3|18.1|17.2|1425|III(b) Astrocytomas|83184292|0-19|All Races|Male and Female|2010|16.3|18.0|17.1
5.6|6.6|6.1|503|III(c) Intracranial and intraspinal embryonal tumors|83184292|0-19|All Races|Male and Female|2010|5.5|6.6|6.0
5.2|6.2|5.7|470|III(d) Other gliomas|83184292|0-19|All Races|Male and Female|2010|5.2|6.2|5.7
0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|83184292|0-19|All Races|Male and Female|2010|0.5|0.8|0.6
0.2|0.5|0.3|27|III(f) Unspecified intracranial and intraspinal neoplasms|83184292|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
8.0|9.3|8.6|715|IV Neuroblastoma and other peripheral nervous cell tumors|83184292|0-19|All Races|Male and Female|2010|8.0|9.2|8.6
7.8|9.0|8.4|697|IV(a) Neuroblastoma and ganglioneuroblastoma|83184292|0-19|All Races|Male and Female|2010|7.8|9.0|8.4
0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|83184292|0-19|All Races|Male and Female|2010|0.1|0.3|0.2
12.1|13.7|12.9|1078|IX Soft tissue and other extraosseous sarcomas|83184292|0-19|All Races|Male and Female|2010|12.2|13.8|13.0
4.8|5.8|5.3|439|IX(a) Rhabdomyosarcomas|83184292|0-19|All Races|Male and Female|2010|4.8|5.8|5.3
0.8|1.3|1.1|89|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83184292|0-19|All Races|Male and Female|2010|0.9|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|83184292|0-19|All Races|Male and Female|2010|~|~|~
4.3|5.3|4.8|400|IX(d) Other specified soft tissue sarcomas|83184292|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
1.5|2.0|1.7|146|IX(e) Unspecified soft tissue sarcomas|83184292|0-19|All Races|Male and Female|2010|1.5|2.1|1.8
0.1|0.4|0.2|19|Not classified by ICCC|83184292|0-19|All Races|Male and Female|2010|0.1|0.4|0.2
3.0|3.8|3.4|284|V Retinoblastoma|83184292|0-19|All Races|Male and Female|2010|3.0|3.8|3.4
6.1|7.3|6.7|556|VI Renal tumors|83184292|0-19|All Races|Male and Female|2010|6.1|7.3|6.7
5.6|6.7|6.2|513|VI(a) Nephroblastoma and other nonepithelial renal tumors|83184292|0-19|All Races|Male and Female|2010|5.6|6.7|6.2
0.4|0.7|0.5|42|VI(b) Renal carcinomas|83184292|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|83184292|0-19|All Races|Male and Female|2010|~|~|~
2.3|3.0|2.6|221|VII Hepatic tumors|83184292|0-19|All Races|Male and Female|2010|2.3|3.0|2.7
1.6|2.2|1.9|159|VII(a) Hepatoblastoma|83184292|0-19|All Races|Male and Female|2010|1.6|2.2|1.9
0.5|0.9|0.7|60|VII(b) Hepatic carcinomas|83184292|0-19|All Races|Male and Female|2010|0.6|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83184292|0-19|All Races|Male and Female|2010|~|~|~
7.7|9.0|8.4|699|VIII Malignant bone tumors|83184292|0-19|All Races|Male and Female|2010|7.8|9.0|8.4
4.3|5.2|4.7|397|VIII(a) Osteosarcomas|83184292|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
0.3|0.5|0.4|33|VIII(b) Chondrosarcomas|83184292|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
2.3|3.0|2.6|217|VIII(c) Ewing tumor and related sarcomas of bone|83184292|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
0.3|0.6|0.4|37|VIII(d) Other specified malignant bone tumors|83184292|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|83184292|0-19|All Races|Male and Female|2010|~|~|~
10.9|12.3|11.6|985|X Germ cell, trophoblastic tumors & neoplasms of gonads|83184292|0-19|All Races|Male and Female|2010|11.1|12.6|11.8
1.7|2.3|2.0|167|X(a) Intracranial & intraspinal germ cell tumors|83184292|0-19|All Races|Male and Female|2010|1.7|2.3|2.0
1.1|1.6|1.3|112|X(b) Malignant extracranial & extragonadal germ cell tumors|83184292|0-19|All Races|Male and Female|2010|1.1|1.6|1.3
6.8|7.9|7.3|628|X(c) Malignant gonadal germ cell tumors|83184292|0-19|All Races|Male and Female|2010|7.0|8.2|7.5
0.4|0.7|0.5|43|X(d) Gonadal carcinomas|83184292|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
0.3|0.6|0.4|35|X(e) Other and unspecified malignant gonadal tumors|83184292|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
17.2|19.0|18.1|1546|XI Other malignant epithelial neoplasms and malignant melanomas|83184292|0-19|All Races|Male and Female|2010|17.7|19.5|18.6
0.2|0.4|0.3|21|XI(a) Adrenocortical carcinomas|83184292|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
8.0|9.3|8.6|742|XI(b) Thyroid carcinomas|83184292|0-19|All Races|Male and Female|2010|8.3|9.6|8.9
0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|83184292|0-19|All Races|Male and Female|2010|0.4|0.8|0.6
3.6|4.5|4.0|343|XI(d) Malignant melanomas|83184292|0-19|All Races|Male and Female|2010|3.7|4.6|4.1
~|~|~|~|XI(e) Skin carcinomas|83184292|0-19|All Races|Male and Female|2010|~|~|~
4.0|4.9|4.5|382|XI(f) Other and unspecified carcinomas|83184292|0-19|All Races|Male and Female|2010|4.1|5.1|4.6
0.5|0.9|0.7|59|XII Other and unspecified malignant neoplasms|83184292|0-19|All Races|Male and Female|2010|0.5|0.9|0.7
0.3|0.6|0.4|34|XII(a) Other specified malignant tumors|83184292|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
0.2|0.4|0.3|25|XII(b) Other unspecified malignant tumors|83184292|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
181.8|187.7|184.8|15393|All ICCC Groups Combined|82838469|0-19|All Races|Male and Female|2011|182.9|188.8|185.8
47.9|50.9|49.4|4096|I Leukemias, myeloproliferative & myelodysplastic diseases|82838469|0-19|All Races|Male and Female|2011|47.9|51.0|49.4
34.6|37.2|35.9|2969|I(a) Lymphoid leukemias|82838469|0-19|All Races|Male and Female|2011|34.6|37.2|35.8
7.7|9.0|8.3|694|I(b) Acute myeloid leukemias|82838469|0-19|All Races|Male and Female|2011|7.8|9.0|8.4
2.1|2.8|2.4|204|I(c) Chronic myeloproliferative diseases|82838469|0-19|All Races|Male and Female|2011|2.1|2.8|2.5
1.1|1.6|1.3|107|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82838469|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
1.2|1.8|1.5|122|I(e) Unspecified and other specified leukemias|82838469|0-19|All Races|Male and Female|2011|1.2|1.8|1.5
27.0|29.2|28.1|2349|II Lymphomas and reticuloendothelial neoplasms|82838469|0-19|All Races|Male and Female|2011|27.2|29.5|28.4
11.2|12.6|11.9|1004|II(a) Hodgkin lymphomas|82838469|0-19|All Races|Male and Female|2011|11.4|12.9|12.1
7.9|9.1|8.5|707|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82838469|0-19|All Races|Male and Female|2011|7.9|9.2|8.5
2.2|2.9|2.5|208|II(c) Burkitt lymphoma|82838469|0-19|All Races|Male and Female|2011|2.2|2.9|2.5
4.4|5.4|4.9|401|II(d) Miscellaneous lymphoreticular neoplasms|82838469|0-19|All Races|Male and Female|2011|4.4|5.3|4.8
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|82838469|0-19|All Races|Male and Female|2011|0.2|0.5|0.4
32.3|34.8|33.5|2775|III CNS and misc intracranial and intraspinal neoplasms|82838469|0-19|All Races|Male and Female|2011|32.3|34.8|33.5
2.5|3.3|2.9|238|III(a) Ependymomas and choroid plexus tumor|82838469|0-19|All Races|Male and Female|2011|2.5|3.3|2.9
16.6|18.4|17.5|1449|III(b) Astrocytomas|82838469|0-19|All Races|Male and Female|2011|16.6|18.4|17.5
5.6|6.7|6.1|507|III(c) Intracranial and intraspinal embryonal tumors|82838469|0-19|All Races|Male and Female|2011|5.6|6.7|6.1
5.5|6.6|6.0|496|III(d) Other gliomas|82838469|0-19|All Races|Male and Female|2011|5.5|6.5|6.0
0.4|0.8|0.6|50|III(e) Other specified intracranial & intraspinal neoplasms|82838469|0-19|All Races|Male and Female|2011|0.4|0.8|0.6
0.3|0.6|0.4|35|III(f) Unspecified intracranial and intraspinal neoplasms|82838469|0-19|All Races|Male and Female|2011|0.3|0.6|0.4
8.0|9.3|8.7|717|IV Neuroblastoma and other peripheral nervous cell tumors|82838469|0-19|All Races|Male and Female|2011|8.0|9.3|8.7
7.8|9.1|8.4|696|IV(a) Neuroblastoma and ganglioneuroblastoma|82838469|0-19|All Races|Male and Female|2011|7.8|9.0|8.4
0.2|0.4|0.3|21|IV(b) Other peripheral nervous cell tumors|82838469|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
11.5|13.0|12.2|1019|IX Soft tissue and other extraosseous sarcomas|82838469|0-19|All Races|Male and Female|2011|11.6|13.1|12.3
4.3|5.2|4.7|392|IX(a) Rhabdomyosarcomas|82838469|0-19|All Races|Male and Female|2011|4.3|5.2|4.7
1.1|1.6|1.3|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82838469|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82838469|0-19|All Races|Male and Female|2011|~|~|~
4.4|5.3|4.8|404|IX(d) Other specified soft tissue sarcomas|82838469|0-19|All Races|Male and Female|2011|4.4|5.4|4.9
1.1|1.6|1.3|107|IX(e) Unspecified soft tissue sarcomas|82838469|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
0.2|0.4|0.3|22|Not classified by ICCC|82838469|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
2.8|3.6|3.2|263|V Retinoblastoma|82838469|0-19|All Races|Male and Female|2011|2.8|3.6|3.2
6.6|7.8|7.2|597|VI Renal tumors|82838469|0-19|All Races|Male and Female|2011|6.6|7.8|7.2
6.0|7.1|6.5|540|VI(a) Nephroblastoma and other nonepithelial renal tumors|82838469|0-19|All Races|Male and Female|2011|6.0|7.1|6.5
0.5|0.9|0.7|56|VI(b) Renal carcinomas|82838469|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82838469|0-19|All Races|Male and Female|2011|~|~|~
2.3|3.0|2.6|216|VII Hepatic tumors|82838469|0-19|All Races|Male and Female|2011|2.3|3.0|2.6
1.7|2.4|2.0|168|VII(a) Hepatoblastoma|82838469|0-19|All Races|Male and Female|2011|1.7|2.4|2.0
0.4|0.7|0.5|44|VII(b) Hepatic carcinomas|82838469|0-19|All Races|Male and Female|2011|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82838469|0-19|All Races|Male and Female|2011|~|~|~
8.3|9.6|8.9|743|VIII Malignant bone tumors|82838469|0-19|All Races|Male and Female|2011|8.3|9.6|9.0
4.6|5.6|5.1|422|VIII(a) Osteosarcomas|82838469|0-19|All Races|Male and Female|2011|4.6|5.6|5.1
0.2|0.4|0.2|21|VIII(b) Chondrosarcomas|82838469|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
2.8|3.6|3.1|261|VIII(c) Ewing tumor and related sarcomas of bone|82838469|0-19|All Races|Male and Female|2011|2.8|3.6|3.2
0.2|0.5|0.3|26|VIII(d) Other specified malignant bone tumors|82838469|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82838469|0-19|All Races|Male and Female|2011|~|~|~
10.1|11.5|10.8|915|X Germ cell, trophoblastic tumors & neoplasms of gonads|82838469|0-19|All Races|Male and Female|2011|10.3|11.8|11.0
1.4|2.0|1.7|138|X(a) Intracranial & intraspinal germ cell tumors|82838469|0-19|All Races|Male and Female|2011|1.4|2.0|1.7
1.2|1.7|1.4|117|X(b) Malignant extracranial & extragonadal germ cell tumors|82838469|0-19|All Races|Male and Female|2011|1.2|1.7|1.4
6.6|7.8|7.2|612|X(c) Malignant gonadal germ cell tumors|82838469|0-19|All Races|Male and Female|2011|6.8|8.0|7.4
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|82838469|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.4|0.3|22|X(e) Other and unspecified malignant gonadal tumors|82838469|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
18.2|20.1|19.2|1623|XI Other malignant epithelial neoplasms and malignant melanomas|82838469|0-19|All Races|Male and Female|2011|18.7|20.6|19.6
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|82838469|0-19|All Races|Male and Female|2011|0.1|0.4|0.2
8.8|10.1|9.4|799|XI(b) Thyroid carcinomas|82838469|0-19|All Races|Male and Female|2011|9.0|10.3|9.6
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82838469|0-19|All Races|Male and Female|2011|0.5|0.8|0.6
3.9|4.8|4.3|363|XI(d) Malignant melanomas|82838469|0-19|All Races|Male and Female|2011|3.9|4.9|4.4
~|~|~|~|XI(e) Skin carcinomas|82838469|0-19|All Races|Male and Female|2011|~|~|~
4.1|5.0|4.5|382|XI(f) Other and unspecified carcinomas|82838469|0-19|All Races|Male and Female|2011|4.2|5.1|4.6
0.5|0.9|0.7|58|XII Other and unspecified malignant neoplasms|82838469|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|82838469|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.5|0.4|30|XII(b) Other unspecified malignant tumors|82838469|0-19|All Races|Male and Female|2011|0.2|0.5|0.4
183.1|189.0|186.0|15415|All ICCC Groups Combined|82501478|0-19|All Races|Male and Female|2012|183.9|189.8|186.8
46.4|49.4|47.9|3956|I Leukemias, myeloproliferative & myelodysplastic diseases|82501478|0-19|All Races|Male and Female|2012|46.5|49.5|48.0
32.9|35.5|34.2|2821|I(a) Lymphoid leukemias|82501478|0-19|All Races|Male and Female|2012|32.9|35.5|34.2
7.2|8.5|7.8|650|I(b) Acute myeloid leukemias|82501478|0-19|All Races|Male and Female|2012|7.3|8.5|7.9
2.2|2.9|2.6|214|I(c) Chronic myeloproliferative diseases|82501478|0-19|All Races|Male and Female|2012|2.3|3.0|2.6
1.3|1.8|1.5|125|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82501478|0-19|All Races|Male and Female|2012|1.3|1.8|1.5
1.5|2.1|1.8|146|I(e) Unspecified and other specified leukemias|82501478|0-19|All Races|Male and Female|2012|1.5|2.1|1.8
28.9|31.3|30.1|2499|II Lymphomas and reticuloendothelial neoplasms|82501478|0-19|All Races|Male and Female|2012|29.1|31.5|30.3
11.8|13.3|12.6|1051|II(a) Hodgkin lymphomas|82501478|0-19|All Races|Male and Female|2012|12.0|13.5|12.7
9.2|10.6|9.9|819|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82501478|0-19|All Races|Male and Female|2012|9.3|10.6|9.9
2.0|2.7|2.3|191|II(c) Burkitt lymphoma|82501478|0-19|All Races|Male and Female|2012|2.0|2.7|2.3
4.4|5.3|4.8|399|II(d) Miscellaneous lymphoreticular neoplasms|82501478|0-19|All Races|Male and Female|2012|4.4|5.3|4.8
0.3|0.6|0.5|39|II(e) Unspecified lymphomas|82501478|0-19|All Races|Male and Female|2012|0.3|0.6|0.5
31.3|33.7|32.5|2678|III CNS and misc intracranial and intraspinal neoplasms|82501478|0-19|All Races|Male and Female|2012|31.2|33.7|32.5
2.3|3.1|2.7|222|III(a) Ependymomas and choroid plexus tumor|82501478|0-19|All Races|Male and Female|2012|2.3|3.1|2.7
16.6|18.4|17.5|1443|III(b) Astrocytomas|82501478|0-19|All Races|Male and Female|2012|16.6|18.4|17.5
5.3|6.4|5.8|480|III(c) Intracranial and intraspinal embryonal tumors|82501478|0-19|All Races|Male and Female|2012|5.3|6.4|5.8
4.8|5.8|5.2|432|III(d) Other gliomas|82501478|0-19|All Races|Male and Female|2012|4.8|5.8|5.2
0.4|0.8|0.6|47|III(e) Other specified intracranial & intraspinal neoplasms|82501478|0-19|All Races|Male and Female|2012|0.4|0.8|0.6
0.5|0.9|0.7|54|III(f) Unspecified intracranial and intraspinal neoplasms|82501478|0-19|All Races|Male and Female|2012|0.5|0.9|0.7
8.2|9.5|8.8|727|IV Neuroblastoma and other peripheral nervous cell tumors|82501478|0-19|All Races|Male and Female|2012|8.2|9.5|8.8
8.0|9.2|8.6|707|IV(a) Neuroblastoma and ganglioneuroblastoma|82501478|0-19|All Races|Male and Female|2012|7.9|9.2|8.6
0.1|0.4|0.2|20|IV(b) Other peripheral nervous cell tumors|82501478|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
11.1|12.6|11.8|979|IX Soft tissue and other extraosseous sarcomas|82501478|0-19|All Races|Male and Female|2012|11.1|12.6|11.9
4.1|5.0|4.5|375|IX(a) Rhabdomyosarcomas|82501478|0-19|All Races|Male and Female|2012|4.1|5.0|4.5
1.0|1.5|1.3|104|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82501478|0-19|All Races|Male and Female|2012|1.0|1.5|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82501478|0-19|All Races|Male and Female|2012|~|~|~
4.1|5.1|4.6|379|IX(d) Other specified soft tissue sarcomas|82501478|0-19|All Races|Male and Female|2012|4.1|5.1|4.6
1.2|1.7|1.4|116|IX(e) Unspecified soft tissue sarcomas|82501478|0-19|All Races|Male and Female|2012|1.2|1.7|1.4
0.1|0.4|0.2|20|Not classified by ICCC|82501478|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
2.9|3.7|3.3|273|V Retinoblastoma|82501478|0-19|All Races|Male and Female|2012|2.9|3.7|3.3
6.5|7.6|7.0|582|VI Renal tumors|82501478|0-19|All Races|Male and Female|2012|6.5|7.7|7.1
5.7|6.8|6.3|516|VI(a) Nephroblastoma and other nonepithelial renal tumors|82501478|0-19|All Races|Male and Female|2012|5.7|6.8|6.3
0.6|0.9|0.7|61|VI(b) Renal carcinomas|82501478|0-19|All Races|Male and Female|2012|0.6|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82501478|0-19|All Races|Male and Female|2012|~|~|~
2.4|3.2|2.8|229|VII Hepatic tumors|82501478|0-19|All Races|Male and Female|2012|2.4|3.2|2.8
1.8|2.5|2.1|175|VII(a) Hepatoblastoma|82501478|0-19|All Races|Male and Female|2012|1.8|2.5|2.1
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82501478|0-19|All Races|Male and Female|2012|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82501478|0-19|All Races|Male and Female|2012|~|~|~
8.4|9.8|9.1|751|VIII Malignant bone tumors|82501478|0-19|All Races|Male and Female|2012|8.5|9.8|9.1
4.8|5.8|5.2|433|VIII(a) Osteosarcomas|82501478|0-19|All Races|Male and Female|2012|4.8|5.8|5.2
0.2|0.5|0.3|29|VIII(b) Chondrosarcomas|82501478|0-19|All Races|Male and Female|2012|0.2|0.5|0.4
2.5|3.2|2.8|235|VIII(c) Ewing tumor and related sarcomas of bone|82501478|0-19|All Races|Male and Female|2012|2.5|3.2|2.8
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|82501478|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.1|0.3|0.2|18|VIII(e) Unspecified malignant bone tumors|82501478|0-19|All Races|Male and Female|2012|0.1|0.3|0.2
11.0|12.4|11.7|979|X Germ cell, trophoblastic tumors & neoplasms of gonads|82501478|0-19|All Races|Male and Female|2012|11.1|12.6|11.9
1.3|1.9|1.6|131|X(a) Intracranial & intraspinal germ cell tumors|82501478|0-19|All Races|Male and Female|2012|1.3|1.9|1.6
1.4|2.0|1.7|141|X(b) Malignant extracranial & extragonadal germ cell tumors|82501478|0-19|All Races|Male and Female|2012|1.4|2.0|1.7
7.1|8.3|7.7|645|X(c) Malignant gonadal germ cell tumors|82501478|0-19|All Races|Male and Female|2012|7.2|8.4|7.8
0.3|0.6|0.4|35|X(d) Gonadal carcinomas|82501478|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|82501478|0-19|All Races|Male and Female|2012|0.2|0.5|0.3
18.8|20.8|19.8|1660|XI Other malignant epithelial neoplasms and malignant melanomas|82501478|0-19|All Races|Male and Female|2012|19.2|21.1|20.1
0.2|0.4|0.3|22|XI(a) Adrenocortical carcinomas|82501478|0-19|All Races|Male and Female|2012|0.2|0.4|0.3
9.1|10.4|9.7|819|XI(b) Thyroid carcinomas|82501478|0-19|All Races|Male and Female|2012|9.3|10.6|9.9
0.3|0.6|0.5|38|XI(c) Nasopharyngeal carcinomas|82501478|0-19|All Races|Male and Female|2012|0.3|0.6|0.5
3.8|4.7|4.2|356|XI(d) Malignant melanomas|82501478|0-19|All Races|Male and Female|2012|3.9|4.8|4.3
~|~|~|~|XI(e) Skin carcinomas|82501478|0-19|All Races|Male and Female|2012|~|~|~
4.5|5.5|5.0|416|XI(f) Other and unspecified carcinomas|82501478|0-19|All Races|Male and Female|2012|4.6|5.6|5.0
0.8|1.2|1.0|82|XII Other and unspecified malignant neoplasms|82501478|0-19|All Races|Male and Female|2012|0.8|1.2|1.0
0.3|0.6|0.4|36|XII(a) Other specified malignant tumors|82501478|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.4|0.7|0.6|46|XII(b) Other unspecified malignant tumors|82501478|0-19|All Races|Male and Female|2012|0.4|0.7|0.6
182.5|188.4|185.4|15293|All ICCC Groups Combined|82271238|0-19|All Races|Male and Female|2013|183.0|188.9|185.9
45.5|48.5|47.0|3869|I Leukemias, myeloproliferative & myelodysplastic diseases|82271238|0-19|All Races|Male and Female|2013|45.6|48.5|47.0
31.4|33.9|32.7|2686|I(a) Lymphoid leukemias|82271238|0-19|All Races|Male and Female|2013|31.4|33.9|32.6
7.7|8.9|8.3|683|I(b) Acute myeloid leukemias|82271238|0-19|All Races|Male and Female|2013|7.7|8.9|8.3
2.1|2.8|2.4|202|I(c) Chronic myeloproliferative diseases|82271238|0-19|All Races|Male and Female|2013|2.1|2.8|2.5
1.4|1.9|1.6|135|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82271238|0-19|All Races|Male and Female|2013|1.4|1.9|1.6
1.7|2.3|2.0|163|I(e) Unspecified and other specified leukemias|82271238|0-19|All Races|Male and Female|2013|1.7|2.3|2.0
27.3|29.6|28.5|2354|II Lymphomas and reticuloendothelial neoplasms|82271238|0-19|All Races|Male and Female|2013|27.5|29.8|28.6
10.9|12.4|11.6|966|II(a) Hodgkin lymphomas|82271238|0-19|All Races|Male and Female|2013|11.0|12.5|11.7
8.5|9.8|9.1|752|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82271238|0-19|All Races|Male and Female|2013|8.5|9.8|9.1
2.0|2.7|2.3|190|II(c) Burkitt lymphoma|82271238|0-19|All Races|Male and Female|2013|2.0|2.7|2.3
4.6|5.6|5.1|416|II(d) Miscellaneous lymphoreticular neoplasms|82271238|0-19|All Races|Male and Female|2013|4.6|5.6|5.1
0.2|0.5|0.4|30|II(e) Unspecified lymphomas|82271238|0-19|All Races|Male and Female|2013|0.2|0.5|0.4
32.3|34.8|33.5|2754|III CNS and misc intracranial and intraspinal neoplasms|82271238|0-19|All Races|Male and Female|2013|32.2|34.7|33.5
2.4|3.1|2.7|223|III(a) Ependymomas and choroid plexus tumor|82271238|0-19|All Races|Male and Female|2013|2.4|3.1|2.7
17.2|19.0|18.1|1487|III(b) Astrocytomas|82271238|0-19|All Races|Male and Female|2013|17.2|19.0|18.1
5.2|6.3|5.7|469|III(c) Intracranial and intraspinal embryonal tumors|82271238|0-19|All Races|Male and Female|2013|5.2|6.2|5.7
5.3|6.3|5.8|475|III(d) Other gliomas|82271238|0-19|All Races|Male and Female|2013|5.3|6.3|5.8
0.6|0.9|0.7|60|III(e) Other specified intracranial & intraspinal neoplasms|82271238|0-19|All Races|Male and Female|2013|0.6|0.9|0.7
0.3|0.7|0.5|40|III(f) Unspecified intracranial and intraspinal neoplasms|82271238|0-19|All Races|Male and Female|2013|0.3|0.7|0.5
8.7|10.0|9.4|768|IV Neuroblastoma and other peripheral nervous cell tumors|82271238|0-19|All Races|Male and Female|2013|8.7|10.0|9.3
8.4|9.7|9.0|741|IV(a) Neuroblastoma and ganglioneuroblastoma|82271238|0-19|All Races|Male and Female|2013|8.4|9.7|9.0
0.2|0.5|0.3|27|IV(b) Other peripheral nervous cell tumors|82271238|0-19|All Races|Male and Female|2013|0.2|0.5|0.3
11.2|12.7|11.9|980|IX Soft tissue and other extraosseous sarcomas|82271238|0-19|All Races|Male and Female|2013|11.2|12.7|11.9
4.4|5.3|4.8|396|IX(a) Rhabdomyosarcomas|82271238|0-19|All Races|Male and Female|2013|4.4|5.3|4.8
1.0|1.5|1.3|104|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82271238|0-19|All Races|Male and Female|2013|1.0|1.5|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82271238|0-19|All Races|Male and Female|2013|~|~|~
4.1|5.0|4.6|376|IX(d) Other specified soft tissue sarcomas|82271238|0-19|All Races|Male and Female|2013|4.1|5.1|4.6
1.0|1.5|1.2|103|IX(e) Unspecified soft tissue sarcomas|82271238|0-19|All Races|Male and Female|2013|1.0|1.5|1.3
0.2|0.4|0.3|23|Not classified by ICCC|82271238|0-19|All Races|Male and Female|2013|0.2|0.4|0.3
2.9|3.7|3.3|269|V Retinoblastoma|82271238|0-19|All Races|Male and Female|2013|2.9|3.7|3.3
6.8|8.0|7.4|605|VI Renal tumors|82271238|0-19|All Races|Male and Female|2013|6.8|8.0|7.4
5.9|7.0|6.5|531|VI(a) Nephroblastoma and other nonepithelial renal tumors|82271238|0-19|All Races|Male and Female|2013|5.9|7.0|6.5
0.7|1.1|0.9|71|VI(b) Renal carcinomas|82271238|0-19|All Races|Male and Female|2013|0.7|1.1|0.9
~|~|~|~|VI(c) Unspecified malignant renal tumors|82271238|0-19|All Races|Male and Female|2013|~|~|~
2.2|2.9|2.5|206|VII Hepatic tumors|82271238|0-19|All Races|Male and Female|2013|2.2|2.9|2.5
1.6|2.2|1.8|151|VII(a) Hepatoblastoma|82271238|0-19|All Races|Male and Female|2013|1.6|2.2|1.8
0.5|0.8|0.6|53|VII(b) Hepatic carcinomas|82271238|0-19|All Races|Male and Female|2013|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82271238|0-19|All Races|Male and Female|2013|~|~|~
8.6|9.9|9.2|760|VIII Malignant bone tumors|82271238|0-19|All Races|Male and Female|2013|8.6|9.9|9.2
4.5|5.5|5.0|411|VIII(a) Osteosarcomas|82271238|0-19|All Races|Male and Female|2013|4.5|5.5|5.0
0.2|0.5|0.3|29|VIII(b) Chondrosarcomas|82271238|0-19|All Races|Male and Female|2013|0.2|0.5|0.4
2.8|3.6|3.2|261|VIII(c) Ewing tumor and related sarcomas of bone|82271238|0-19|All Races|Male and Female|2013|2.8|3.6|3.2
0.4|0.7|0.5|45|VIII(d) Other specified malignant bone tumors|82271238|0-19|All Races|Male and Female|2013|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82271238|0-19|All Races|Male and Female|2013|~|~|~
11.2|12.7|11.9|993|X Germ cell, trophoblastic tumors & neoplasms of gonads|82271238|0-19|All Races|Male and Female|2013|11.3|12.8|12.1
1.7|2.3|2.0|161|X(a) Intracranial & intraspinal germ cell tumors|82271238|0-19|All Races|Male and Female|2013|1.7|2.3|2.0
1.1|1.7|1.4|114|X(b) Malignant extracranial & extragonadal germ cell tumors|82271238|0-19|All Races|Male and Female|2013|1.1|1.7|1.4
7.0|8.2|7.6|636|X(c) Malignant gonadal germ cell tumors|82271238|0-19|All Races|Male and Female|2013|7.1|8.4|7.7
0.4|0.7|0.6|47|X(d) Gonadal carcinomas|82271238|0-19|All Races|Male and Female|2013|0.4|0.8|0.6
0.3|0.6|0.4|35|X(e) Other and unspecified malignant gonadal tumors|82271238|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
18.8|20.7|19.7|1641|XI Other malignant epithelial neoplasms and malignant melanomas|82271238|0-19|All Races|Male and Female|2013|19.0|20.9|19.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82271238|0-19|All Races|Male and Female|2013|~|~|~
8.8|10.1|9.4|787|XI(b) Thyroid carcinomas|82271238|0-19|All Races|Male and Female|2013|8.9|10.3|9.6
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82271238|0-19|All Races|Male and Female|2013|0.5|0.8|0.6
3.8|4.7|4.2|352|XI(d) Malignant melanomas|82271238|0-19|All Races|Male and Female|2013|3.8|4.7|4.3
~|~|~|~|XI(e) Skin carcinomas|82271238|0-19|All Races|Male and Female|2013|~|~|~
4.7|5.7|5.2|434|XI(f) Other and unspecified carcinomas|82271238|0-19|All Races|Male and Female|2013|4.8|5.8|5.3
0.7|1.1|0.9|71|XII Other and unspecified malignant neoplasms|82271238|0-19|All Races|Male and Female|2013|0.7|1.1|0.9
0.3|0.6|0.4|37|XII(a) Other specified malignant tumors|82271238|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
0.3|0.6|0.4|34|XII(b) Other unspecified malignant tumors|82271238|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
188.4|194.4|191.3|15759|All ICCC Groups Combined|82139198|0-19|All Races|Male and Female|2014|188.9|194.9|191.9
46.8|49.9|48.3|3973|I Leukemias, myeloproliferative & myelodysplastic diseases|82139198|0-19|All Races|Male and Female|2014|46.9|49.9|48.4
32.4|35.0|33.7|2767|I(a) Lymphoid leukemias|82139198|0-19|All Races|Male and Female|2014|32.4|35.0|33.7
8.0|9.2|8.6|707|I(b) Acute myeloid leukemias|82139198|0-19|All Races|Male and Female|2014|8.0|9.3|8.6
2.2|2.9|2.5|207|I(c) Chronic myeloproliferative diseases|82139198|0-19|All Races|Male and Female|2014|2.2|2.9|2.5
1.3|1.9|1.6|128|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82139198|0-19|All Races|Male and Female|2014|1.3|1.9|1.6
1.7|2.3|2.0|164|I(e) Unspecified and other specified leukemias|82139198|0-19|All Races|Male and Female|2014|1.7|2.3|2.0
30.1|32.6|31.3|2585|II Lymphomas and reticuloendothelial neoplasms|82139198|0-19|All Races|Male and Female|2014|30.3|32.7|31.5
11.2|12.7|11.9|989|II(a) Hodgkin lymphomas|82139198|0-19|All Races|Male and Female|2014|11.3|12.8|12.0
10.1|11.6|10.8|894|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82139198|0-19|All Races|Male and Female|2014|10.2|11.6|10.9
2.3|3.0|2.7|218|II(c) Burkitt lymphoma|82139198|0-19|All Races|Male and Female|2014|2.3|3.0|2.7
5.0|6.0|5.5|451|II(d) Miscellaneous lymphoreticular neoplasms|82139198|0-19|All Races|Male and Female|2014|5.0|6.0|5.5
0.3|0.6|0.4|33|II(e) Unspecified lymphomas|82139198|0-19|All Races|Male and Female|2014|0.3|0.6|0.4
32.4|34.9|33.6|2758|III CNS and misc intracranial and intraspinal neoplasms|82139198|0-19|All Races|Male and Female|2014|32.3|34.9|33.6
2.5|3.2|2.8|230|III(a) Ependymomas and choroid plexus tumor|82139198|0-19|All Races|Male and Female|2014|2.4|3.2|2.8
17.0|18.8|17.9|1470|III(b) Astrocytomas|82139198|0-19|All Races|Male and Female|2014|17.0|18.8|17.9
5.5|6.6|6.1|497|III(c) Intracranial and intraspinal embryonal tumors|82139198|0-19|All Races|Male and Female|2014|5.5|6.6|6.1
4.9|6.0|5.4|445|III(d) Other gliomas|82139198|0-19|All Races|Male and Female|2014|4.9|5.9|5.4
0.7|1.1|0.8|69|III(e) Other specified intracranial & intraspinal neoplasms|82139198|0-19|All Races|Male and Female|2014|0.7|1.1|0.8
0.4|0.8|0.6|47|III(f) Unspecified intracranial and intraspinal neoplasms|82139198|0-19|All Races|Male and Female|2014|0.4|0.8|0.6
8.6|9.9|9.3|761|IV Neuroblastoma and other peripheral nervous cell tumors|82139198|0-19|All Races|Male and Female|2014|8.6|9.9|9.3
8.3|9.6|8.9|732|IV(a) Neuroblastoma and ganglioneuroblastoma|82139198|0-19|All Races|Male and Female|2014|8.3|9.6|8.9
0.2|0.5|0.4|29|IV(b) Other peripheral nervous cell tumors|82139198|0-19|All Races|Male and Female|2014|0.2|0.5|0.4
11.7|13.2|12.4|1023|IX Soft tissue and other extraosseous sarcomas|82139198|0-19|All Races|Male and Female|2014|11.7|13.2|12.5
3.9|4.8|4.4|358|IX(a) Rhabdomyosarcomas|82139198|0-19|All Races|Male and Female|2014|3.9|4.8|4.4
1.3|1.8|1.5|127|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82139198|0-19|All Races|Male and Female|2014|1.3|1.8|1.5
~|~|~|~|IX(c) Kaposi sarcoma|82139198|0-19|All Races|Male and Female|2014|~|~|~
4.6|5.6|5.0|416|IX(d) Other specified soft tissue sarcomas|82139198|0-19|All Races|Male and Female|2014|4.6|5.6|5.1
1.2|1.7|1.4|117|IX(e) Unspecified soft tissue sarcomas|82139198|0-19|All Races|Male and Female|2014|1.2|1.7|1.4
0.2|0.5|0.3|26|Not classified by ICCC|82139198|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
2.9|3.7|3.3|268|V Retinoblastoma|82139198|0-19|All Races|Male and Female|2014|2.9|3.7|3.3
6.7|7.9|7.3|601|VI Renal tumors|82139198|0-19|All Races|Male and Female|2014|6.7|7.9|7.3
6.1|7.2|6.6|546|VI(a) Nephroblastoma and other nonepithelial renal tumors|82139198|0-19|All Races|Male and Female|2014|6.1|7.2|6.6
0.5|0.8|0.6|53|VI(b) Renal carcinomas|82139198|0-19|All Races|Male and Female|2014|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82139198|0-19|All Races|Male and Female|2014|~|~|~
2.2|2.9|2.5|208|VII Hepatic tumors|82139198|0-19|All Races|Male and Female|2014|2.2|2.9|2.5
1.7|2.3|2.0|161|VII(a) Hepatoblastoma|82139198|0-19|All Races|Male and Female|2014|1.7|2.3|2.0
0.4|0.7|0.6|46|VII(b) Hepatic carcinomas|82139198|0-19|All Races|Male and Female|2014|0.4|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82139198|0-19|All Races|Male and Female|2014|~|~|~
8.8|10.1|9.4|773|VIII Malignant bone tumors|82139198|0-19|All Races|Male and Female|2014|8.8|10.1|9.4
4.7|5.7|5.2|429|VIII(a) Osteosarcomas|82139198|0-19|All Races|Male and Female|2014|4.7|5.7|5.2
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|82139198|0-19|All Races|Male and Female|2014|0.2|0.5|0.4
2.7|3.4|3.0|249|VIII(c) Ewing tumor and related sarcomas of bone|82139198|0-19|All Races|Male and Female|2014|2.7|3.4|3.0
0.4|0.7|0.5|45|VIII(d) Other specified malignant bone tumors|82139198|0-19|All Races|Male and Female|2014|0.4|0.7|0.5
0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82139198|0-19|All Races|Male and Female|2014|0.2|0.4|0.3
10.6|12.0|11.3|937|X Germ cell, trophoblastic tumors & neoplasms of gonads|82139198|0-19|All Races|Male and Female|2014|10.7|12.2|11.4
1.4|2.0|1.7|137|X(a) Intracranial & intraspinal germ cell tumors|82139198|0-19|All Races|Male and Female|2014|1.4|2.0|1.7
1.4|2.0|1.7|138|X(b) Malignant extracranial & extragonadal germ cell tumors|82139198|0-19|All Races|Male and Female|2014|1.4|2.0|1.7
6.5|7.7|7.1|589|X(c) Malignant gonadal germ cell tumors|82139198|0-19|All Races|Male and Female|2014|6.6|7.8|7.2
0.3|0.7|0.5|40|X(d) Gonadal carcinomas|82139198|0-19|All Races|Male and Female|2014|0.3|0.7|0.5
0.3|0.6|0.4|33|X(e) Other and unspecified malignant gonadal tumors|82139198|0-19|All Races|Male and Female|2014|0.3|0.6|0.4
20.6|22.6|21.6|1792|XI Other malignant epithelial neoplasms and malignant melanomas|82139198|0-19|All Races|Male and Female|2014|20.8|22.9|21.8
0.2|0.4|0.3|21|XI(a) Adrenocortical carcinomas|82139198|0-19|All Races|Male and Female|2014|0.2|0.4|0.3
10.0|11.5|10.7|892|XI(b) Thyroid carcinomas|82139198|0-19|All Races|Male and Female|2014|10.2|11.6|10.9
0.2|0.5|0.4|30|XI(c) Nasopharyngeal carcinomas|82139198|0-19|All Races|Male and Female|2014|0.2|0.5|0.4
3.7|4.6|4.2|344|XI(d) Malignant melanomas|82139198|0-19|All Races|Male and Female|2014|3.8|4.7|4.2
~|~|~|~|XI(e) Skin carcinomas|82139198|0-19|All Races|Male and Female|2014|~|~|~
5.5|6.6|6.0|499|XI(f) Other and unspecified carcinomas|82139198|0-19|All Races|Male and Female|2014|5.6|6.6|6.1
0.5|0.9|0.7|54|XII Other and unspecified malignant neoplasms|82139198|0-19|All Races|Male and Female|2014|0.5|0.9|0.7
0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|82139198|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
0.2|0.5|0.3|26|XII(b) Other unspecified malignant tumors|82139198|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
193.6|199.7|196.6|16203|All ICCC Groups Combined|82120410|0-19|All Races|Male and Female|2015|194.3|200.4|197.3
49.1|52.1|50.6|4160|I Leukemias, myeloproliferative & myelodysplastic diseases|82120410|0-19|All Races|Male and Female|2015|49.1|52.2|50.7
34.7|37.3|36.0|2955|I(a) Lymphoid leukemias|82120410|0-19|All Races|Male and Female|2015|34.7|37.3|36.0
7.8|9.1|8.4|693|I(b) Acute myeloid leukemias|82120410|0-19|All Races|Male and Female|2015|7.8|9.1|8.4
2.4|3.1|2.7|226|I(c) Chronic myeloproliferative diseases|82120410|0-19|All Races|Male and Female|2015|2.4|3.1|2.8
1.3|1.8|1.5|124|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82120410|0-19|All Races|Male and Female|2015|1.3|1.8|1.5
1.7|2.3|2.0|162|I(e) Unspecified and other specified leukemias|82120410|0-19|All Races|Male and Female|2015|1.7|2.3|2.0
29.8|32.3|31.0|2559|II Lymphomas and reticuloendothelial neoplasms|82120410|0-19|All Races|Male and Female|2015|30.0|32.4|31.2
11.7|13.2|12.4|1031|II(a) Hodgkin lymphomas|82120410|0-19|All Races|Male and Female|2015|11.8|13.3|12.6
9.3|10.7|10.0|822|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82120410|0-19|All Races|Male and Female|2015|9.3|10.7|10.0
2.1|2.8|2.5|202|II(c) Burkitt lymphoma|82120410|0-19|All Races|Male and Female|2015|2.1|2.8|2.5
5.2|6.3|5.7|469|II(d) Miscellaneous lymphoreticular neoplasms|82120410|0-19|All Races|Male and Female|2015|5.2|6.3|5.7
0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82120410|0-19|All Races|Male and Female|2015|0.3|0.6|0.4
31.5|34.0|32.7|2687|III CNS and misc intracranial and intraspinal neoplasms|82120410|0-19|All Races|Male and Female|2015|31.5|34.0|32.7
2.4|3.2|2.8|229|III(a) Ependymomas and choroid plexus tumor|82120410|0-19|All Races|Male and Female|2015|2.4|3.2|2.8
15.8|17.6|16.7|1367|III(b) Astrocytomas|82120410|0-19|All Races|Male and Female|2015|15.8|17.6|16.6
5.6|6.7|6.1|500|III(c) Intracranial and intraspinal embryonal tumors|82120410|0-19|All Races|Male and Female|2015|5.6|6.6|6.1
5.4|6.5|6.0|489|III(d) Other gliomas|82120410|0-19|All Races|Male and Female|2015|5.4|6.5|6.0
0.6|1.0|0.8|66|III(e) Other specified intracranial & intraspinal neoplasms|82120410|0-19|All Races|Male and Female|2015|0.6|1.0|0.8
0.3|0.6|0.4|36|III(f) Unspecified intracranial and intraspinal neoplasms|82120410|0-19|All Races|Male and Female|2015|0.3|0.6|0.4
8.9|10.2|9.6|788|IV Neuroblastoma and other peripheral nervous cell tumors|82120410|0-19|All Races|Male and Female|2015|8.9|10.3|9.6
8.6|9.9|9.2|761|IV(a) Neuroblastoma and ganglioneuroblastoma|82120410|0-19|All Races|Male and Female|2015|8.6|9.9|9.3
0.2|0.5|0.3|27|IV(b) Other peripheral nervous cell tumors|82120410|0-19|All Races|Male and Female|2015|0.2|0.5|0.3
11.8|13.4|12.6|1037|IX Soft tissue and other extraosseous sarcomas|82120410|0-19|All Races|Male and Female|2015|11.9|13.4|12.6
4.4|5.4|4.9|399|IX(a) Rhabdomyosarcomas|82120410|0-19|All Races|Male and Female|2015|4.4|5.4|4.9
1.2|1.7|1.4|118|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82120410|0-19|All Races|Male and Female|2015|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82120410|0-19|All Races|Male and Female|2015|~|~|~
4.3|5.3|4.8|394|IX(d) Other specified soft tissue sarcomas|82120410|0-19|All Races|Male and Female|2015|4.3|5.3|4.8
1.2|1.8|1.5|122|IX(e) Unspecified soft tissue sarcomas|82120410|0-19|All Races|Male and Female|2015|1.2|1.8|1.5
~|~|~|~|Not classified by ICCC|82120410|0-19|All Races|Male and Female|2015|~|~|~
3.3|4.1|3.7|306|V Retinoblastoma|82120410|0-19|All Races|Male and Female|2015|3.3|4.2|3.7
7.3|8.5|7.9|651|VI Renal tumors|82120410|0-19|All Races|Male and Female|2015|7.3|8.6|7.9
6.5|7.7|7.1|582|VI(a) Nephroblastoma and other nonepithelial renal tumors|82120410|0-19|All Races|Male and Female|2015|6.5|7.7|7.1
0.6|1.0|0.8|67|VI(b) Renal carcinomas|82120410|0-19|All Races|Male and Female|2015|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|82120410|0-19|All Races|Male and Female|2015|~|~|~
2.5|3.2|2.8|232|VII Hepatic tumors|82120410|0-19|All Races|Male and Female|2015|2.5|3.2|2.8
1.8|2.4|2.1|174|VII(a) Hepatoblastoma|82120410|0-19|All Races|Male and Female|2015|1.8|2.5|2.1
0.5|0.9|0.7|56|VII(b) Hepatic carcinomas|82120410|0-19|All Races|Male and Female|2015|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82120410|0-19|All Races|Male and Female|2015|~|~|~
8.6|9.9|9.2|758|VIII Malignant bone tumors|82120410|0-19|All Races|Male and Female|2015|8.6|9.9|9.2
4.5|5.4|4.9|405|VIII(a) Osteosarcomas|82120410|0-19|All Races|Male and Female|2015|4.5|5.4|4.9
0.3|0.5|0.4|31|VIII(b) Chondrosarcomas|82120410|0-19|All Races|Male and Female|2015|0.3|0.5|0.4
2.8|3.5|3.1|257|VIII(c) Ewing tumor and related sarcomas of bone|82120410|0-19|All Races|Male and Female|2015|2.8|3.5|3.1
0.4|0.7|0.6|46|VIII(d) Other specified malignant bone tumors|82120410|0-19|All Races|Male and Female|2015|0.4|0.7|0.6
0.1|0.4|0.2|19|VIII(e) Unspecified malignant bone tumors|82120410|0-19|All Races|Male and Female|2015|0.1|0.4|0.2
11.0|12.5|11.7|974|X Germ cell, trophoblastic tumors & neoplasms of gonads|82120410|0-19|All Races|Male and Female|2015|11.1|12.6|11.9
1.6|2.2|1.9|153|X(a) Intracranial & intraspinal germ cell tumors|82120410|0-19|All Races|Male and Female|2015|1.6|2.2|1.9
1.1|1.7|1.4|115|X(b) Malignant extracranial & extragonadal germ cell tumors|82120410|0-19|All Races|Male and Female|2015|1.2|1.7|1.4
7.0|8.2|7.6|635|X(c) Malignant gonadal germ cell tumors|82120410|0-19|All Races|Male and Female|2015|7.1|8.4|7.7
0.3|0.7|0.5|40|X(d) Gonadal carcinomas|82120410|0-19|All Races|Male and Female|2015|0.3|0.7|0.5
0.3|0.5|0.4|31|X(e) Other and unspecified malignant gonadal tumors|82120410|0-19|All Races|Male and Female|2015|0.3|0.5|0.4
22.6|24.7|23.6|1962|XI Other malignant epithelial neoplasms and malignant melanomas|82120410|0-19|All Races|Male and Female|2015|22.8|25.0|23.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82120410|0-19|All Races|Male and Female|2015|~|~|~
10.2|11.6|10.9|903|XI(b) Thyroid carcinomas|82120410|0-19|All Races|Male and Female|2015|10.3|11.7|11.0
0.4|0.8|0.6|50|XI(c) Nasopharyngeal carcinomas|82120410|0-19|All Races|Male and Female|2015|0.5|0.8|0.6
3.5|4.3|3.9|322|XI(d) Malignant melanomas|82120410|0-19|All Races|Male and Female|2015|3.5|4.4|3.9
~|~|~|~|XI(e) Skin carcinomas|82120410|0-19|All Races|Male and Female|2015|~|~|~
7.5|8.7|8.1|670|XI(f) Other and unspecified carcinomas|82120410|0-19|All Races|Male and Female|2015|7.6|8.8|8.2
0.7|1.1|0.9|74|XII Other and unspecified malignant neoplasms|82120410|0-19|All Races|Male and Female|2015|0.7|1.1|0.9
0.4|0.8|0.6|48|XII(a) Other specified malignant tumors|82120410|0-19|All Races|Male and Female|2015|0.4|0.8|0.6
0.2|0.5|0.3|26|XII(b) Other unspecified malignant tumors|82120410|0-19|All Races|Male and Female|2015|0.2|0.5|0.3
189.1|191.7|190.4|77612|All ICCC Groups Combined|406294186|0-19|All Races|Male and Female|2015-2019|189.7|192.4|191.0
48.0|49.4|48.7|19811|I Leukemias, myeloproliferative & myelodysplastic diseases|406294186|0-19|All Races|Male and Female|2015-2019|48.1|49.4|48.8
34.3|35.5|34.9|14169|I(a) Lymphoid leukemias|406294186|0-19|All Races|Male and Female|2015-2019|34.3|35.5|34.9
7.8|8.4|8.1|3297|I(b) Acute myeloid leukemias|406294186|0-19|All Races|Male and Female|2015-2019|7.8|8.4|8.1
2.4|2.7|2.5|1026|I(c) Chronic myeloproliferative diseases|406294186|0-19|All Races|Male and Female|2015-2019|2.4|2.7|2.5
1.2|1.4|1.3|525|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|406294186|0-19|All Races|Male and Female|2015-2019|1.2|1.4|1.3
1.8|2.1|2.0|794|I(e) Unspecified and other specified leukemias|406294186|0-19|All Races|Male and Female|2015-2019|1.8|2.1|2.0
29.4|30.4|29.9|12223|II Lymphomas and reticuloendothelial neoplasms|406294186|0-19|All Races|Male and Female|2015-2019|29.6|30.6|30.1
12.0|12.7|12.4|5084|II(a) Hodgkin lymphomas|406294186|0-19|All Races|Male and Female|2015-2019|12.2|12.9|12.5
9.6|10.2|9.9|4031|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|406294186|0-19|All Races|Male and Female|2015-2019|9.6|10.2|9.9
2.2|2.5|2.4|960|II(c) Burkitt lymphoma|406294186|0-19|All Races|Male and Female|2015-2019|2.2|2.5|2.4
4.8|5.2|5.0|2012|II(d) Miscellaneous lymphoreticular neoplasms|406294186|0-19|All Races|Male and Female|2015-2019|4.7|5.2|5.0
0.3|0.4|0.3|136|II(e) Unspecified lymphomas|406294186|0-19|All Races|Male and Female|2015-2019|0.3|0.4|0.3
29.6|30.6|30.1|12216|III CNS and misc intracranial and intraspinal neoplasms|406294186|0-19|All Races|Male and Female|2015-2019|29.5|30.6|30.1
2.4|2.7|2.6|1045|III(a) Ependymomas and choroid plexus tumor|406294186|0-19|All Races|Male and Female|2015-2019|2.4|2.7|2.6
15.3|16.0|15.7|6356|III(b) Astrocytomas|406294186|0-19|All Races|Male and Female|2015-2019|15.3|16.0|15.6
4.9|5.3|5.1|2066|III(c) Intracranial and intraspinal embryonal tumors|406294186|0-19|All Races|Male and Female|2015-2019|4.9|5.3|5.1
5.3|5.8|5.6|2258|III(d) Other gliomas|406294186|0-19|All Races|Male and Female|2015-2019|5.3|5.8|5.6
0.6|0.8|0.7|281|III(e) Other specified intracranial & intraspinal neoplasms|406294186|0-19|All Races|Male and Female|2015-2019|0.6|0.8|0.7
0.4|0.6|0.5|210|III(f) Unspecified intracranial and intraspinal neoplasms|406294186|0-19|All Races|Male and Female|2015-2019|0.4|0.6|0.5
8.6|9.2|8.9|3614|IV Neuroblastoma and other peripheral nervous cell tumors|406294186|0-19|All Races|Male and Female|2015-2019|8.6|9.2|8.9
8.4|9.0|8.7|3518|IV(a) Neuroblastoma and ganglioneuroblastoma|406294186|0-19|All Races|Male and Female|2015-2019|8.4|8.9|8.7
0.2|0.3|0.2|96|IV(b) Other peripheral nervous cell tumors|406294186|0-19|All Races|Male and Female|2015-2019|0.2|0.3|0.2
12.1|12.8|12.4|5061|IX Soft tissue and other extraosseous sarcomas|406294186|0-19|All Races|Male and Female|2015-2019|12.1|12.8|12.5
4.6|5.0|4.8|1949|IX(a) Rhabdomyosarcomas|406294186|0-19|All Races|Male and Female|2015-2019|4.6|5.0|4.8
1.1|1.3|1.2|491|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|406294186|0-19|All Races|Male and Female|2015-2019|1.1|1.3|1.2
~|~|~|~|IX(c) Kaposi sarcoma|406294186|0-19|All Races|Male and Female|2015-2019|~|~|~
4.6|5.0|4.8|1958|IX(d) Other specified soft tissue sarcomas|406294186|0-19|All Races|Male and Female|2015-2019|4.6|5.0|4.8
1.5|1.7|1.6|648|IX(e) Unspecified soft tissue sarcomas|406294186|0-19|All Races|Male and Female|2015-2019|1.5|1.7|1.6
1.4|1.7|1.5|621|Not classified by ICCC|406294186|0-19|All Races|Male and Female|2015-2019|1.4|1.7|1.5
3.0|3.4|3.2|1286|V Retinoblastoma|406294186|0-19|All Races|Male and Female|2015-2019|3.0|3.3|3.2
6.8|7.3|7.0|2844|VI Renal tumors|406294186|0-19|All Races|Male and Female|2015-2019|6.7|7.3|7.0
6.0|6.4|6.2|2513|VI(a) Nephroblastoma and other nonepithelial renal tumors|406294186|0-19|All Races|Male and Female|2015-2019|5.9|6.4|6.2
0.7|0.9|0.8|317|VI(b) Renal carcinomas|406294186|0-19|All Races|Male and Female|2015-2019|0.7|0.9|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|406294186|0-19|All Races|Male and Female|2015-2019|~|~|~
2.5|2.8|2.7|1078|VII Hepatic tumors|406294186|0-19|All Races|Male and Female|2015-2019|2.5|2.8|2.7
1.9|2.2|2.0|815|VII(a) Hepatoblastoma|406294186|0-19|All Races|Male and Female|2015-2019|1.9|2.1|2.0
0.5|0.7|0.6|247|VII(b) Hepatic carcinomas|406294186|0-19|All Races|Male and Female|2015-2019|0.5|0.7|0.6
0.0|0.1|0.0|16|VII(c) Unspecified malignant hepatic tumors|406294186|0-19|All Races|Male and Female|2015-2019|0.0|0.1|0.0
9.2|9.8|9.5|3866|VIII Malignant bone tumors|406294186|0-19|All Races|Male and Female|2015-2019|9.2|9.8|9.5
5.0|5.5|5.2|2133|VIII(a) Osteosarcomas|406294186|0-19|All Races|Male and Female|2015-2019|5.0|5.5|5.2
0.3|0.4|0.3|142|VIII(b) Chondrosarcomas|406294186|0-19|All Races|Male and Female|2015-2019|0.3|0.4|0.3
3.0|3.3|3.1|1277|VIII(c) Ewing tumor and related sarcomas of bone|406294186|0-19|All Races|Male and Female|2015-2019|3.0|3.3|3.1
0.5|0.6|0.5|218|VIII(d) Other specified malignant bone tumors|406294186|0-19|All Races|Male and Female|2015-2019|0.5|0.6|0.5
0.2|0.3|0.2|96|VIII(e) Unspecified malignant bone tumors|406294186|0-19|All Races|Male and Female|2015-2019|0.2|0.3|0.2
10.8|11.4|11.1|4550|X Germ cell, trophoblastic tumors & neoplasms of gonads|406294186|0-19|All Races|Male and Female|2015-2019|10.9|11.5|11.2
1.8|2.0|1.9|771|X(a) Intracranial & intraspinal germ cell tumors|406294186|0-19|All Races|Male and Female|2015-2019|1.8|2.0|1.9
1.3|1.5|1.4|558|X(b) Malignant extracranial & extragonadal germ cell tumors|406294186|0-19|All Races|Male and Female|2015-2019|1.3|1.5|1.4
6.7|7.2|7.0|2873|X(c) Malignant gonadal germ cell tumors|406294186|0-19|All Races|Male and Female|2015-2019|6.8|7.3|7.1
0.4|0.5|0.4|179|X(d) Gonadal carcinomas|406294186|0-19|All Races|Male and Female|2015-2019|0.4|0.5|0.4
0.4|0.5|0.4|169|X(e) Other and unspecified malignant gonadal tumors|406294186|0-19|All Races|Male and Female|2015-2019|0.4|0.5|0.4
23.9|24.9|24.4|10051|XI Other malignant epithelial neoplasms and malignant melanomas|406294186|0-19|All Races|Male and Female|2015-2019|24.3|25.2|24.7
0.2|0.2|0.2|81|XI(a) Adrenocortical carcinomas|406294186|0-19|All Races|Male and Female|2015-2019|0.2|0.2|0.2
10.9|11.6|11.2|4635|XI(b) Thyroid carcinomas|406294186|0-19|All Races|Male and Female|2015-2019|11.1|11.7|11.4
0.4|0.5|0.5|192|XI(c) Nasopharyngeal carcinomas|406294186|0-19|All Races|Male and Female|2015-2019|0.4|0.5|0.5
3.3|3.7|3.5|1446|XI(d) Malignant melanomas|406294186|0-19|All Races|Male and Female|2015-2019|3.4|3.7|3.6
0.1|0.1|0.1|41|XI(e) Skin carcinomas|406294186|0-19|All Races|Male and Female|2015-2019|0.1|0.1|0.1
8.6|9.2|8.9|3656|XI(f) Other and unspecified carcinomas|406294186|0-19|All Races|Male and Female|2015-2019|8.7|9.3|9.0
0.9|1.1|1.0|391|XII Other and unspecified malignant neoplasms|406294186|0-19|All Races|Male and Female|2015-2019|0.9|1.1|1.0
0.4|0.6|0.5|210|XII(a) Other specified malignant tumors|406294186|0-19|All Races|Male and Female|2015-2019|0.4|0.6|0.5
0.4|0.5|0.4|181|XII(b) Other unspecified malignant tumors|406294186|0-19|All Races|Male and Female|2015-2019|0.4|0.5|0.4
191.8|197.8|194.8|16063|All ICCC Groups Combined|82161437|0-19|All Races|Male and Female|2016|192.5|198.6|195.5
49.0|52.1|50.6|4158|I Leukemias, myeloproliferative & myelodysplastic diseases|82161437|0-19|All Races|Male and Female|2016|49.1|52.2|50.6
34.6|37.2|35.9|2946|I(a) Lymphoid leukemias|82161437|0-19|All Races|Male and Female|2016|34.6|37.2|35.9
7.9|9.2|8.5|701|I(b) Acute myeloid leukemias|82161437|0-19|All Races|Male and Female|2016|7.9|9.2|8.5
2.5|3.2|2.8|234|I(c) Chronic myeloproliferative diseases|82161437|0-19|All Races|Male and Female|2016|2.5|3.2|2.8
1.2|1.7|1.5|120|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82161437|0-19|All Races|Male and Female|2016|1.2|1.7|1.5
1.6|2.2|1.9|157|I(e) Unspecified and other specified leukemias|82161437|0-19|All Races|Male and Female|2016|1.6|2.2|1.9
29.3|31.7|30.5|2518|II Lymphomas and reticuloendothelial neoplasms|82161437|0-19|All Races|Male and Female|2016|29.5|31.9|30.6
11.8|13.3|12.5|1040|II(a) Hodgkin lymphomas|82161437|0-19|All Races|Male and Female|2016|11.9|13.5|12.7
9.8|11.2|10.5|862|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82161437|0-19|All Races|Male and Female|2016|9.8|11.2|10.5
2.2|2.9|2.5|205|II(c) Burkitt lymphoma|82161437|0-19|All Races|Male and Female|2016|2.2|2.9|2.5
4.2|5.1|4.6|378|II(d) Miscellaneous lymphoreticular neoplasms|82161437|0-19|All Races|Male and Female|2016|4.1|5.1|4.6
0.3|0.6|0.4|33|II(e) Unspecified lymphomas|82161437|0-19|All Races|Male and Female|2016|0.3|0.6|0.4
30.5|33.0|31.8|2606|III CNS and misc intracranial and intraspinal neoplasms|82161437|0-19|All Races|Male and Female|2016|30.5|33.0|31.7
2.2|2.9|2.5|206|III(a) Ependymomas and choroid plexus tumor|82161437|0-19|All Races|Male and Female|2016|2.2|2.9|2.5
15.0|16.7|15.9|1302|III(b) Astrocytomas|82161437|0-19|All Races|Male and Female|2016|15.0|16.7|15.8
5.1|6.2|5.6|461|III(c) Intracranial and intraspinal embryonal tumors|82161437|0-19|All Races|Male and Female|2016|5.1|6.1|5.6
5.8|6.9|6.3|519|III(d) Other gliomas|82161437|0-19|All Races|Male and Female|2016|5.8|6.9|6.3
0.7|1.1|0.9|73|III(e) Other specified intracranial & intraspinal neoplasms|82161437|0-19|All Races|Male and Female|2016|0.7|1.1|0.9
0.4|0.7|0.5|45|III(f) Unspecified intracranial and intraspinal neoplasms|82161437|0-19|All Races|Male and Female|2016|0.4|0.7|0.5
8.2|9.5|8.8|726|IV Neuroblastoma and other peripheral nervous cell tumors|82161437|0-19|All Races|Male and Female|2016|8.2|9.5|8.8
8.0|9.3|8.7|713|IV(a) Neuroblastoma and ganglioneuroblastoma|82161437|0-19|All Races|Male and Female|2016|8.1|9.3|8.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82161437|0-19|All Races|Male and Female|2016|~|~|~
11.9|13.4|12.6|1040|IX Soft tissue and other extraosseous sarcomas|82161437|0-19|All Races|Male and Female|2016|11.9|13.5|12.7
4.7|5.7|5.1|423|IX(a) Rhabdomyosarcomas|82161437|0-19|All Races|Male and Female|2016|4.7|5.7|5.1
0.9|1.3|1.1|89|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82161437|0-19|All Races|Male and Female|2016|0.9|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|82161437|0-19|All Races|Male and Female|2016|~|~|~
4.4|5.4|4.9|402|IX(d) Other specified soft tissue sarcomas|82161437|0-19|All Races|Male and Female|2016|4.4|5.4|4.9
1.2|1.8|1.5|124|IX(e) Unspecified soft tissue sarcomas|82161437|0-19|All Races|Male and Female|2016|1.3|1.8|1.5
0.2|0.5|0.3|26|Not classified by ICCC|82161437|0-19|All Races|Male and Female|2016|0.2|0.5|0.3
2.8|3.6|3.2|264|V Retinoblastoma|82161437|0-19|All Races|Male and Female|2016|2.8|3.6|3.2
6.5|7.6|7.0|577|VI Renal tumors|82161437|0-19|All Races|Male and Female|2016|6.5|7.6|7.0
5.6|6.7|6.1|504|VI(a) Nephroblastoma and other nonepithelial renal tumors|82161437|0-19|All Races|Male and Female|2016|5.6|6.7|6.1
0.7|1.1|0.8|70|VI(b) Renal carcinomas|82161437|0-19|All Races|Male and Female|2016|0.7|1.1|0.9
~|~|~|~|VI(c) Unspecified malignant renal tumors|82161437|0-19|All Races|Male and Female|2016|~|~|~
2.3|3.0|2.6|215|VII Hepatic tumors|82161437|0-19|All Races|Male and Female|2016|2.3|3.0|2.6
1.8|2.5|2.1|176|VII(a) Hepatoblastoma|82161437|0-19|All Races|Male and Female|2016|1.8|2.5|2.1
0.3|0.6|0.4|37|VII(b) Hepatic carcinomas|82161437|0-19|All Races|Male and Female|2016|0.3|0.6|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82161437|0-19|All Races|Male and Female|2016|~|~|~
9.3|10.6|9.9|817|VIII Malignant bone tumors|82161437|0-19|All Races|Male and Female|2016|9.3|10.6|9.9
4.8|5.8|5.3|435|VIII(a) Osteosarcomas|82161437|0-19|All Races|Male and Female|2016|4.8|5.8|5.3
0.2|0.4|0.3|25|VIII(b) Chondrosarcomas|82161437|0-19|All Races|Male and Female|2016|0.2|0.4|0.3
3.1|4.0|3.5|291|VIII(c) Ewing tumor and related sarcomas of bone|82161437|0-19|All Races|Male and Female|2016|3.1|4.0|3.5
0.5|0.8|0.6|53|VIII(d) Other specified malignant bone tumors|82161437|0-19|All Races|Male and Female|2016|0.5|0.8|0.6
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82161437|0-19|All Races|Male and Female|2016|~|~|~
10.7|12.1|11.4|945|X Germ cell, trophoblastic tumors & neoplasms of gonads|82161437|0-19|All Races|Male and Female|2016|10.8|12.3|11.5
1.7|2.4|2.0|168|X(a) Intracranial & intraspinal germ cell tumors|82161437|0-19|All Races|Male and Female|2016|1.7|2.4|2.0
1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|82161437|0-19|All Races|Male and Female|2016|1.1|1.6|1.3
6.6|7.8|7.2|597|X(c) Malignant gonadal germ cell tumors|82161437|0-19|All Races|Male and Female|2016|6.7|7.9|7.3
0.3|0.6|0.4|37|X(d) Gonadal carcinomas|82161437|0-19|All Races|Male and Female|2016|0.3|0.6|0.5
0.3|0.6|0.4|33|X(e) Other and unspecified malignant gonadal tumors|82161437|0-19|All Races|Male and Female|2016|0.3|0.6|0.4
24.0|26.1|25.0|2083|XI Other malignant epithelial neoplasms and malignant melanomas|82161437|0-19|All Races|Male and Female|2016|24.3|26.5|25.4
~|~|~|~|XI(a) Adrenocortical carcinomas|82161437|0-19|All Races|Male and Female|2016|~|~|~
10.5|12.0|11.3|938|XI(b) Thyroid carcinomas|82161437|0-19|All Races|Male and Female|2016|10.7|12.2|11.4
0.2|0.5|0.3|28|XI(c) Nasopharyngeal carcinomas|82161437|0-19|All Races|Male and Female|2016|0.2|0.5|0.3
3.5|4.3|3.9|323|XI(d) Malignant melanomas|82161437|0-19|All Races|Male and Female|2016|3.5|4.4|3.9
~|~|~|~|XI(e) Skin carcinomas|82161437|0-19|All Races|Male and Female|2016|~|~|~
8.6|9.9|9.2|768|XI(f) Other and unspecified carcinomas|82161437|0-19|All Races|Male and Female|2016|8.7|10.0|9.3
0.9|1.3|1.1|88|XII Other and unspecified malignant neoplasms|82161437|0-19|All Races|Male and Female|2016|0.9|1.3|1.1
0.4|0.8|0.6|47|XII(a) Other specified malignant tumors|82161437|0-19|All Races|Male and Female|2016|0.4|0.8|0.6
0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|82161437|0-19|All Races|Male and Female|2016|0.4|0.7|0.5
186.3|192.2|189.2|15590|All ICCC Groups Combined|82114364|0-19|All Races|Male and Female|2017|186.9|192.9|189.9
45.8|48.8|47.3|3890|I Leukemias, myeloproliferative & myelodysplastic diseases|82114364|0-19|All Races|Male and Female|2017|45.9|48.9|47.4
32.4|35.0|33.7|2768|I(a) Lymphoid leukemias|82114364|0-19|All Races|Male and Female|2017|32.5|35.0|33.7
7.3|8.6|7.9|653|I(b) Acute myeloid leukemias|82114364|0-19|All Races|Male and Female|2017|7.4|8.6|8.0
2.3|3.0|2.6|214|I(c) Chronic myeloproliferative diseases|82114364|0-19|All Races|Male and Female|2017|2.3|3.0|2.6
1.0|1.4|1.2|97|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82114364|0-19|All Races|Male and Female|2017|1.0|1.4|1.2
1.6|2.2|1.9|158|I(e) Unspecified and other specified leukemias|82114364|0-19|All Races|Male and Female|2017|1.6|2.2|1.9
28.9|31.3|30.1|2483|II Lymphomas and reticuloendothelial neoplasms|82114364|0-19|All Races|Male and Female|2017|29.1|31.5|30.2
11.5|13.0|12.2|1016|II(a) Hodgkin lymphomas|82114364|0-19|All Races|Male and Female|2017|11.6|13.2|12.4
8.9|10.3|9.6|791|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82114364|0-19|All Races|Male and Female|2017|9.0|10.3|9.6
2.1|2.8|2.5|203|II(c) Burkitt lymphoma|82114364|0-19|All Races|Male and Female|2017|2.1|2.8|2.5
5.0|6.0|5.4|446|II(d) Miscellaneous lymphoreticular neoplasms|82114364|0-19|All Races|Male and Female|2017|4.9|6.0|5.4
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|82114364|0-19|All Races|Male and Female|2017|0.2|0.5|0.3
32.6|35.2|33.9|2778|III CNS and misc intracranial and intraspinal neoplasms|82114364|0-19|All Races|Male and Female|2017|32.6|35.1|33.8
2.6|3.3|2.9|241|III(a) Ependymomas and choroid plexus tumor|82114364|0-19|All Races|Male and Female|2017|2.6|3.3|2.9
16.7|18.6|17.6|1448|III(b) Astrocytomas|82114364|0-19|All Races|Male and Female|2017|16.7|18.6|17.6
5.2|6.3|5.7|470|III(c) Intracranial and intraspinal embryonal tumors|82114364|0-19|All Races|Male and Female|2017|5.2|6.3|5.7
5.8|7.0|6.4|523|III(d) Other gliomas|82114364|0-19|All Races|Male and Female|2017|5.8|6.9|6.4
0.4|0.7|0.6|46|III(e) Other specified intracranial & intraspinal neoplasms|82114364|0-19|All Races|Male and Female|2017|0.4|0.7|0.6
0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82114364|0-19|All Races|Male and Female|2017|0.5|0.8|0.6
7.9|9.2|8.5|697|IV Neuroblastoma and other peripheral nervous cell tumors|82114364|0-19|All Races|Male and Female|2017|7.9|9.1|8.5
7.7|9.0|8.3|681|IV(a) Neuroblastoma and ganglioneuroblastoma|82114364|0-19|All Races|Male and Female|2017|7.7|8.9|8.3
0.1|0.3|0.2|16|IV(b) Other peripheral nervous cell tumors|82114364|0-19|All Races|Male and Female|2017|0.1|0.3|0.2
11.8|13.3|12.5|1033|IX Soft tissue and other extraosseous sarcomas|82114364|0-19|All Races|Male and Female|2017|11.8|13.4|12.6
4.6|5.6|5.0|415|IX(a) Rhabdomyosarcomas|82114364|0-19|All Races|Male and Female|2017|4.6|5.6|5.1
0.9|1.3|1.1|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82114364|0-19|All Races|Male and Female|2017|0.9|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|82114364|0-19|All Races|Male and Female|2017|~|~|~
4.1|5.0|4.6|376|IX(d) Other specified soft tissue sarcomas|82114364|0-19|All Races|Male and Female|2017|4.1|5.1|4.6
1.5|2.1|1.8|150|IX(e) Unspecified soft tissue sarcomas|82114364|0-19|All Races|Male and Female|2017|1.5|2.1|1.8
0.1|0.3|0.2|16|Not classified by ICCC|82114364|0-19|All Races|Male and Female|2017|0.1|0.3|0.2
2.8|3.5|3.1|256|V Retinoblastoma|82114364|0-19|All Races|Male and Female|2017|2.7|3.5|3.1
6.2|7.4|6.8|557|VI Renal tumors|82114364|0-19|All Races|Male and Female|2017|6.2|7.4|6.8
5.5|6.6|6.1|498|VI(a) Nephroblastoma and other nonepithelial renal tumors|82114364|0-19|All Races|Male and Female|2017|5.5|6.6|6.1
0.5|0.9|0.7|57|VI(b) Renal carcinomas|82114364|0-19|All Races|Male and Female|2017|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82114364|0-19|All Races|Male and Female|2017|~|~|~
2.1|2.8|2.5|203|VII Hepatic tumors|82114364|0-19|All Races|Male and Female|2017|2.1|2.8|2.5
1.5|2.1|1.8|150|VII(a) Hepatoblastoma|82114364|0-19|All Races|Male and Female|2017|1.5|2.1|1.8
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|82114364|0-19|All Races|Male and Female|2017|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82114364|0-19|All Races|Male and Female|2017|~|~|~
8.8|10.2|9.5|781|VIII Malignant bone tumors|82114364|0-19|All Races|Male and Female|2017|8.9|10.2|9.5
5.0|6.0|5.5|451|VIII(a) Osteosarcomas|82114364|0-19|All Races|Male and Female|2017|5.0|6.0|5.5
0.2|0.5|0.3|27|VIII(b) Chondrosarcomas|82114364|0-19|All Races|Male and Female|2017|0.2|0.5|0.3
2.6|3.3|2.9|240|VIII(c) Ewing tumor and related sarcomas of bone|82114364|0-19|All Races|Male and Female|2017|2.6|3.3|2.9
0.4|0.7|0.5|41|VIII(d) Other specified malignant bone tumors|82114364|0-19|All Races|Male and Female|2017|0.4|0.7|0.5
0.2|0.4|0.3|22|VIII(e) Unspecified malignant bone tumors|82114364|0-19|All Races|Male and Female|2017|0.2|0.4|0.3
10.5|12.0|11.2|929|X Germ cell, trophoblastic tumors & neoplasms of gonads|82114364|0-19|All Races|Male and Female|2017|10.6|12.1|11.3
1.8|2.5|2.1|175|X(a) Intracranial & intraspinal germ cell tumors|82114364|0-19|All Races|Male and Female|2017|1.8|2.5|2.1
1.1|1.6|1.3|109|X(b) Malignant extracranial & extragonadal germ cell tumors|82114364|0-19|All Races|Male and Female|2017|1.1|1.6|1.3
6.3|7.4|6.8|567|X(c) Malignant gonadal germ cell tumors|82114364|0-19|All Races|Male and Female|2017|6.3|7.5|6.9
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82114364|0-19|All Races|Male and Female|2017|0.3|0.6|0.4
0.4|0.7|0.6|46|X(e) Other and unspecified malignant gonadal tumors|82114364|0-19|All Races|Male and Female|2017|0.4|0.7|0.6
21.6|23.7|22.6|1880|XI Other malignant epithelial neoplasms and malignant melanomas|82114364|0-19|All Races|Male and Female|2017|21.9|24.0|22.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82114364|0-19|All Races|Male and Female|2017|~|~|~
9.6|10.9|10.2|853|XI(b) Thyroid carcinomas|82114364|0-19|All Races|Male and Female|2017|9.7|11.1|10.4
0.4|0.7|0.5|42|XI(c) Nasopharyngeal carcinomas|82114364|0-19|All Races|Male and Female|2017|0.4|0.7|0.5
2.6|3.4|3.0|249|XI(d) Malignant melanomas|82114364|0-19|All Races|Male and Female|2017|2.7|3.4|3.0
~|~|~|~|XI(e) Skin carcinomas|82114364|0-19|All Races|Male and Female|2017|~|~|~
7.9|9.2|8.6|711|XI(f) Other and unspecified carcinomas|82114364|0-19|All Races|Male and Female|2017|8.0|9.3|8.7
0.8|1.3|1.1|87|XII Other and unspecified malignant neoplasms|82114364|0-19|All Races|Male and Female|2017|0.8|1.3|1.1
0.4|0.8|0.6|47|XII(a) Other specified malignant tumors|82114364|0-19|All Races|Male and Female|2017|0.4|0.8|0.6
0.3|0.7|0.5|40|XII(b) Other unspecified malignant tumors|82114364|0-19|All Races|Male and Female|2017|0.3|0.7|0.5
186.5|192.5|189.5|15436|All ICCC Groups Combined|81200720|0-19|All Races|Male and Female|2018|187.1|193.1|190.1
47.7|50.8|49.2|4001|I Leukemias, myeloproliferative & myelodysplastic diseases|81200720|0-19|All Races|Male and Female|2018|47.8|50.8|49.3
34.7|37.3|36.0|2921|I(a) Lymphoid leukemias|81200720|0-19|All Races|Male and Female|2018|34.7|37.3|36.0
7.2|8.4|7.8|633|I(b) Acute myeloid leukemias|81200720|0-19|All Races|Male and Female|2018|7.2|8.4|7.8
2.0|2.6|2.3|187|I(c) Chronic myeloproliferative diseases|81200720|0-19|All Races|Male and Female|2018|2.0|2.7|2.3
0.9|1.3|1.1|86|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81200720|0-19|All Races|Male and Female|2018|0.8|1.3|1.1
1.8|2.5|2.1|174|I(e) Unspecified and other specified leukemias|81200720|0-19|All Races|Male and Female|2018|1.8|2.5|2.1
28.2|30.5|29.3|2395|II Lymphomas and reticuloendothelial neoplasms|81200720|0-19|All Races|Male and Female|2018|28.3|30.7|29.5
11.7|13.2|12.4|1022|II(a) Hodgkin lymphomas|81200720|0-19|All Races|Male and Female|2018|11.8|13.4|12.6
9.2|10.6|9.9|804|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81200720|0-19|All Races|Male and Female|2018|9.2|10.6|9.9
1.9|2.5|2.2|178|II(c) Burkitt lymphoma|81200720|0-19|All Races|Male and Female|2018|1.9|2.5|2.2
4.1|5.1|4.6|368|II(d) Miscellaneous lymphoreticular neoplasms|81200720|0-19|All Races|Male and Female|2018|4.1|5.0|4.5
0.2|0.4|0.3|23|II(e) Unspecified lymphomas|81200720|0-19|All Races|Male and Female|2018|0.2|0.4|0.3
26.4|28.7|27.6|2237|III CNS and misc intracranial and intraspinal neoplasms|81200720|0-19|All Races|Male and Female|2018|26.4|28.7|27.5
2.0|2.7|2.4|192|III(a) Ependymomas and choroid plexus tumor|81200720|0-19|All Races|Male and Female|2018|2.0|2.7|2.4
14.0|15.7|14.9|1208|III(b) Astrocytomas|81200720|0-19|All Races|Male and Female|2018|14.0|15.7|14.9
3.9|4.8|4.4|352|III(c) Intracranial and intraspinal embryonal tumors|81200720|0-19|All Races|Male and Female|2018|3.9|4.8|4.3
4.3|5.3|4.8|390|III(d) Other gliomas|81200720|0-19|All Races|Male and Female|2018|4.3|5.3|4.8
0.5|0.8|0.6|52|III(e) Other specified intracranial & intraspinal neoplasms|81200720|0-19|All Races|Male and Female|2018|0.5|0.8|0.6
0.4|0.7|0.5|43|III(f) Unspecified intracranial and intraspinal neoplasms|81200720|0-19|All Races|Male and Female|2018|0.4|0.7|0.5
8.2|9.5|8.9|713|IV Neuroblastoma and other peripheral nervous cell tumors|81200720|0-19|All Races|Male and Female|2018|8.1|9.4|8.8
8.0|9.3|8.6|693|IV(a) Neuroblastoma and ganglioneuroblastoma|81200720|0-19|All Races|Male and Female|2018|7.9|9.2|8.5
0.1|0.4|0.2|20|IV(b) Other peripheral nervous cell tumors|81200720|0-19|All Races|Male and Female|2018|0.2|0.4|0.2
11.1|12.6|11.8|960|IX Soft tissue and other extraosseous sarcomas|81200720|0-19|All Races|Male and Female|2018|11.1|12.6|11.8
4.1|5.0|4.5|366|IX(a) Rhabdomyosarcomas|81200720|0-19|All Races|Male and Female|2018|4.1|5.0|4.5
0.9|1.4|1.2|95|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81200720|0-19|All Races|Male and Female|2018|0.9|1.4|1.2
~|~|~|~|IX(c) Kaposi sarcoma|81200720|0-19|All Races|Male and Female|2018|~|~|~
4.3|5.2|4.7|387|IX(d) Other specified soft tissue sarcomas|81200720|0-19|All Races|Male and Female|2018|4.3|5.3|4.8
1.1|1.6|1.3|109|IX(e) Unspecified soft tissue sarcomas|81200720|0-19|All Races|Male and Female|2018|1.1|1.6|1.3
2.9|3.7|3.3|265|Not classified by ICCC|81200720|0-19|All Races|Male and Female|2018|2.9|3.7|3.3
2.6|3.4|3.0|241|V Retinoblastoma|81200720|0-19|All Races|Male and Female|2018|2.6|3.4|3.0
6.4|7.6|7.0|564|VI Renal tumors|81200720|0-19|All Races|Male and Female|2018|6.4|7.5|6.9
5.7|6.8|6.2|500|VI(a) Nephroblastoma and other nonepithelial renal tumors|81200720|0-19|All Races|Male and Female|2018|5.6|6.7|6.2
0.6|0.9|0.7|60|VI(b) Renal carcinomas|81200720|0-19|All Races|Male and Female|2018|0.6|1.0|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|81200720|0-19|All Races|Male and Female|2018|~|~|~
2.3|3.1|2.7|217|VII Hepatic tumors|81200720|0-19|All Races|Male and Female|2018|2.3|3.1|2.7
1.7|2.3|2.0|159|VII(a) Hepatoblastoma|81200720|0-19|All Races|Male and Female|2018|1.7|2.3|2.0
0.5|0.9|0.7|55|VII(b) Hepatic carcinomas|81200720|0-19|All Races|Male and Female|2018|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81200720|0-19|All Races|Male and Female|2018|~|~|~
9.1|10.5|9.8|798|VIII Malignant bone tumors|81200720|0-19|All Races|Male and Female|2018|9.2|10.5|9.8
4.8|5.9|5.3|436|VIII(a) Osteosarcomas|81200720|0-19|All Races|Male and Female|2018|4.9|5.9|5.4
0.3|0.6|0.4|33|VIII(b) Chondrosarcomas|81200720|0-19|All Races|Male and Female|2018|0.3|0.6|0.4
2.9|3.7|3.3|269|VIII(c) Ewing tumor and related sarcomas of bone|81200720|0-19|All Races|Male and Female|2018|2.9|3.7|3.3
0.4|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|81200720|0-19|All Races|Male and Female|2018|0.4|0.7|0.5
0.1|0.4|0.2|20|VIII(e) Unspecified malignant bone tumors|81200720|0-19|All Races|Male and Female|2018|0.2|0.4|0.2
9.8|11.2|10.4|857|X Germ cell, trophoblastic tumors & neoplasms of gonads|81200720|0-19|All Races|Male and Female|2018|9.9|11.3|10.6
1.3|1.9|1.6|127|X(a) Intracranial & intraspinal germ cell tumors|81200720|0-19|All Races|Male and Female|2018|1.3|1.9|1.6
1.1|1.7|1.4|111|X(b) Malignant extracranial & extragonadal germ cell tumors|81200720|0-19|All Races|Male and Female|2018|1.1|1.6|1.4
6.2|7.3|6.7|554|X(c) Malignant gonadal germ cell tumors|81200720|0-19|All Races|Male and Female|2018|6.3|7.4|6.8
0.3|0.6|0.5|39|X(d) Gonadal carcinomas|81200720|0-19|All Races|Male and Female|2018|0.3|0.7|0.5
0.2|0.5|0.3|26|X(e) Other and unspecified malignant gonadal tumors|81200720|0-19|All Races|Male and Female|2018|0.2|0.5|0.3
24.5|26.7|25.6|2110|XI Other malignant epithelial neoplasms and malignant melanomas|81200720|0-19|All Races|Male and Female|2018|24.9|27.1|26.0
0.2|0.5|0.3|28|XI(a) Adrenocortical carcinomas|81200720|0-19|All Races|Male and Female|2018|0.2|0.5|0.3
11.5|13.0|12.2|1010|XI(b) Thyroid carcinomas|81200720|0-19|All Races|Male and Female|2018|11.7|13.2|12.4
0.3|0.6|0.4|35|XI(c) Nasopharyngeal carcinomas|81200720|0-19|All Races|Male and Female|2018|0.3|0.6|0.4
3.0|3.8|3.4|280|XI(d) Malignant melanomas|81200720|0-19|All Races|Male and Female|2018|3.1|3.9|3.4
~|~|~|~|XI(e) Skin carcinomas|81200720|0-19|All Races|Male and Female|2018|~|~|~
8.5|9.8|9.1|750|XI(f) Other and unspecified carcinomas|81200720|0-19|All Races|Male and Female|2018|8.6|9.9|9.2
0.8|1.2|1.0|78|XII Other and unspecified malignant neoplasms|81200720|0-19|All Races|Male and Female|2018|0.8|1.2|1.0
0.3|0.6|0.4|34|XII(a) Other specified malignant tumors|81200720|0-19|All Races|Male and Female|2018|0.3|0.6|0.4
0.4|0.7|0.5|44|XII(b) Other unspecified malignant tumors|81200720|0-19|All Races|Male and Female|2018|0.4|0.7|0.5
179.0|184.9|182.0|14766|All ICCC Groups Combined|80916924|0-19|All Races|Male and Female|2019|179.6|185.5|182.5
44.7|47.7|46.2|3736|I Leukemias, myeloproliferative & myelodysplastic diseases|80916924|0-19|All Races|Male and Female|2019|44.7|47.7|46.2
31.9|34.4|33.1|2677|I(a) Lymphoid leukemias|80916924|0-19|All Races|Male and Female|2019|31.8|34.4|33.1
7.2|8.5|7.8|634|I(b) Acute myeloid leukemias|80916924|0-19|All Races|Male and Female|2019|7.2|8.5|7.8
1.7|2.4|2.0|167|I(c) Chronic myeloproliferative diseases|80916924|0-19|All Races|Male and Female|2019|1.8|2.4|2.1
1.0|1.5|1.2|100|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80916924|0-19|All Races|Male and Female|2019|1.0|1.5|1.2
1.7|2.3|2.0|158|I(e) Unspecified and other specified leukemias|80916924|0-19|All Races|Male and Female|2019|1.7|2.3|2.0
27.4|29.7|28.5|2326|II Lymphomas and reticuloendothelial neoplasms|80916924|0-19|All Races|Male and Female|2019|27.6|29.9|28.7
11.4|13.0|12.2|1001|II(a) Hodgkin lymphomas|80916924|0-19|All Races|Male and Female|2019|11.6|13.2|12.4
8.8|10.2|9.5|773|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80916924|0-19|All Races|Male and Female|2019|8.9|10.3|9.6
1.9|2.5|2.2|175|II(c) Burkitt lymphoma|80916924|0-19|All Races|Male and Female|2019|1.9|2.5|2.2
4.0|5.0|4.5|359|II(d) Miscellaneous lymphoreticular neoplasms|80916924|0-19|All Races|Male and Female|2019|4.0|4.9|4.4
0.1|0.3|0.2|18|II(e) Unspecified lymphomas|80916924|0-19|All Races|Male and Female|2019|0.1|0.4|0.2
23.5|25.7|24.6|1988|III CNS and misc intracranial and intraspinal neoplasms|80916924|0-19|All Races|Male and Female|2019|23.5|25.7|24.6
2.0|2.7|2.3|188|III(a) Ependymomas and choroid plexus tumor|80916924|0-19|All Races|Male and Female|2019|2.0|2.7|2.3
12.4|14.0|13.2|1070|III(b) Astrocytomas|80916924|0-19|All Races|Male and Female|2019|12.4|14.0|13.2
3.3|4.1|3.7|295|III(c) Intracranial and intraspinal embryonal tumors|80916924|0-19|All Races|Male and Female|2019|3.2|4.1|3.6
3.9|4.8|4.3|348|III(d) Other gliomas|80916924|0-19|All Races|Male and Female|2019|3.9|4.8|4.3
0.4|0.7|0.6|45|III(e) Other specified intracranial & intraspinal neoplasms|80916924|0-19|All Races|Male and Female|2019|0.4|0.7|0.6
0.4|0.7|0.5|42|III(f) Unspecified intracranial and intraspinal neoplasms|80916924|0-19|All Races|Male and Female|2019|0.4|0.7|0.5
8.3|9.6|8.9|710|IV Neuroblastoma and other peripheral nervous cell tumors|80916924|0-19|All Races|Male and Female|2019|8.1|9.4|8.8
8.0|9.3|8.6|690|IV(a) Neuroblastoma and ganglioneuroblastoma|80916924|0-19|All Races|Male and Female|2019|7.9|9.2|8.5
0.1|0.4|0.2|20|IV(b) Other peripheral nervous cell tumors|80916924|0-19|All Races|Male and Female|2019|0.2|0.4|0.2
11.7|13.3|12.5|1015|IX Soft tissue and other extraosseous sarcomas|80916924|0-19|All Races|Male and Female|2019|11.8|13.3|12.5
4.0|4.9|4.4|359|IX(a) Rhabdomyosarcomas|80916924|0-19|All Races|Male and Female|2019|4.0|4.9|4.4
1.0|1.5|1.2|101|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80916924|0-19|All Races|Male and Female|2019|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|80916924|0-19|All Races|Male and Female|2019|~|~|~
4.5|5.5|5.0|408|IX(d) Other specified soft tissue sarcomas|80916924|0-19|All Races|Male and Female|2019|4.6|5.6|5.0
1.5|2.1|1.8|143|IX(e) Unspecified soft tissue sarcomas|80916924|0-19|All Races|Male and Female|2019|1.5|2.1|1.8
3.3|4.2|3.7|299|Not classified by ICCC|80916924|0-19|All Races|Male and Female|2019|3.3|4.1|3.7
2.6|3.3|2.9|232|V Retinoblastoma|80916924|0-19|All Races|Male and Female|2019|2.5|3.3|2.9
5.9|7.0|6.4|515|VI Renal tumors|80916924|0-19|All Races|Male and Female|2019|5.8|6.9|6.4
5.1|6.1|5.6|448|VI(a) Nephroblastoma and other nonepithelial renal tumors|80916924|0-19|All Races|Male and Female|2019|5.0|6.1|5.5
0.6|1.0|0.8|64|VI(b) Renal carcinomas|80916924|0-19|All Races|Male and Female|2019|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|80916924|0-19|All Races|Male and Female|2019|~|~|~
2.4|3.1|2.7|219|VII Hepatic tumors|80916924|0-19|All Races|Male and Female|2019|2.4|3.1|2.7
1.7|2.4|2.0|161|VII(a) Hepatoblastoma|80916924|0-19|All Races|Male and Female|2019|1.7|2.3|2.0
0.5|0.9|0.6|53|VII(b) Hepatic carcinomas|80916924|0-19|All Races|Male and Female|2019|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80916924|0-19|All Races|Male and Female|2019|~|~|~
8.4|9.7|9.0|733|VIII Malignant bone tumors|80916924|0-19|All Races|Male and Female|2019|8.4|9.7|9.1
4.6|5.6|5.1|415|VIII(a) Osteosarcomas|80916924|0-19|All Races|Male and Female|2019|4.6|5.6|5.1
0.2|0.5|0.3|26|VIII(b) Chondrosarcomas|80916924|0-19|All Races|Male and Female|2019|0.2|0.5|0.3
2.5|3.2|2.8|229|VIII(c) Ewing tumor and related sarcomas of bone|80916924|0-19|All Races|Male and Female|2019|2.5|3.2|2.8
0.3|0.6|0.5|38|VIII(d) Other specified malignant bone tumors|80916924|0-19|All Races|Male and Female|2019|0.3|0.6|0.5
0.2|0.5|0.3|25|VIII(e) Unspecified malignant bone tumors|80916924|0-19|All Races|Male and Female|2019|0.2|0.5|0.3
10.0|11.4|10.7|875|X Germ cell, trophoblastic tumors & neoplasms of gonads|80916924|0-19|All Races|Male and Female|2019|10.1|11.6|10.8
1.6|2.2|1.9|152|X(a) Intracranial & intraspinal germ cell tumors|80916924|0-19|All Races|Male and Female|2019|1.6|2.2|1.9
1.2|1.7|1.4|116|X(b) Malignant extracranial & extragonadal germ cell tumors|80916924|0-19|All Races|Male and Female|2019|1.2|1.7|1.4
6.0|7.2|6.6|542|X(c) Malignant gonadal germ cell tumors|80916924|0-19|All Races|Male and Female|2019|6.1|7.3|6.7
0.3|0.5|0.4|31|X(d) Gonadal carcinomas|80916924|0-19|All Races|Male and Female|2019|0.3|0.5|0.4
0.3|0.6|0.4|34|X(e) Other and unspecified malignant gonadal tumors|80916924|0-19|All Races|Male and Female|2019|0.3|0.6|0.4
23.9|26.1|25.0|2052|XI Other malignant epithelial neoplasms and malignant melanomas|80916924|0-19|All Races|Male and Female|2019|24.3|26.5|25.4
~|~|~|~|XI(a) Adrenocortical carcinomas|80916924|0-19|All Races|Male and Female|2019|~|~|~
10.8|12.3|11.5|952|XI(b) Thyroid carcinomas|80916924|0-19|All Races|Male and Female|2019|11.0|12.5|11.8
0.3|0.6|0.5|38|XI(c) Nasopharyngeal carcinomas|80916924|0-19|All Races|Male and Female|2019|0.3|0.6|0.5
3.0|3.8|3.4|275|XI(d) Malignant melanomas|80916924|0-19|All Races|Male and Female|2019|3.0|3.8|3.4
~|~|~|~|XI(e) Skin carcinomas|80916924|0-19|All Races|Male and Female|2019|~|~|~
8.7|10.0|9.3|767|XI(f) Other and unspecified carcinomas|80916924|0-19|All Races|Male and Female|2019|8.8|10.2|9.5
0.6|1.0|0.8|66|XII Other and unspecified malignant neoplasms|80916924|0-19|All Races|Male and Female|2019|0.6|1.0|0.8
0.3|0.6|0.4|35|XII(a) Other specified malignant tumors|80916924|0-19|All Races|Male and Female|2019|0.3|0.6|0.4
0.3|0.5|0.4|31|XII(b) Other unspecified malignant tumors|80916924|0-19|All Races|Male and Female|2019|0.3|0.5|0.4
